1 00:00:06,134 --> 00:00:09,037 >> GOOD MORNING, EVERYONE. 2 00:00:09,037 --> 00:00:13,075 WELCOME TO THIS -- THIS IS THE 3 00:00:13,075 --> 00:00:16,445 171st MEETING OF THE NATIONAL 4 00:00:16,445 --> 00:00:18,113 ADVISORY EYE INSTITUTE'S 5 00:00:18,113 --> 00:00:18,547 COUNCIL. 6 00:00:18,547 --> 00:00:22,284 I DON'T HAVE A GAVEL WITH ME I 7 00:00:22,284 --> 00:00:24,586 DIDN'T HAVE A VIRTUAL ONE SO 8 00:00:24,586 --> 00:00:27,789 IMAGINE ONE IN YOUR MINDS. 9 00:00:27,789 --> 00:00:29,458 I'M MICHAEL CHIANG DIRECTOR OF 10 00:00:29,458 --> 00:00:31,827 THE NATIONAL EYE INSTITUTE AND 11 00:00:31,827 --> 00:00:33,028 LOOKING FORWARD TO SPENDING THE 12 00:00:33,028 --> 00:00:34,663 REST OF THE DAY WITH YOU HERE. 13 00:00:34,663 --> 00:00:39,468 WE'VE ALWAYS DONE THIS IN PERSON 14 00:00:39,468 --> 00:00:44,206 RECENTLY BUT WE MADE IT VIRTUAL 15 00:00:44,206 --> 00:00:47,342 BECAUSE OF SO MANY THINGS 16 00:00:47,342 --> 00:00:49,378 EVOLVING AND HAVE A SMALLER 17 00:00:49,378 --> 00:00:51,246 GROUP OF SO MANY PENDING 18 00:00:51,246 --> 00:00:51,680 APPROVAL SLATES. 19 00:00:51,680 --> 00:00:53,815 I'M LOOKING FORWARD TO GIVING 20 00:00:53,815 --> 00:00:54,750 THE UPDATE AND DISCUSSING 21 00:00:54,750 --> 00:00:56,218 EVERYTHING WE'RE GOING TO 22 00:00:56,218 --> 00:00:58,921 DISCUSS AND ALSO GOING TO BE 23 00:00:58,921 --> 00:01:00,422 LOOKING FORWARD TO DOING THIS 24 00:01:00,422 --> 00:01:01,890 BACK IN BETHESDA SOON. 25 00:01:01,890 --> 00:01:05,460 I'D LIKE TO START WITH A ROLL 26 00:01:05,460 --> 00:01:07,429 CALL OF THE PEOPLE MANAGING THE 27 00:01:07,429 --> 00:01:07,663 COUNCIL. 28 00:01:07,663 --> 00:01:18,373 I WANT TO START BY THANK IING 29 00:01:24,413 --> 00:01:25,914 NATHAN BROWN FOR MAKING IT 30 00:01:25,914 --> 00:01:27,783 VIRTUAL IN A SMALL AMOUNT OF 31 00:01:27,783 --> 00:01:32,187 TIME AND THEN ANNA AND OTHERS. 32 00:01:32,187 --> 00:01:34,189 I'M MICHAEL CHIANG, DIRECTOR OF 33 00:01:34,189 --> 00:01:38,961 THE EYE INSTITUTE. 34 00:01:38,961 --> 00:01:43,932 >> I'M DEPUTY DIRECTOR OF THE 35 00:01:43,932 --> 00:01:45,267 NATIONAL EYE INSTITUTE. 36 00:01:45,267 --> 00:01:48,337 >> ANNA HAN ACTING DIRECTOR OF 37 00:01:48,337 --> 00:01:51,506 EXTRAMURAL ACTIVITIES. 38 00:01:51,506 --> 00:01:59,281 >> UNIVERSITY OF ALABAMA 39 00:01:59,281 --> 00:01:59,581 RETINOPATHY. 40 00:01:59,581 --> 00:02:03,952 >> I'M WITH THE OHIO STATE 41 00:02:03,952 --> 00:02:05,887 UNIVERSITY IN REFRACTIVE 42 00:02:05,887 --> 00:02:06,321 DEVELOPMENT. 43 00:02:06,321 --> 00:02:07,589 >> THANK YOU TO EVERYONE. 44 00:02:07,589 --> 00:02:08,890 ANNA, CAN WE TURN TO YOU TO GIVE 45 00:02:08,890 --> 00:02:12,494 SOME AND TO THE REST OF GROUP, 46 00:02:12,494 --> 00:02:13,328 WE'LL INTRODUCE A LITTLE BIT 47 00:02:13,328 --> 00:02:20,836 MORE ABOUT ANNA WHEN I DO MY 48 00:02:20,836 --> 00:02:25,073 REMARKS BUT TO ANNA FOR 49 00:02:25,073 --> 00:02:25,540 INTRODUCTORY REMARKS. 50 00:02:25,540 --> 00:02:31,013 >> THANK YOU FOR BEING HERE I'M 51 00:02:31,013 --> 00:02:33,648 ANNA HAHN THE EXECUTIVE 52 00:02:33,648 --> 00:02:35,784 SECRETARY AND OFFICIAL FOR THE 53 00:02:35,784 --> 00:02:37,652 NATIONAL EYE COUNCIL. 54 00:02:37,652 --> 00:02:39,788 I'M TEMPORARILY STEPPING IN FOR 55 00:02:39,788 --> 00:02:43,358 KATHY ANDERSON WHO RETIRED IN 56 00:02:43,358 --> 00:02:45,694 MAY AFTER A CAREER SPANNING 57 00:02:45,694 --> 00:02:47,796 DECADES OF SERVICE. 58 00:02:47,796 --> 00:02:50,298 HER LEADERSHIP AND COMMITMENT 59 00:02:50,298 --> 00:02:51,933 HAVE LEFT A LARGE GAP VERY HARD 60 00:02:51,933 --> 00:02:54,469 TO FILL AND WE'RE DEEPLY 61 00:02:54,469 --> 00:02:57,806 GRATEFUL FOR HER MANY 62 00:02:57,806 --> 00:03:05,714 CONTRIBUTIONS TO NAEC AND NIE 63 00:03:05,714 --> 00:03:07,716 MEMBERS AND I WANT TO WELCOME 64 00:03:07,716 --> 00:03:08,683 STAFF HERE INCLUDING OUR 65 00:03:08,683 --> 00:03:11,420 COLLEAGUES FROM CENTER FOR 66 00:03:11,420 --> 00:03:13,455 SCIENTIFIC REVIEW OEM AND 67 00:03:13,455 --> 00:03:15,824 MEMBERS OF THE PUBLIC WATCHING 68 00:03:15,824 --> 00:03:18,627 VIRTUALLY SO WELCOME. 69 00:03:18,627 --> 00:03:23,398 AS DR. CHIANG SAYS, I WANT TO 70 00:03:23,398 --> 00:03:27,369 THANK NATHAN BROWN FOR THE 71 00:03:27,369 --> 00:03:28,103 LOGISTICAL DETAILS FOR THE 72 00:03:28,103 --> 00:03:28,370 MEETING. 73 00:03:28,370 --> 00:03:30,772 HE WENT ABOVE AND BEYOND 74 00:03:30,772 --> 00:03:33,942 ESPECIALLY TAKING ON EXTRA 75 00:03:33,942 --> 00:03:34,543 RESPONSIBILITIES LEFT BY OUR 76 00:03:34,543 --> 00:03:39,681 LOST STAFF. 77 00:03:39,681 --> 00:03:43,785 AND EVERYTHING IS THANKS TO 78 00:03:43,785 --> 00:03:45,120 NATHAN BROWN. 79 00:03:45,120 --> 00:03:47,589 BEFORE WE GET STARTED FOR 80 00:03:47,589 --> 00:03:48,890 MEETING ETIQUETTE AND BEST 81 00:03:48,890 --> 00:03:49,157 PRACTICES. 82 00:03:49,157 --> 00:03:51,793 PLEASE IDENTIFY YOURSELF WITH 83 00:03:51,793 --> 00:03:54,896 YOUR FULL NAME EACH TIME YOU 84 00:03:54,896 --> 00:03:57,866 SPEAK AS THERE PEOPLE IN THE 85 00:03:57,866 --> 00:03:58,867 AUDIENCE VISUALLY IMPAIRED. 86 00:03:58,867 --> 00:04:03,238 ON TEAMS PUT YOUR FULL NAME IN 87 00:04:03,238 --> 00:04:04,573 THE WINDOW TO CAPTURE 88 00:04:04,573 --> 00:04:05,874 PARTICIPANTS ACCURATELY FOR 89 00:04:05,874 --> 00:04:07,409 OFFICIAL MEETING MINUTES AND IF 90 00:04:07,409 --> 00:04:09,177 YOU'RE NOT A COUNCIL MEMBER OR 91 00:04:09,177 --> 00:04:11,379 SPEAKING, PLEASE HAVE YOUR VIDEO 92 00:04:11,379 --> 00:04:13,682 OFF SO WE CAN SAVE SOME 93 00:04:13,682 --> 00:04:15,250 BANDWIDTH AND REMEMBER TO MUTE 94 00:04:15,250 --> 00:04:16,051 YOURSELF UNLESS YOUR PRESENTING 95 00:04:16,051 --> 00:04:20,889 OR SPEAKING. 96 00:04:20,889 --> 00:04:23,458 IF YOU HAVE ANY QUESTIONS TURN 97 00:04:23,458 --> 00:04:26,561 ON YOUR VIDEO SO WE CAN SEE YOU 98 00:04:26,561 --> 00:04:27,896 AND USE YOUR RAISE HAND FUNCTION 99 00:04:27,896 --> 00:04:29,798 AND INTRODUCE YOURSELF AND WE'LL 100 00:04:29,798 --> 00:04:33,068 CALL ON YOU WHEN WE SEE YOUR 101 00:04:33,068 --> 00:04:34,870 HAND RAISED DON'T USE THE CHAT 102 00:04:34,870 --> 00:04:36,304 BOX IN TEAMS BECAUSE WE'RE USING 103 00:04:36,304 --> 00:04:37,839 NIH VIDEOCAST AND THEY CANNOT 104 00:04:37,839 --> 00:04:38,440 SEE COMMENTS. 105 00:04:38,440 --> 00:04:40,642 THIS IS A PUBLIC MEETING SO ALL 106 00:04:40,642 --> 00:04:42,544 COMMENTS NEED TO BE FULLY 107 00:04:42,544 --> 00:04:43,378 ACCESSIBLE TO ALL PARTICIPANTS 108 00:04:43,378 --> 00:04:53,822 AND MEMBERS OF THE PUBLIC. 109 00:05:00,028 --> 00:05:02,063 FOR FUTURE COUNCIL DATES ARE 110 00:05:02,063 --> 00:05:03,365 LISTED ON OUR OPEN SESSION 111 00:05:03,365 --> 00:05:06,368 AGENDA AND ON NEI'S WEBSITE. 112 00:05:06,368 --> 00:05:07,903 OUR NEXT MEETING IS SCHEDULED 113 00:05:07,903 --> 00:05:10,238 FOR FRIDAY, OCTOBER 3, 2025. 114 00:05:10,238 --> 00:05:15,777 WE HOPE TO HAVE THAT ONE IN 115 00:05:15,777 --> 00:05:18,146 PERSON. 116 00:05:18,146 --> 00:05:19,981 LET ME STOP AND ASK IF THERE'S 117 00:05:19,981 --> 00:05:29,524 ANY QUESTIONS BEFORE WE GO ON. 118 00:05:29,524 --> 00:05:32,861 WE NO LONGER REQUIRE APPROVAL OF 119 00:05:32,861 --> 00:05:35,797 MEETING MINUTES AT THE MEETING 120 00:05:35,797 --> 00:05:38,934 HOWEVER WE'LL CONTINUE TO MAKE 121 00:05:38,934 --> 00:05:39,935 THEM AVAILABLE IN ELECTRIC 122 00:05:39,935 --> 00:05:41,670 COUNCIL BOOK FOR YOUR REVIEW AND 123 00:05:41,670 --> 00:05:43,438 EDITS AND COMMENTS. 124 00:05:43,438 --> 00:05:51,379 WITH THAT I WILL TURN IT OVER TO 125 00:05:51,379 --> 00:05:54,649 DR. CHIANG FOR HIS DIRECT'S 126 00:05:54,649 --> 00:05:54,883 REPORT. 127 00:05:54,883 --> 00:05:55,951 >> THANK YOU FOR THE 128 00:05:55,951 --> 00:05:56,651 INTRODUCTION AND SAYING 129 00:05:56,651 --> 00:05:59,387 EVERYTHING YOU DID. 130 00:05:59,387 --> 00:06:09,764 I'LL SHARE MY SCREEN. 131 00:06:12,867 --> 00:06:14,736 THIS IS ALWAYS A PRIVILEGE FOR 132 00:06:14,736 --> 00:06:15,704 ME TO BE ABLE TO DO. 133 00:06:15,704 --> 00:06:16,871 WE'RE GOING TO COVER A LOT OF 134 00:06:16,871 --> 00:06:17,973 THINGS AND I'LL GO THROUGH IT AS 135 00:06:17,973 --> 00:06:24,946 WE GET TO THE SLIDES. 136 00:06:24,946 --> 00:06:28,149 SINCE WE MET LAST TIME IN 137 00:06:28,149 --> 00:06:30,085 OCTOBER, 2024 THERE'S BEEN MANY 138 00:06:30,085 --> 00:06:33,888 CHANGES AT NIH AND ONE IS NEW 139 00:06:33,888 --> 00:06:36,591 LEADERSHIP. 140 00:06:36,591 --> 00:06:39,594 MOST OF YOU ALREADY KNOW THIS, 141 00:06:39,594 --> 00:06:42,697 JAY BHATTACHARYA STARTED AS THE 142 00:06:42,697 --> 00:06:47,202 NEW NIH DIRECTOR IN APRIL 2025 143 00:06:47,202 --> 00:06:49,604 AND THE 18th DIRECTOR AND CAME 144 00:06:49,604 --> 00:06:51,206 FROM STANFORD WHERE HE HAD A 145 00:06:51,206 --> 00:06:52,607 LONG CAREER AT THE INTERSECTION 146 00:06:52,607 --> 00:06:56,745 MUCH MEDICINE, SCIENCE, HEALTH 147 00:06:56,745 --> 00:06:57,946 POLICY AND SCIENCE. 148 00:06:57,946 --> 00:07:00,382 HE WAS PROFESSOR OF HEALTH 149 00:07:00,382 --> 00:07:02,717 POLICY AT STANFORD AND A SENIOR 150 00:07:02,717 --> 00:07:03,752 FELLOW IN THE INSTITUTE OF 151 00:07:03,752 --> 00:07:06,321 ECONOMIC POLICY RESEARCH AND 152 00:07:06,321 --> 00:07:09,924 DIRECTED A CENTER ON DEMOGRAPHY 153 00:07:09,924 --> 00:07:13,094 AND ECONOMICS OF HEALTH CARE 154 00:07:13,094 --> 00:07:13,361 ENGAGING. 155 00:07:13,361 --> 00:07:15,797 DR. BHATTACHARYA'S BEEN VERY 156 00:07:15,797 --> 00:07:17,766 CLEAR ABOUT KEY SPECIFIC 157 00:07:17,766 --> 00:07:18,066 PRIORITIES. 158 00:07:18,066 --> 00:07:19,868 ONE IS CHRONIC DISEASE. 159 00:07:19,868 --> 00:07:23,538 ONE IS INNOVATION AND HE'S MADE 160 00:07:23,538 --> 00:07:25,940 A VERY CLEAR POINT ABOUT DOING 161 00:07:25,940 --> 00:07:29,477 INNOVATIVE RESEARCH OPPOSED TO 162 00:07:29,477 --> 00:07:32,914 WHAT ARE INCREMENTAL ADVANCES 163 00:07:32,914 --> 00:07:39,354 AND REPRODUCIBILITY AND 164 00:07:39,354 --> 00:07:40,622 REPLICABLE AND GENERALIZABLE AND 165 00:07:40,622 --> 00:07:41,756 THESE ARE PRIORITIES WE'VE BEEN 166 00:07:41,756 --> 00:07:42,190 THINKING ABOUT. 167 00:07:42,190 --> 00:07:47,062 ONE POINT I WANT TO MAKE IS THAT 168 00:07:47,062 --> 00:07:49,798 I AND MANY PEOPLE AT THE 169 00:07:49,798 --> 00:07:51,399 NATIONAL EYE INSTITUTE WERE 170 00:07:51,399 --> 00:07:53,401 EXCITED TO HEAR ABOUT THE 171 00:07:53,401 --> 00:07:54,502 PRIORITIES BECAUSE THEY'VE BEEN 172 00:07:54,502 --> 00:07:57,972 THINGS WE'VE BEEN EXTREMELY 173 00:07:57,972 --> 00:07:58,873 INTERESTED IN AS WELL. 174 00:07:58,873 --> 00:08:00,942 I'LL BE EXCITED TO TALK ABOUT 175 00:08:00,942 --> 00:08:01,142 THAT. 176 00:08:01,142 --> 00:08:03,178 THE OTHER PERSON IN LEADERSHIP 177 00:08:03,178 --> 00:08:06,448 IS DR. MELOE THE ACTING DIRECTOR 178 00:08:06,448 --> 00:08:09,184 AT NIH FOR SEVERAL MONTHS AND 179 00:08:09,184 --> 00:08:10,018 NOW HAS BECOME THE PRINCIPLE 180 00:08:10,018 --> 00:08:18,293 DEPUTY DIRECTOR. 181 00:08:18,293 --> 00:08:21,029 HE'S BEEN HERE 20 YEARS AND WAS 182 00:08:21,029 --> 00:08:23,798 THE OF THE CLINICAL STUDIES 183 00:08:23,798 --> 00:08:24,866 UNIT. 184 00:08:24,866 --> 00:08:30,905 THE LABORATORY OF INFECTIOUS 185 00:08:30,905 --> 00:08:31,172 DISEASES. 186 00:08:31,172 --> 00:08:33,675 HIS RESEARCH PROGRAM HAS BEEN 187 00:08:33,675 --> 00:08:35,944 DOING CLINICAL IN RESEARCH IN 188 00:08:35,944 --> 00:08:38,113 INFLUENZA AND OTHER RESPIRATORY 189 00:08:38,113 --> 00:08:38,480 DISEASES. 190 00:08:38,480 --> 00:08:40,215 HIS TEAM LOOKED AT 191 00:08:40,215 --> 00:08:42,884 INVESTIGATIONAL VACCINES AND 192 00:08:42,884 --> 00:08:43,952 TREATMENTS. 193 00:08:43,952 --> 00:08:47,822 BEYOND THAT THERE'S A NEW 194 00:08:47,822 --> 00:08:50,325 ADMINISTRATIVE LEADERSHIP WITHIN 195 00:08:50,325 --> 00:08:53,628 NIH THAT IS ERIC SCHUNABLE AND 196 00:08:53,628 --> 00:08:56,765 JAMES McILROY AND OTHERS AND 197 00:08:56,765 --> 00:08:58,032 THEY'RE NEW TO NIH AND THEY'VE 198 00:08:58,032 --> 00:09:02,404 BEEN GOOD TO WORK WITH. 199 00:09:02,404 --> 00:09:04,506 A NEW LEADERSHIP TEAM HERE AT 200 00:09:04,506 --> 00:09:04,873 THE NIH. 201 00:09:04,873 --> 00:09:08,977 WITHIN THE NEI, I WANT TO TALK 202 00:09:08,977 --> 00:09:09,744 WITH YOU ABOUT LEADERSHIP 203 00:09:09,744 --> 00:09:12,313 TRANSITIONS. 204 00:09:12,313 --> 00:09:16,951 NOW, ONE OF THEM IS WITHIN THE 205 00:09:16,951 --> 00:09:19,254 DIVISION OF INTRAMURAL SCIENCE 206 00:09:19,254 --> 00:09:24,559 PROGRAMS WE HAVE A NEW DIRECTOR. 207 00:09:24,559 --> 00:09:27,762 MANY KNOW HER WELL AND SHE 208 00:09:27,762 --> 00:09:29,831 STARTED IN THAT POSITION IN 209 00:09:29,831 --> 00:09:30,765 NOVEMBER 2024. 210 00:09:30,765 --> 00:09:32,667 SHE WAS ACTING BEFORE THAT AND I 211 00:09:32,667 --> 00:09:36,137 WANT TO MAKE SURE YOU KNOW WHAT 212 00:09:36,137 --> 00:09:37,071 DESP DOES, EXTRAMURAL SCIENCE 213 00:09:37,071 --> 00:09:40,942 PROGRAMS IS THEY MANAGE ALL THE 214 00:09:40,942 --> 00:09:42,243 PROGRAMS SO ALL THE PROGRAM 215 00:09:42,243 --> 00:09:46,181 OFFICERS ARE WITHIN THE DESP. 216 00:09:46,181 --> 00:09:53,388 IN CASE YOU DIDN'T KNOW SHE'S A 217 00:09:53,388 --> 00:09:54,389 Ph.D. IN REPRODUCTIVIVE AND 218 00:09:54,389 --> 00:09:56,024 TRAINED IN INDIA AND DID A 219 00:09:56,024 --> 00:09:58,026 POSTDOC AT THE UNIVERSITY OF 220 00:09:58,026 --> 00:10:01,062 PENNSYLVANIA WHERE SHE FOCUSSED 221 00:10:01,062 --> 00:10:11,439 ON MUCOSAL IMMUNOLOGY. 222 00:10:19,347 --> 00:10:21,049 SHE WORKED IN CSR IN THE 223 00:10:21,049 --> 00:10:22,750 DIVISION OF RESET AND REFERRAL 224 00:10:22,750 --> 00:10:26,421 AND WHERE SHE BECAME ONE OF THE 225 00:10:26,421 --> 00:10:27,121 ADMINISTRATIVE LEADERSHIP THERE 226 00:10:27,121 --> 00:10:31,826 AND SHE'S BEEN HERE AT THE NIH 227 00:10:31,826 --> 00:10:38,233 FOR ABOUT 10 YEARS WHERE SHE GOT 228 00:10:38,233 --> 00:10:44,405 TO KNOW THE COMMUNITY AND NEI 229 00:10:44,405 --> 00:10:47,809 VERY WELL AND WAS ACTING DEPUTY 230 00:10:47,809 --> 00:10:53,748 FOR SEVERAL YEARS ACTUALLY. 231 00:10:53,748 --> 00:10:56,651 WE'RE EXCITED TO HAVE HER ON 232 00:10:56,651 --> 00:10:59,954 BOARD AND I WANT TO GIVE A SHOUT 233 00:10:59,954 --> 00:11:05,159 OUT TO KATHY ANDERSON FOR DOING 234 00:11:05,159 --> 00:11:14,836 DOUBLE DUTY. 235 00:11:14,836 --> 00:11:17,972 CARRIE GETZ HAS MOVED TO 236 00:11:17,972 --> 00:11:26,748 INDUSTRY AND WE MISS HER SHE'S 237 00:11:26,748 --> 00:11:31,819 AT TOPGOM. 238 00:11:31,819 --> 00:11:37,158 A 239 00:11:37,158 --> 00:11:38,893 AND WE HAVE OTHERS WHO ED A 240 00:11:38,893 --> 00:11:42,530 REDUCTION IN FORCE NOTICE AND SO 241 00:11:42,530 --> 00:11:51,806 WE'RE MISSING SHEFA'S PRESENCE 242 00:11:51,806 --> 00:11:56,177 AND MARIA ZACHARIAHS RETIRED IN 243 00:11:56,177 --> 00:11:58,980 MAY AS DID KATHY ANDERSON AND 244 00:11:58,980 --> 00:12:02,050 ANNA ALREADY SAID. 245 00:12:02,050 --> 00:12:07,855 WE REALLY MISS MARIA AND KATHY 246 00:12:07,855 --> 00:12:11,826 AND ANNA HAS DONE A GREAT JOB IN 247 00:12:11,826 --> 00:12:15,830 FILLING IN AS THE DIRECTOR OF 248 00:12:15,830 --> 00:12:17,065 EXTRAMURAL ACTIVITIES. 249 00:12:17,065 --> 00:12:22,303 AND REALLY APPRECIATE WHAT ANNA 250 00:12:22,303 --> 00:12:23,371 HAS BEEN DOING. 251 00:12:23,371 --> 00:12:24,572 CLEARLY THERE'S BEEN A LOT OF 252 00:12:24,572 --> 00:12:26,507 CHANGE AND ONE GOAL IS SOME 253 00:12:26,507 --> 00:12:28,776 THINGS LIKE PROGRAM PLANNING AND 254 00:12:28,776 --> 00:12:30,445 COMMUNICATIONS, THE INTENT IS TO 255 00:12:30,445 --> 00:12:34,082 MOVE THOSE CENTRALLY WITHIN 256 00:12:34,082 --> 00:12:37,218 BUILDING ONE AT NIH SO WE'LL 257 00:12:37,218 --> 00:12:38,653 STILL HAVE THOSE SERVICES NOT 258 00:12:38,653 --> 00:12:40,054 NECESSARILY THE SAME AS IN THE 259 00:12:40,054 --> 00:12:40,421 PAST. 260 00:12:40,421 --> 00:12:41,689 IT'S ALL IN EVOLUTION RIGHT NOW 261 00:12:41,689 --> 00:12:43,591 AND I LOOK FORWARD TO UPDATING 262 00:12:43,591 --> 00:12:46,094 YOU AS MORE THINGS HAPPEN BUT 263 00:12:46,094 --> 00:12:47,362 WE'RE EVOLVING. 264 00:12:47,362 --> 00:12:51,833 WE'VE EVOLVED A LOT BUT WE'RE 265 00:12:51,833 --> 00:12:55,670 GETTING THROUGH. 266 00:12:55,670 --> 00:12:58,339 THIS IS A SLIDE ON AWARD AND 267 00:12:58,339 --> 00:12:59,741 RECOGNITION. 268 00:12:59,741 --> 00:13:02,076 WE'VE ALWAYS DONE THIS AND I 269 00:13:02,076 --> 00:13:07,382 LOVE THIS PART OF THE UPDATES. 270 00:13:07,382 --> 00:13:12,420 BRIGHT FOCUS FOUNDATION THEY 271 00:13:12,420 --> 00:13:16,290 GAVE IN AWARD FOR MACULAR 272 00:13:16,290 --> 00:13:24,032 DEGENERATION AND RUCHI SHARMA 273 00:13:24,032 --> 00:13:25,833 RECEIVED IT AND THE 274 00:13:25,833 --> 00:13:28,102 INTERNATIONAL SOCIETY FOR STEM 275 00:13:28,102 --> 00:13:34,342 CELL RESEARCH WENT TO KAPIL 276 00:13:34,342 --> 00:13:34,575 BHARTI. 277 00:13:34,575 --> 00:13:35,243 WITHIN THE EXTRAMURAL COMMUNITY 278 00:13:35,243 --> 00:13:36,544 THERE'S A COUPLE THINGS I WANT 279 00:13:36,544 --> 00:13:39,580 TO LET YOU KNOW ABOUT. 280 00:13:39,580 --> 00:13:43,584 THE 2025 STOCKTON KIMBALL AWARD 281 00:13:43,584 --> 00:13:44,919 THE HIGHEST AWARD AT THE 282 00:13:44,919 --> 00:13:48,456 UNIVERSITY OF BUFF BUFF WAS 283 00:13:48,456 --> 00:13:55,063 GIVEN TO STEVE FIESLER AND 284 00:13:55,063 --> 00:13:56,330 STUDIED MANY THINGS AND ONE 285 00:13:56,330 --> 00:13:59,801 THING HE'S BEST KNOWN FOR IS THE 286 00:13:59,801 --> 00:14:03,705 RELATIONSHIP BETWEEN THE RETINA 287 00:14:03,705 --> 00:14:07,842 AND LIPID INTERMEDIATE PATHWAY 288 00:14:07,842 --> 00:14:10,511 IN GLYCOPROTEIN SYNTHESIS AND 289 00:14:10,511 --> 00:14:12,513 HE'S STUDIED THIS AND LOOKING AT 290 00:14:12,513 --> 00:14:14,415 THE RELATIONSHIP THAT ARE LINKED 291 00:14:14,415 --> 00:14:19,520 TO CHOLESTEROL PROCESSING AND 292 00:14:19,520 --> 00:14:23,691 IT'S GONE TO THE POINT THERE MAY 293 00:14:23,691 --> 00:14:26,728 BE THERAPIES HE'S SHOWN IN 294 00:14:26,728 --> 00:14:27,095 ANIMAL MODELS. 295 00:14:27,095 --> 00:14:33,301 THE COZZARELLI PRIZE BY PNAS 296 00:14:33,301 --> 00:14:35,169 USED TO BE CALLED THE BEST PAPER 297 00:14:35,169 --> 00:14:36,471 OF THE YEAR AWARD. 298 00:14:36,471 --> 00:14:39,807 ONE OF THE THE PRIZES WENT TO 299 00:14:39,807 --> 00:14:42,610 SEVERAL PEOPLE IN OUR COMMUNITY. 300 00:14:42,610 --> 00:14:47,381 FIN YANG, JANIS INOY AND 301 00:14:47,381 --> 00:14:52,620 MICHELLE RUCCI FOR EYE BLINKS IN 302 00:14:52,620 --> 00:14:54,455 THE VISUAL PROCESSING STAGE. 303 00:14:54,455 --> 00:14:57,525 THE PREMISE OF THE PAPER IS IT'S 304 00:14:57,525 --> 00:15:02,130 BEEN ASSUMED BLINKING SERVES TO 305 00:15:02,130 --> 00:15:03,831 LUBRICATE THE EYES AND THE 306 00:15:03,831 --> 00:15:07,368 ASSUMPTION IS IT DECREASES YOUR 307 00:15:07,368 --> 00:15:09,203 VISION OR INTERRUPTS VISUAL 308 00:15:09,203 --> 00:15:10,071 PROCESSING BUT THE GROUP USED 309 00:15:10,071 --> 00:15:14,809 EYE TRACKING STUDY AND ALSO 310 00:15:14,809 --> 00:15:16,144 VISUAL INPUT MODELLING TO LOOK 311 00:15:16,144 --> 00:15:18,880 AT THE EFFECTS OF BLINKING ON 312 00:15:18,880 --> 00:15:20,148 VISUAL PERCEPTION. 313 00:15:20,148 --> 00:15:22,016 AND THEY ACTUALLY FOUND THE 314 00:15:22,016 --> 00:15:25,353 PROCESS OF LINKING IMPROVES THE 315 00:15:25,353 --> 00:15:27,688 CONTRAST OF A VISUAL STIMULUS, 316 00:15:27,688 --> 00:15:29,090 FROM WHAT WE'D ALWAYS THOUGHT. 317 00:15:29,090 --> 00:15:33,194 SO CONGRATULATIONS TO THAT 318 00:15:33,194 --> 00:15:34,095 GROUP. 319 00:15:34,095 --> 00:15:37,765 AND LASTLY ON THIS SLIDE, TWO 320 00:15:37,765 --> 00:15:39,133 NEWLY ELECTED MEMBERS OF THE 321 00:15:39,133 --> 00:15:40,201 NATIONAL ACADEMY OF SCIENCES 322 00:15:40,201 --> 00:15:41,736 WITHIN OUR COMMUNITY AND THESE 323 00:15:41,736 --> 00:15:44,939 ARE GOING TO BE WELL KNOWN TO 324 00:15:44,939 --> 00:15:52,013 SOME OF YOU. 325 00:15:52,013 --> 00:15:59,687 HEIDI HAMM AND GREG LEMKE. 326 00:15:59,687 --> 00:16:04,292 SO CONGRATULATIONS. 327 00:16:04,292 --> 00:16:07,395 NOW, WITH THIS I RECENTLY WE'VE 328 00:16:07,395 --> 00:16:09,263 GOTTEN TO KNOW THE NEW NIH 329 00:16:09,263 --> 00:16:10,832 LEADERSHIP, ONE OF THE THINGS WE 330 00:16:10,832 --> 00:16:14,402 MENTIONED TO THEM IS WE ALWAYS 331 00:16:14,402 --> 00:16:21,042 FOCUS ON MISSION. 332 00:16:21,042 --> 00:16:25,646 WE ALWAYS TALK ABOUT THIS SLIDE 333 00:16:25,646 --> 00:16:27,815 I HOPE YOU KNOW OUR MISSION IS 334 00:16:27,815 --> 00:16:31,152 TO ELIMINATE VISION LOSS AND 335 00:16:31,152 --> 00:16:32,386 IMPROVE QUALITY OF LIFE THROUGH 336 00:16:32,386 --> 00:16:33,254 VISION RESEARCH. 337 00:16:33,254 --> 00:16:35,957 WE DRIVE INNOVATIVE RESEARCH AND 338 00:16:35,957 --> 00:16:37,959 FOSTERING COLLABORATION AND 339 00:16:37,959 --> 00:16:39,760 RECRUITING, INSPIRING AND 340 00:16:39,760 --> 00:16:44,065 TRAINING TO STRENGTHEN THE 341 00:16:44,065 --> 00:16:45,132 VISION WORKFORCE AND EDUCATING 342 00:16:45,132 --> 00:16:46,100 PEOPLE ON WHAT WE DO AND WHY 343 00:16:46,100 --> 00:16:56,377 IT'S IMPORTANT. 344 00:17:28,476 --> 00:17:30,544 WHAT WE TALK ABOUT IS NOT GOING 345 00:17:30,544 --> 00:17:33,981 TO BE EVERYTHING THAT WE DO IN 346 00:17:33,981 --> 00:17:36,817 TERMS OF INNOVATIVE 347 00:17:36,817 --> 00:17:37,852 METHODOLOGICAL WORK OF CHRONIC 348 00:17:37,852 --> 00:17:40,655 DISEASE AND REPRODUCIBILITY AND 349 00:17:40,655 --> 00:17:42,456 GET THE SENSE THE EYE COMMUNITY 350 00:17:42,456 --> 00:17:45,493 IS BEHIND THIS IN DOING EXCITING 351 00:17:45,493 --> 00:17:45,760 WORK. 352 00:17:45,760 --> 00:17:47,028 SO, INNOVATION. 353 00:17:47,028 --> 00:17:50,298 WE HAVE REALLY TRIED TO PUSH 354 00:17:50,298 --> 00:17:53,968 THIS CONCEPT THAT THE EYE IS AN 355 00:17:53,968 --> 00:17:58,372 AMAZING SITE FOR DOING WORK THAT 356 00:17:58,372 --> 00:18:02,510 IS METHODOLOGICAL AND INNOVATIVE 357 00:18:02,510 --> 00:18:05,880 TO OTHER FIELDS. 358 00:18:05,880 --> 00:18:13,554 ONE IS OPHTHALMIC IMAGING, IT 359 00:18:13,554 --> 00:18:14,488 GIVES HISTOLOGICAL GRADE VIEWS 360 00:18:14,488 --> 00:18:17,458 OF THE RETINA. 361 00:18:17,458 --> 00:18:20,561 YOU CAN SEE ALL THESE THINGS, 362 00:18:20,561 --> 00:18:23,097 BLOOD VESSELS, NERVES, COUPLING, 363 00:18:23,097 --> 00:18:27,034 BLOOD FLOW, STRUCTURE AND 364 00:18:27,034 --> 00:18:29,003 FUNCTION WITHIN SECONDS NON 365 00:18:29,003 --> 00:18:29,437 INVASIVELY. 366 00:18:29,437 --> 00:18:32,573 THAT'S COMPLETELY REVOLUTIONIZED 367 00:18:32,573 --> 00:18:35,810 THE PRACTICE OF OPHTHALMOLOGY 368 00:18:35,810 --> 00:18:36,944 AND OPTOMETRY AND REVOLUTIONIZED 369 00:18:36,944 --> 00:18:37,945 THE WAY WE DO RESEARCH. 370 00:18:37,945 --> 00:18:39,914 YOU KNOW WE HAVE FOLKS IN OUR 371 00:18:39,914 --> 00:18:43,617 COMMUNITY RECEIVING THE LASKAR 372 00:18:43,617 --> 00:18:47,688 AWARD IN 2023 FOR THAT. 373 00:18:47,688 --> 00:18:52,126 DAVID WONG AND OTHERS PICTURED 374 00:18:52,126 --> 00:19:02,269 HERE. 375 00:19:02,269 --> 00:19:04,905 AND THERE'LL OPTICS AND OTHERS 376 00:19:04,905 --> 00:19:07,808 AND EXCITED ABOUT THIS AND HOW 377 00:19:07,808 --> 00:19:08,709 IT'S REVOLUTIONIZED WHAT WE DO 378 00:19:08,709 --> 00:19:11,946 AND WHAT OTHER GROUPS HAVE DONE. 379 00:19:11,946 --> 00:19:14,482 ARTIFICIAL INTELLIGENCE. 380 00:19:14,482 --> 00:19:19,053 THE FIRST FDA APPROVED 381 00:19:19,053 --> 00:19:19,820 AUTONOMOUS ALGORITHM OF ANY 382 00:19:19,820 --> 00:19:27,428 FIELD IN MEDICINE WAS FOR 383 00:19:27,428 --> 00:19:28,362 DIABETIC RETINOPATHY SCREENING 384 00:19:28,362 --> 00:19:30,398 AND SOME OF THESE FINDINGS HAVE 385 00:19:30,398 --> 00:19:32,099 FORMED THE BASIS FOR A LOT OF 386 00:19:32,099 --> 00:19:34,735 THE A.I. REVOLUTION WE SEE NOW. 387 00:19:34,735 --> 00:19:36,637 METHODOLOGICAL WORK, PRIVACY, 388 00:19:36,637 --> 00:19:39,807 SECURITY AND THERE ARE MANY 389 00:19:39,807 --> 00:19:50,351 THINGS IN THE FRONTIER NOW OKAY 390 00:19:53,954 --> 00:19:56,557 OCCULOMICS AND REGENERATIVE 391 00:19:56,557 --> 00:19:56,857 MEDICINE. 392 00:19:56,857 --> 00:20:00,928 THE FIRST FDA APPROVED GENE 393 00:20:00,928 --> 00:20:04,365 THERAPY IN ANY FIELD OF MEDICINE 394 00:20:04,365 --> 00:20:10,137 WAS FOR THE GENE CLOEPD HERE 395 00:20:10,137 --> 00:20:12,973 WITHIN THE INTRAMURAL RESEARCH 396 00:20:12,973 --> 00:20:15,042 PROGRAM WITHIN MIKE'S LAB. 397 00:20:15,042 --> 00:20:24,351 THAT'S SOMETHING WE'RE PROUD OF. 398 00:20:24,351 --> 00:20:27,354 SINCE THE APPROVAL OF ONE 399 00:20:27,354 --> 00:20:30,357 THERAPY THERE'S BEEN SIX MORE 400 00:20:30,357 --> 00:20:32,927 AND A REAL REVOLUTION. 401 00:20:32,927 --> 00:20:36,497 WE'VE BECOME WIDE WITHIN THE NIH 402 00:20:36,497 --> 00:20:39,834 WIDE AMP BESPOKE GENE THERAPY 403 00:20:39,834 --> 00:20:41,168 PROJECT AN $81 MILLION PROJECT 404 00:20:41,168 --> 00:20:44,405 STILL ONGOING LED BY OUR 405 00:20:44,405 --> 00:20:45,940 COLLEAGUES AT NCATS. 406 00:20:45,940 --> 00:20:47,374 OF THE EIGHT CLINICAL TRIALS 407 00:20:47,374 --> 00:20:49,176 FUNDED THROUGH THIS, ONE THING I 408 00:20:49,176 --> 00:20:50,544 WAS REALLY PROUD OF IS THAT 409 00:20:50,544 --> 00:20:53,314 THREE OF THEM WERE FOR EYE 410 00:20:53,314 --> 00:20:53,581 DISEASES. 411 00:20:53,581 --> 00:20:55,416 IT JUST GIVES THE SENSE OF THE 412 00:20:55,416 --> 00:20:58,486 FOOTPRINT WE GOT IN THIS AREA. 413 00:20:58,486 --> 00:21:01,822 AND THE NIH WIDE REGENERATIVE 414 00:21:01,822 --> 00:21:02,890 MEDICINE INNOVATION PROJECT THAT 415 00:21:02,890 --> 00:21:11,799 WENT IN TO UNTIL ABOUT 2021, 416 00:21:11,799 --> 00:21:15,402 FROM 2020 THROUGH THE 21st 417 00:21:15,402 --> 00:21:18,172 CENTURIES CURED ACT AND OF THEM 418 00:21:18,172 --> 00:21:19,874 FIVE WERE FOR EYE DECISE OF 419 00:21:19,874 --> 00:21:20,174 DISEASES. 420 00:21:20,174 --> 00:21:22,209 THERE'S SO MUCH NOW AND CELL 421 00:21:22,209 --> 00:21:24,378 BASED THERAPIES. 422 00:21:24,378 --> 00:21:26,981 NIH HAS BEEN VERY INTERESTED IN 423 00:21:26,981 --> 00:21:28,582 HUMAN MODELS MOVING TOWARD 424 00:21:28,582 --> 00:21:32,419 THINGS LIKE A.I., DIGITAL TWINS, 425 00:21:32,419 --> 00:21:34,288 ORGANOIDS, ORGAN CHIPS. 426 00:21:34,288 --> 00:21:35,823 A LOT OF GREAT WORK WITHIN OUR 427 00:21:35,823 --> 00:21:40,294 COMMUNITY ABOUT THAT. 428 00:21:40,294 --> 00:21:41,929 I'M EXCITED TO SEE MORE AND MORE 429 00:21:41,929 --> 00:21:43,164 OF THAT. 430 00:21:43,164 --> 00:21:45,900 WHAT I WILL DO IS GO THROUGH 431 00:21:45,900 --> 00:21:49,270 SPECIFIC EXAMPLES OF PROJECTS 432 00:21:49,270 --> 00:21:57,178 THAT EXCITED ME AND OUR TEAM AND 433 00:21:57,178 --> 00:21:58,846 SOME ARE EXTRAMURAL AND SOME 434 00:21:58,846 --> 00:22:01,315 INTRAMURAL PROJECTS-ONE INVOLVES 435 00:22:01,315 --> 00:22:02,550 METHODOLOGICAL INNOVATIONS IN 436 00:22:02,550 --> 00:22:04,084 GENE EDITING AND PRECISION 437 00:22:04,084 --> 00:22:06,787 MEDICINE. 438 00:22:06,787 --> 00:22:09,390 SO THIS PARTICULAR SET OF WORK 439 00:22:09,390 --> 00:22:11,125 WAS DONE IN COLLABORATION 440 00:22:11,125 --> 00:22:14,828 BETWEEN U.C. IRVINE AND A 441 00:22:14,828 --> 00:22:23,537 TRAINEE THERE AND OTHERS AT THE 442 00:22:23,537 --> 00:22:27,808 BROAD INSTITUTE IN BOSTON AND 443 00:22:27,808 --> 00:22:33,581 PRIME EDITING WAS FROM DAVID LU 444 00:22:33,581 --> 00:22:35,816 AT HARVARD NOT LONG AGO WITHIN 445 00:22:35,816 --> 00:22:38,919 THE PAST FIVE YEARS. 446 00:22:38,919 --> 00:22:42,256 AND IT MAKES LONGER, MORE 447 00:22:42,256 --> 00:22:43,824 DIVERSE TYPES OF DNA CHANGES AND 448 00:22:43,824 --> 00:22:48,028 THERE'S POTENTIAL TREATMENTS FOR 449 00:22:48,028 --> 00:22:49,964 DISEASES. 450 00:22:49,964 --> 00:22:52,800 BY TARGETING THESE MUTATIONS BUT 451 00:22:52,800 --> 00:22:55,202 THE CHALLENGE IS DELIVERING 452 00:22:55,202 --> 00:22:57,338 THESE GENE EDITING MACHINERY HAS 453 00:22:57,338 --> 00:22:59,073 BEEN CHALLENGING. 454 00:22:59,073 --> 00:23:02,243 A VIRUS LIKE PARTICLE HERE ARE 455 00:23:02,243 --> 00:23:04,144 ONE MECHANISM FOR DELIVERING 456 00:23:04,144 --> 00:23:04,445 THAT. 457 00:23:04,445 --> 00:23:06,480 BUT THE OUTCOMES IN ANIMAL 458 00:23:06,480 --> 00:23:08,115 MODELS HAS BEEN MOD EVIDENT AND 459 00:23:08,115 --> 00:23:10,751 THE CHALLENGE IS THAT YOU REALLY 460 00:23:10,751 --> 00:23:12,953 NEED TO SPECIFICALLY ENGINEER 461 00:23:12,953 --> 00:23:15,823 FOR EACH DIFFERENT TYPE OF 462 00:23:15,823 --> 00:23:20,561 CAKINGO -- CARGO TO MAKE IT MOST 463 00:23:20,561 --> 00:23:20,928 EFFICIENT. 464 00:23:20,928 --> 00:23:23,297 THEY'VE RE-ENGINEERED THE VIRUS 465 00:23:23,297 --> 00:23:25,599 LIKE PARTICLES TO GREATLY 466 00:23:25,599 --> 00:23:26,867 IMPROVE GENE EFFICIENCY AND 467 00:23:26,867 --> 00:23:29,737 VERSATILITY AND TESTED THIS IN 468 00:23:29,737 --> 00:23:33,340 ANIMAL MODELS AND INHERITED 469 00:23:33,340 --> 00:23:36,343 REGENERATIONS SUCH AS PIGMENTOSA 470 00:23:36,343 --> 00:23:38,846 AND IT'S THE FIRST TIME THE 471 00:23:38,846 --> 00:23:41,515 DELIVERY OF THE PROTEIN 472 00:23:41,515 --> 00:23:43,150 COMPLEXES HAS ACHIEVED 473 00:23:43,150 --> 00:23:45,252 THERAPEUTIC EDITING IN ANIMAL 474 00:23:45,252 --> 00:23:46,220 MODELS. 475 00:23:46,220 --> 00:23:56,597 THAT'S BEEN EXCITING. 476 00:24:02,069 --> 00:24:06,106 AND DEMONSTRATED PRODUCTION IN 477 00:24:06,106 --> 00:24:11,478 THIS MOUSE MODEL OF AUTOSOMAL 478 00:24:11,478 --> 00:24:15,082 RECESSIVE FORMS OF PIGMENTOSA 479 00:24:15,082 --> 00:24:16,917 AND EXCITE ABOUT THE EYE AS THE 480 00:24:16,917 --> 00:24:19,820 TARGET FOR GENE EDITING AND 481 00:24:19,820 --> 00:24:27,094 PRECISION MEDICINE. 482 00:24:27,094 --> 00:24:37,604 MACKTELL AND EMILY WORKED IN 483 00:24:45,879 --> 00:24:51,685 THIS AREA WITH COLLEAGUES AND 484 00:24:51,685 --> 00:24:54,221 THEY HAVE RECEIVED AFDA APPROVAL 485 00:24:54,221 --> 00:24:57,658 FOR NOVEL SURGICALLY-IMPLANTED 486 00:24:57,658 --> 00:25:03,597 DEVICE ENCELTO AND SCRIPPS IN 487 00:25:03,597 --> 00:25:05,265 SAN DIEGO SHOWED THE ROOT CAUSE 488 00:25:05,265 --> 00:25:06,867 WAS NEURAL DE GENE RATION AND 489 00:25:06,867 --> 00:25:11,071 DEATH OF PHOTO RECEPTORS AND IS 490 00:25:11,071 --> 00:25:13,640 THE SUPPORTING GLIAL CELLS AND 491 00:25:13,640 --> 00:25:15,909 THEY WORKED TOGETHER FOR 492 00:25:15,909 --> 00:25:19,813 DECADES, THE SCRIPPS RESEARCH 493 00:25:19,813 --> 00:25:25,552 AND INSTITUTE AND A LARGE 494 00:25:25,552 --> 00:25:33,193 CONSORTIUM OF PHARMACEUTICALS 495 00:25:33,193 --> 00:25:34,628 AND DEVELOPED A MODEL OF 496 00:25:34,628 --> 00:25:36,296 DELIVERING THIS DIRECTLY TO THE 497 00:25:36,296 --> 00:25:37,965 RETINA AND CONDUCTED A 498 00:25:37,965 --> 00:25:39,233 RANDOMIZED CONTROLLED TRIAL. 499 00:25:39,233 --> 00:25:42,536 IT LED TO THE FIRST TIME A 500 00:25:42,536 --> 00:25:46,206 CELL-BASED THERAPY HAS DELIVERED 501 00:25:46,206 --> 00:25:49,877 A NEUROPROTECTANT TO TREAT A 502 00:25:49,877 --> 00:25:50,544 NEUROGENERATIVE DISEASE. 503 00:25:50,544 --> 00:25:52,913 AND SO WE'RE EXCITED ABOUT WHERE 504 00:25:52,913 --> 00:25:56,116 THIS LEADS SO CONGRATULATIONS TO 505 00:25:56,116 --> 00:25:59,820 EMILY AS WELL AS MARTE AND THE 506 00:25:59,820 --> 00:26:00,387 MEDICAL RESEARCH INSTITUTE 507 00:26:00,387 --> 00:26:06,693 GROUP. 508 00:26:06,693 --> 00:26:10,097 THIS WAS A NEED PROJECT THAT GOT 509 00:26:10,097 --> 00:26:11,432 A LOT OF PRESS. 510 00:26:11,432 --> 00:26:15,702 SO A GROUP AT BERKELEY, JAMES 511 00:26:15,702 --> 00:26:20,140 FONG AND HANNAH AND CONGLI AND 512 00:26:20,140 --> 00:26:24,044 AUSTIN AND REN, THE ISSUE HERE 513 00:26:24,044 --> 00:26:33,253 IS THAT THE CONES IN THE EYE 514 00:26:33,253 --> 00:26:35,489 THERE'S THE S CONES AND M CONES 515 00:26:35,489 --> 00:26:38,559 AND L CONES ARE SENSITIVE TO 516 00:26:38,559 --> 00:26:40,260 DIFFERENT LIGHT AND M CONES ARE 517 00:26:40,260 --> 00:26:45,199 MEDIUM AND THE L CONES ARE THE 518 00:26:45,199 --> 00:26:47,267 LONG REDDISH WAVE LENGTHS BUT 519 00:26:47,267 --> 00:26:53,640 THE PROBLEM -- THE ISSUE IS THAT 520 00:26:53,640 --> 00:26:54,074 T 521 00:26:54,074 --> 00:26:57,110 THE M SPECTRUM AND L OVERLAP 522 00:26:57,110 --> 00:26:57,444 SIGNIFICANTLY. 523 00:26:57,444 --> 00:26:59,813 SO THAT MEANS A LOT OF THE LIGHT 524 00:26:59,813 --> 00:27:02,749 THAT ACTIVATES THE MEDIUM WAVE 525 00:27:02,749 --> 00:27:05,219 LENGTH CONES ALSO ACTIVATE THE 526 00:27:05,219 --> 00:27:08,956 LONG WAVE LENGTH CONES AND MY 527 00:27:08,956 --> 00:27:10,991 UNDERSTANDING IS THAT THERE'S NO 528 00:27:10,991 --> 00:27:12,993 WAVE LENGTH OF LIGHT THAT ONLY 529 00:27:12,993 --> 00:27:14,828 STIMULATE THE M CONES. 530 00:27:14,828 --> 00:27:18,031 SO WHAT THIS GROUP BECAME 531 00:27:18,031 --> 00:27:20,400 INTERESTED IN IS CAN THEY 532 00:27:20,400 --> 00:27:27,674 DEVELOP A LASER SYSTEM TO 533 00:27:27,674 --> 00:27:31,812 PROGRAMMABLY CONTROL AND 534 00:27:31,812 --> 00:27:34,248 STIMULATE PHOTO RECEPTORS AT A 535 00:27:34,248 --> 00:27:36,183 POPULATION SCALE. 536 00:27:36,183 --> 00:27:37,751 BY DOING THIS WHERE THEY IN THE 537 00:27:37,751 --> 00:27:40,153 GROUP IT WAS THIS GROUP AND THEY 538 00:27:40,153 --> 00:27:41,788 ALSO HAD A COLLABORATION WITH A 539 00:27:41,788 --> 00:27:44,791 GROUP AT THE UNIVERSITY OF 540 00:27:44,791 --> 00:27:46,360 WASHINGTON TO MAP OUT THE 541 00:27:46,360 --> 00:27:46,660 RETINA. 542 00:27:46,660 --> 00:27:49,496 BUT TO DO THIS BY STIMULATING 543 00:27:49,496 --> 00:27:52,266 DIFFERENT CONES IN THE RETINA 544 00:27:52,266 --> 00:27:54,735 USING THIS PROTOTYPE LASER 545 00:27:54,735 --> 00:27:58,238 SYSTEM, THEY COULD BASICALLY 546 00:27:58,238 --> 00:28:02,309 SHOW PEOPLE -- NOVEL COLORS 547 00:28:02,309 --> 00:28:03,443 THROUGH THE CONE STIMULATION AND 548 00:28:03,443 --> 00:28:06,747 THE WAY THIS WAS PRESENTED TO 549 00:28:06,747 --> 00:28:10,817 THE PRESS RELEASE -- SORRY -- 550 00:28:10,817 --> 00:28:13,520 THIS IS SO SENSITIVE. 551 00:28:13,520 --> 00:28:15,289 FIVE PEOPLE WERE ABLE TO SEE A 552 00:28:15,289 --> 00:28:16,490 NEW COLOR NO HUMAN HAD EVER SEEN 553 00:28:16,490 --> 00:28:19,960 BEFORE. 554 00:28:19,960 --> 00:28:24,731 AND IS THE PREMISE IS THEY 555 00:28:24,731 --> 00:28:27,367 REBUILT THE COLOR SYSTEM FROM 556 00:28:27,367 --> 00:28:28,268 THE GROUND UP USING THIS LASER 557 00:28:28,268 --> 00:28:29,169 COMPUTER SYSTEM. 558 00:28:29,169 --> 00:28:34,007 ONE OF THE IMPLICATIONS -- THIS 559 00:28:34,007 --> 00:28:36,276 MAY GIVE US NEW METHODS FOR 560 00:28:36,276 --> 00:28:37,778 STUDYING VISUAL PERCEPTION TO 561 00:28:37,778 --> 00:28:41,949 UNDERSTAND VISUAL CHANGES FROM 562 00:28:41,949 --> 00:28:44,451 RETINAL DEGENERATIONS INVOLVING 563 00:28:44,451 --> 00:28:46,153 PHOTO RECEPTORS IN THE EYE AND 564 00:28:46,153 --> 00:28:48,255 HELPING WITH COLOR-BLINDNESS AND 565 00:28:48,255 --> 00:28:50,791 STUDY HOW THE BRAIN MAKE SENSE 566 00:28:50,791 --> 00:28:51,792 OF VISION PROCESSING. 567 00:28:51,792 --> 00:29:02,302 SO REALLY FASCINATING PROJECT. 568 00:29:02,970 --> 00:29:05,872 THE MICRONS PROJECT WAS FUNDED 569 00:29:05,872 --> 00:29:08,342 BY ADVANCED RESEARCH PROJECTS 570 00:29:08,342 --> 00:29:08,775 ACTIVITY. 571 00:29:08,775 --> 00:29:12,579 AND THIS BASICALLY -- THIS WAS 572 00:29:12,579 --> 00:29:18,018 AN ENORMOUS CONSORTIUM AND WE 573 00:29:18,018 --> 00:29:19,386 WERE EXCITED ABOUT THIS AND 574 00:29:19,386 --> 00:29:20,654 PARTICULARLY EXCITE WHAT'D THEY 575 00:29:20,654 --> 00:29:24,191 STUDIED WAS THE VISUAL 576 00:29:24,191 --> 00:29:25,492 PROCESSING SYSTEM IN THE MOUSE. 577 00:29:25,492 --> 00:29:27,227 WHAT THIS PROJECT GIVES US IS 578 00:29:27,227 --> 00:29:31,798 BASICALLY AN UNPRECEDENTED DATA 579 00:29:31,798 --> 00:29:35,435 SET OF HIGH RESOLUTION 580 00:29:35,435 --> 00:29:36,470 ANATOMICAL RESOLUTION OF CELLS 581 00:29:36,470 --> 00:29:37,471 IN THE MOUSE VISUAL CORTEX 582 00:29:37,471 --> 00:29:39,339 MAPPED ON TO THEIR RESPONSES. 583 00:29:39,339 --> 00:29:42,442 SO IT'S BASICALLY 200,000 CELLS 584 00:29:42,442 --> 00:29:46,079 AND 520 MILLION CONNECTIONS. 585 00:29:46,079 --> 00:29:48,048 WHAT THIS REALLY DOES IS HELPS 586 00:29:48,048 --> 00:29:51,818 GIVE A FOUNDATION FOR 587 00:29:51,818 --> 00:29:55,088 UNDERSTANDING ON A COMPUTATIONAL 588 00:29:55,088 --> 00:29:56,657 BASIS OF CIRCUITRY IN THE VISUAL 589 00:29:56,657 --> 00:29:59,426 INFORMATION SYSTEM AND THEREFORE 590 00:29:59,426 --> 00:30:00,927 IN THE NEURAL INFORMATION 591 00:30:00,927 --> 00:30:03,530 PROCESSING SYSTEM. 592 00:30:03,530 --> 00:30:06,133 THIS WAS COVERED BY REALLY BIG 593 00:30:06,133 --> 00:30:10,237 AND INTERESTING NEW YORK TIMES 594 00:30:10,237 --> 00:30:12,072 ARTICLE IF YOU'RE INTERESTED. 595 00:30:12,072 --> 00:30:13,640 WHAT WE BASICALLY TAKE FROM THIS 596 00:30:13,640 --> 00:30:17,477 IS OF COURSE THAT BY 597 00:30:17,477 --> 00:30:19,813 UNDERSTANDING NORMAL BRAIN 598 00:30:19,813 --> 00:30:20,947 CONNECTIVITY AND FUNCTION IT 599 00:30:20,947 --> 00:30:25,686 WILL LET US MAKE COMPARISONS TO 600 00:30:25,686 --> 00:30:26,586 UNDERSTAND DISRUPTIONS IN 601 00:30:26,586 --> 00:30:27,821 CHRONIC DISEASE AND OTHER 602 00:30:27,821 --> 00:30:28,588 NEUROLOGICAL CONDITIONS AND ONE 603 00:30:28,588 --> 00:30:31,692 DAY HELP IT GUIDE US TOWARDS 604 00:30:31,692 --> 00:30:34,695 DEVELOPING NEW THERAPEUTICS AND 605 00:30:34,695 --> 00:30:35,562 DIAGNOSTICS THAT TARGET SPECIFIC 606 00:30:35,562 --> 00:30:37,564 NEURAL CONNECTIONS. 607 00:30:37,564 --> 00:30:40,434 SO WE WERE REALLY EXCITED BY 608 00:30:40,434 --> 00:30:46,273 THIS AND MARTHA FLANDERS AND 609 00:30:46,273 --> 00:30:48,575 SHERRI WIGS SHEPHERDED THIS FROM 610 00:30:48,575 --> 00:30:49,976 THE NEI PERSPECTIVE SO 611 00:30:49,976 --> 00:30:50,577 CONGRATULATION TO THAT ENTIRE 612 00:30:50,577 --> 00:30:55,148 GROUP. 613 00:30:55,148 --> 00:30:58,785 ONE OF THE THING I WANTED TO 614 00:30:58,785 --> 00:31:07,861 HIGHLIGHT HERE IS TO SHOW THE 615 00:31:07,861 --> 00:31:10,263 RELATIONSHIP BETWEEN INNOVATION 616 00:31:10,263 --> 00:31:12,099 AND CHRONIC DISEASE AND WOE HAD 617 00:31:12,099 --> 00:31:13,934 A SPEAKER A YEAR AGO AND I 618 00:31:13,934 --> 00:31:15,802 WANTED TO HIGHLIGHT THE WORK 619 00:31:15,802 --> 00:31:16,837 AGAIN BECAUSE IT'S SO LINED UP 620 00:31:16,837 --> 00:31:21,274 WITH THE CONCEPTS HERE THAT ARE 621 00:31:21,274 --> 00:31:24,377 PRIORITIES OF JAY'S. 622 00:31:24,377 --> 00:31:27,781 VINIT WORKED WITH A LONG TIME 623 00:31:27,781 --> 00:31:31,017 COLLEGIATE THE UNIVERSITY OF 624 00:31:31,017 --> 00:31:39,493 IOWA, ZAPPED ZAPPEDER BASSUK ANE 625 00:31:39,493 --> 00:31:43,230 CELL ANALYSIS IN HUMANS IS 626 00:31:43,230 --> 00:31:44,965 ESSENTIAL FOR UNDERSTANDING 627 00:31:44,965 --> 00:31:46,666 MECHANISM OF DISEASE BUT IT'S 628 00:31:46,666 --> 00:31:48,535 HARD TO DO IN TISSUES AND ORGANS 629 00:31:48,535 --> 00:31:52,272 THAT DON'T REGENERATE LIKE THE 630 00:31:52,272 --> 00:31:55,642 BRAIN AND RETINA AND CAN'T 631 00:31:55,642 --> 00:31:59,646 EASILY BIOPSY THEM. 632 00:31:59,646 --> 00:32:02,482 THEY TAKE A LIQUID BIOPSY 633 00:32:02,482 --> 00:32:09,256 APPROACH AND DID PROTEOMICS AND 634 00:32:09,256 --> 00:32:10,123 SINGLE CELL TRANSCRIPTOMICS OF 635 00:32:10,123 --> 00:32:14,494 THE KNOWN OCULAR CELL TYPES AND 636 00:32:14,494 --> 00:32:17,130 DID MULTI-OMIC AND A.I. ANALYSIS 637 00:32:17,130 --> 00:32:19,366 AND CAN LOOK AT IMMUNE AND 638 00:32:19,366 --> 00:32:21,902 VASCULAR CELL TYPES AND NEURONS 639 00:32:21,902 --> 00:32:25,605 AND LIVING PEOPLE AND BASICALLY 640 00:32:25,605 --> 00:32:28,308 STUDY CELL MECHANISMS AT CELL 641 00:32:28,308 --> 00:32:29,876 LEVEL RESOLUTION. 642 00:32:29,876 --> 00:32:31,845 AND THEY FOUND A LOT OF 643 00:32:31,845 --> 00:32:34,314 INTERESTING THINGS BY DOING THIS 644 00:32:34,314 --> 00:32:37,083 ANALYSIS. 645 00:32:37,083 --> 00:32:38,985 BASICALLY STUDIED 6,000 PROTEINS 646 00:32:38,985 --> 00:32:43,557 AND FOUND 26 OF THEM PREDICTED 647 00:32:43,557 --> 00:32:44,191 BIOLOGICAL AGE. 648 00:32:44,191 --> 00:32:53,633 AND THE WAY VINIT SPOKE ABOUT 649 00:32:53,633 --> 00:32:55,802 THIS IS BUILDING A.I. MODEL TO 650 00:32:55,802 --> 00:32:59,105 PREDICT YOUR AGE BASED ON YOUR 651 00:32:59,105 --> 00:33:00,340 PROTEOMIC PROFILE. 652 00:33:00,340 --> 00:33:03,643 FOR PEOPLE WITH CERTAIN 653 00:33:03,643 --> 00:33:12,519 DISEASES, RETINOPATHY AND OTHERS 654 00:33:12,519 --> 00:33:14,087 AND WITH THOSE DISEASE THE 655 00:33:14,087 --> 00:33:16,323 PROTEOMIC AGE AS PREDICTED BY 656 00:33:16,323 --> 00:33:19,793 THE MODELS WAS OLD EVEN THOUGH 657 00:33:19,793 --> 00:33:21,228 YOUR CHRONOLOGICAL AGE WAS 658 00:33:21,228 --> 00:33:21,595 YOUNG. 659 00:33:21,595 --> 00:33:24,164 WHEN YOU TREAT IT WITH STANDARD 660 00:33:24,164 --> 00:33:26,132 THERAPIES, THE AGE MODEL STILL 661 00:33:26,132 --> 00:33:29,803 SHOWED YOUR PROTEOMIC AGE WAS 662 00:33:29,803 --> 00:33:32,072 OLD THOUGH YOUR SYMPTOMS HAD 663 00:33:32,072 --> 00:33:32,505 IMPROVED. 664 00:33:32,505 --> 00:33:36,009 I THINK THAT HAS A LOT OF REALLY 665 00:33:36,009 --> 00:33:38,745 FASCINATING IMPLICATIONS THAT'S 666 00:33:38,745 --> 00:33:41,848 INTERSECTION OF MULT OMICS, 667 00:33:41,848 --> 00:33:43,483 CHRONIC DISEASE, INNOVATION. 668 00:33:43,483 --> 00:33:46,319 MAYBE BETTER BIOMARKERS TO 669 00:33:46,319 --> 00:33:48,355 INFORM CLINICAL TRIALS AND 670 00:33:48,355 --> 00:33:49,656 THERAPIES TO GET ROOT CAUSES AND 671 00:33:49,656 --> 00:33:50,357 REALLY EXCITING. 672 00:33:50,357 --> 00:33:52,859 OF COURSE IT'S NOT JUST THIS 673 00:33:52,859 --> 00:33:54,361 WORK BUT A LOT OF GREAT WORK 674 00:33:54,361 --> 00:33:55,829 GOING ON IN THE VISION COMMUNITY 675 00:33:55,829 --> 00:34:06,139 ALONG THESE LINES. 676 00:34:13,046 --> 00:34:17,150 I WANT TO HIGHLIGHT THIS WORK 677 00:34:17,150 --> 00:34:20,687 AND I WANTED TO MAKE SURE YOU 678 00:34:20,687 --> 00:34:25,392 KNOW ABOUT IT. 679 00:34:25,392 --> 00:34:27,761 S 680 00:34:30,630 --> 00:34:33,500 WE BECAME INTERESTED IN NEURO 681 00:34:33,500 --> 00:34:34,334 PLASTICITY AND THE STRATEGIC 682 00:34:34,334 --> 00:34:36,503 PLAN WAS ISSUED AND CONDUCTED A 683 00:34:36,503 --> 00:34:39,806 WORKSHOP LED BY THE CREW AT THE 684 00:34:39,806 --> 00:34:41,608 BOTTOM ABOUT A YEAR AGO. 685 00:34:41,608 --> 00:34:45,178 THE GOAL WAS TO IDENTIFY 686 00:34:45,178 --> 00:34:46,780 COST-CUTTING PRINCIPLES IN THE 687 00:34:46,780 --> 00:34:47,981 FIELD OF VISUAL AND NEURAL 688 00:34:47,981 --> 00:34:48,315 PLASTICITY. 689 00:34:48,315 --> 00:34:51,785 AND WE SPECIFICALLY WANTED TO 690 00:34:51,785 --> 00:34:54,955 FOCUS ON MECHANISMS OF NEURO 691 00:34:54,955 --> 00:34:58,325 PLASTICITY AT THE LEVEL OF CELL 692 00:34:58,325 --> 00:35:07,334 AND BRAIN STRUCTURE AND AND WHY 693 00:35:07,334 --> 00:35:08,268 ARE WE INTERESTED IN THIS? 694 00:35:08,268 --> 00:35:10,603 WE MAY BE ABLE TO TAKE ADVANTAGE 695 00:35:10,603 --> 00:35:14,407 OF NEURAL PLASTICITY TO IMPROVE 696 00:35:14,407 --> 00:35:25,085 VISION IN DISEASE S DISEASES SO 697 00:35:30,590 --> 00:35:34,594 THAT CAME OUT WERE THE EI 698 00:35:34,594 --> 00:35:37,597 BALANCE THAT WAS DRIVING NEURAL 699 00:35:37,597 --> 00:35:38,999 PLASTICITY. 700 00:35:38,999 --> 00:35:41,534 THE SENSORY DEPRIVATION CAN 701 00:35:41,534 --> 00:35:44,170 PERTURB THE EI BALANCE AND 702 00:35:44,170 --> 00:35:49,175 VARIOUS HOMEOSTATIC PROCESSES 703 00:35:49,175 --> 00:35:49,876 WORK TO MAINTAIN FUNCTION AND 704 00:35:49,876 --> 00:35:51,678 DECLINE WITH AGE. 705 00:35:51,678 --> 00:35:53,980 WE SAW SOME OPPORTUNITIES TO 706 00:35:53,980 --> 00:35:57,217 LEVERAGE THIS BASICALLY FOR ALL 707 00:35:57,217 --> 00:36:00,420 THE GOALS AND HAS BEEN WORKING 708 00:36:00,420 --> 00:36:03,823 THROUGH THIS AND THEY HAVE GREAT 709 00:36:03,823 --> 00:36:07,427 IDEAS ABOUT THIS. 710 00:36:07,427 --> 00:36:11,798 I WANTED TO MAKE SURE YOU KNOW 711 00:36:11,798 --> 00:36:13,133 NEUROPLASTICITY IS ONE THING 712 00:36:13,133 --> 00:36:19,172 WE'RE INTERESTED IN WE HAD A 713 00:36:19,172 --> 00:36:22,475 WORKSHOP A YEAR AND A HALF AGO 714 00:36:22,475 --> 00:36:25,845 ABOUT EXTRA CELLULAR VESICLES. 715 00:36:25,845 --> 00:36:30,884 AND THE WORKSHOP REPORT WAS 716 00:36:30,884 --> 00:36:35,722 PUBLISHED AND THERE WAS A NICE 717 00:36:35,722 --> 00:36:37,123 JOB AND THEY STUCK WITH IT TO 718 00:36:37,123 --> 00:36:39,225 GET TO THE POINT WHERE WE ARE 719 00:36:39,225 --> 00:36:41,161 RIGHT NOW. 720 00:36:41,161 --> 00:36:47,067 AND THE WORKSHOP IDENTIFIED 721 00:36:47,067 --> 00:36:51,438 NEEDS, GAPS AND RESEARCH AND IT 722 00:36:51,438 --> 00:36:53,973 INCLUDED CHARACTERIZING -- THE 723 00:36:53,973 --> 00:36:57,544 NEED TO CHARACTERIZE EXTRA 724 00:36:57,544 --> 00:36:58,978 CELLULAR VESICLES WITH DISCOVERY 725 00:36:58,978 --> 00:37:02,482 AND PREDICTING EYE DISEASE. 726 00:37:02,482 --> 00:37:07,353 THE NEED TO IDENTIFY ENDOGENOUS 727 00:37:07,353 --> 00:37:10,590 CARGO IN THE EYE THAT OCCUR IN 728 00:37:10,590 --> 00:37:15,095 RESPONSE TO DISEASE OR INJURY 729 00:37:15,095 --> 00:37:19,599 AND VESICLES. 730 00:37:19,599 --> 00:37:30,143 AND THERE'S SMALL SCALE ANATOMY 731 00:37:38,751 --> 00:37:41,254 AND IMMUNE PRIVILEGE AND 732 00:37:41,254 --> 00:37:42,555 ACCESSIBILITY TO ITS OWN BIO 733 00:37:42,555 --> 00:37:44,991 FLUID AND THE FEASIBILITY FOR 734 00:37:44,991 --> 00:37:45,658 LOCAL DRUG DELIVERY. 735 00:37:45,658 --> 00:37:46,392 THERE'S BEEN NICE WORK IN THAT 736 00:37:46,392 --> 00:37:56,503 AREA. 737 00:38:02,008 --> 00:38:03,843 THERE'S BEEN GAPS IN RESEARCH 738 00:38:03,843 --> 00:38:05,945 FROM 2010 TO 2023 THERE'S OVER 739 00:38:05,945 --> 00:38:10,817 ALL BEEN A SIGNIFICANT IN THE 740 00:38:10,817 --> 00:38:14,020 CLINICAL TRIALS INVOLVING EXTRA 741 00:38:14,020 --> 00:38:21,127 CELLULAR VESICLES AND THERE'S 742 00:38:21,127 --> 00:38:26,399 ONLY BEEN NINE CLINICAL TRIALS, 743 00:38:26,399 --> 00:38:30,703 AMB, ALLERGIC CONJUNCTIVITIS AND 744 00:38:30,703 --> 00:38:34,374 MAYBE THERE'S AREAS FOR GROWTH 745 00:38:34,374 --> 00:38:36,643 AND TRADITIONALLY CHINA AND THE 746 00:38:36,643 --> 00:38:38,344 U.S. HAVE LED AND THE GROWTH HAS 747 00:38:38,344 --> 00:38:39,045 SLOANE DOWN A LITTLE BIT. 748 00:38:39,045 --> 00:38:42,248 WE'VE BEEN THINKING ABOUT WHERE 749 00:38:42,248 --> 00:38:43,917 THIS COULD LEAD BUT I WANT TO 750 00:38:43,917 --> 00:38:46,352 MAKE SURE YOU ALL KNOW THIS HAS 751 00:38:46,352 --> 00:38:47,854 BEEN ON OUR MINDS FOR THE PAST 752 00:38:47,854 --> 00:38:50,657 YEAR, YEAR AND A HALF. 753 00:38:50,657 --> 00:38:57,597 SO THANK YOU TO ASHLEY AND TO 754 00:38:57,597 --> 00:38:59,799 HANG FOR DOING SO MUCH WORK IN 755 00:38:59,799 --> 00:39:01,201 THIS AREA. 756 00:39:01,201 --> 00:39:04,270 BRIDGE TO A.I. I THINK IS A 757 00:39:04,270 --> 00:39:06,439 UNIQUE PROJECT AT THE 758 00:39:06,439 --> 00:39:09,242 INTERSECTION OF INNOVATION AND 759 00:39:09,242 --> 00:39:09,876 CHRONIC DISEASE. 760 00:39:09,876 --> 00:39:11,511 SO THIS IS A COMMON FUND PROJECT 761 00:39:11,511 --> 00:39:15,782 AS A REFRESHER THAT'S $130 762 00:39:15,782 --> 00:39:18,051 BILLION OVER FOUR YEARS FOR 763 00:39:18,051 --> 00:39:18,418 STAGE 1. 764 00:39:18,418 --> 00:39:20,620 STAGE 1 IS COMING TO AN END 765 00:39:20,620 --> 00:39:21,621 RIGHT NOW. 766 00:39:21,621 --> 00:39:22,622 THERE'S FIVE I.C.s LEAVING THIS. 767 00:39:22,622 --> 00:39:27,827 WE'RE ONE OF THEM AND HERE ARE 768 00:39:27,827 --> 00:39:38,271 THE OTHER FOUR INSTITUTES. 769 00:39:43,176 --> 00:39:47,280 WE SAID BEFORE WE HAVE THIS 770 00:39:47,280 --> 00:39:50,817 MANTRA EVERYBODY KNOWS, 771 00:39:50,817 --> 00:39:52,385 HYPOTHESIS DRIVEN RESEARCH AT 772 00:39:52,385 --> 00:39:57,657 NIH. 773 00:39:57,657 --> 00:39:59,826 THIS IS A DATA SET FOR 774 00:39:59,826 --> 00:40:00,927 GENERATING NEW KNOWLEDGE. 775 00:40:00,927 --> 00:40:02,528 A LITTLE BIT OF A DIFFERENT 776 00:40:02,528 --> 00:40:05,198 PARADIGM, ACTUALLY A LOT OF A 777 00:40:05,198 --> 00:40:05,932 DIFFERENT PARADIGM FOR NIH. 778 00:40:05,932 --> 00:40:10,370 I WANT TO GIVE A SHOUT OUT TO 779 00:40:10,370 --> 00:40:15,408 JAMES GAO WHO HAS DONE A TON OF 780 00:40:15,408 --> 00:40:25,718 WORK IN THIS AREA. 781 00:40:32,625 --> 00:40:36,963 THE GOAL WAS TO RECRUIT VARIOUS 782 00:40:36,963 --> 00:40:39,365 STAGES OF TYPE II DIABETES AND 783 00:40:39,365 --> 00:40:40,433 THEY'RE COLLECTING EVERY TYPE OF 784 00:40:40,433 --> 00:40:50,810 DATA FROM THE COHORT. 785 00:40:52,612 --> 00:40:55,815 ELECTRONIC HEALTH RECORD DATA 786 00:40:55,815 --> 00:41:01,321 AND ECG DATA AND OCULAR IMAGING, 787 00:41:01,321 --> 00:41:04,357 OCT IMAGERY AND THE GOAL IS IT 788 00:41:04,357 --> 00:41:07,827 WOULD GIVE US A DATA SET TO 789 00:41:07,827 --> 00:41:09,896 HARNESS THE POWER OF A.I. TO 790 00:41:09,896 --> 00:41:11,297 UNDERSTAND CHRONIC DISEASE 791 00:41:11,297 --> 00:41:11,597 PROGRESSION. 792 00:41:11,597 --> 00:41:15,468 HOW YOU GO FROM BETTER TO WORSE. 793 00:41:15,468 --> 00:41:17,537 BUT MORE IMPORTANTLY AND 794 00:41:17,537 --> 00:41:19,005 PROBABLY MORE INTERESTINGLY, HOW 795 00:41:19,005 --> 00:41:22,709 DO YOU GO FROM WORSE TO BETTER? 796 00:41:22,709 --> 00:41:33,219 THE TERM IS DISEASE RECOVERY. 797 00:41:41,894 --> 00:41:45,098 THE FIRST PART WAS RELEASED IN 798 00:41:45,098 --> 00:41:46,099 THE PAST MONTHS. 799 00:41:46,099 --> 00:41:48,167 IF YOU GO TO THE WEBSITE IS HOW 800 00:41:48,167 --> 00:41:49,869 YOU GET ACCESS TO IT. 801 00:41:49,869 --> 00:41:52,972 THE SUBSET OF THIS OVER ALL DATA 802 00:41:52,972 --> 00:42:00,246 SET IN PROGRESS IS OVER 1,000 803 00:42:00,246 --> 00:42:06,519 PEOPLE AND 2 IT TERABYTES OF 804 00:42:06,519 --> 00:42:07,954 DATA AND EXCITED ABOUT THAT AND 805 00:42:07,954 --> 00:42:09,589 ONE THING I WANT TO MAKE SURE 806 00:42:09,589 --> 00:42:11,457 YOU KNOW ABOUT IS THERE'S BEEN 807 00:42:11,457 --> 00:42:13,793 DISCUSSING A LOT AND JAMES HAS 808 00:42:13,793 --> 00:42:16,863 DONE A LOT OF WORK IN THIS WITH 809 00:42:16,863 --> 00:42:18,598 PLANNING FOR STAGE 2 OF BRIDGE 810 00:42:18,598 --> 00:42:19,332 TO A.I. 811 00:42:19,332 --> 00:42:23,436 IS IT GOING TO OCCUR, YES, NO 812 00:42:23,436 --> 00:42:25,972 AND WHAT WILL IT LOOK LIKE IF WE 813 00:42:25,972 --> 00:42:27,807 END UP PROPOSING THAT. 814 00:42:27,807 --> 00:42:29,375 STAY TUNED BECAUSE WE'VE BEEN 815 00:42:29,375 --> 00:42:31,811 THINKING ABOUT THOSE ISSUES A 816 00:42:31,811 --> 00:42:32,278 LOT. 817 00:42:32,278 --> 00:42:34,380 CONGRATULATIONS TO THEM FOR 818 00:42:34,380 --> 00:42:35,815 DOING THIS AND THANK YOU TO 819 00:42:35,815 --> 00:42:43,256 JAMES FOR DOING ALL THIS WORK. 820 00:42:43,256 --> 00:42:46,526 I WANT TO TALK WITH ONE PROJECT 821 00:42:46,526 --> 00:42:52,899 IN THE PIPELINE ALONG THE LINE 822 00:42:52,899 --> 00:42:55,968 OF A.I. AND A NEW EMERGING 823 00:42:55,968 --> 00:42:58,371 CONFIDENT PROGRAM CALLED PRIMED 824 00:42:58,371 --> 00:42:58,538 A.I. 825 00:42:58,538 --> 00:43:05,578 THE PREMISE OF PRIMED A.I. IS 826 00:43:05,578 --> 00:43:08,815 IMAGING AND MULTI-MODAL A.I. FOR 827 00:43:08,815 --> 00:43:11,617 PRECISION MEDICINE. 828 00:43:11,617 --> 00:43:22,161 SO THIS WAS A PROJECT SANGEETA 829 00:43:27,867 --> 00:43:33,172 PROPOSED AND IT GOT SELECTED TO 830 00:43:33,172 --> 00:43:33,973 POTENTIALLY BUILD OUT FOR 831 00:43:33,973 --> 00:43:35,641 APPROVAL AND THERE'S A TEAM 832 00:43:35,641 --> 00:43:39,512 WORKING ON THIS. 833 00:43:39,512 --> 00:43:47,820 NIBIB, NIAID IT'S NEI AND ODSS, 834 00:43:47,820 --> 00:43:50,456 OFFICE OF DATA STRATEGY AND US 835 00:43:50,456 --> 00:43:53,059 AT THE NEI. 836 00:43:53,059 --> 00:43:59,632 THE PROJECT WAS APPROVED BY THE 837 00:43:59,632 --> 00:44:02,335 NIH COUNCIL OF COUNCILS TWO 838 00:44:02,335 --> 00:44:03,703 MONTHS AGO AND BRUCE TROMBERG 839 00:44:03,703 --> 00:44:04,804 AND I GAVE THE PRESENTATION TO 840 00:44:04,804 --> 00:44:09,342 THE COC AND THE PROPOSAL IS IT 841 00:44:09,342 --> 00:44:11,310 WILL BE A $121 BILLION PROJECT 842 00:44:11,310 --> 00:44:13,579 OVER FIVE YEARS AND CURRENTLY 843 00:44:13,579 --> 00:44:15,481 UNDER DEVELOPMENT. 844 00:44:15,481 --> 00:44:20,753 JAMES AND SANGEETA HAVE DONE A 845 00:44:20,753 --> 00:44:24,857 LOT OF WORK AND SANGEETA HELPED 846 00:44:24,857 --> 00:44:27,927 CONCEPTUALIZE THIS AND THE 847 00:44:27,927 --> 00:44:30,897 NOFOS -- THERE ARE NOTICES OF 848 00:44:30,897 --> 00:44:32,798 INTENT TO PUBLIC OUT THERE AS OF 849 00:44:32,798 --> 00:44:43,109 ABOUT A WEEK AGO. 850 00:44:47,413 --> 00:44:50,783 IT LOOKS AT DEVELOPING SYSTEMS 851 00:44:50,783 --> 00:44:58,424 AND THE SECOND IS ALGORITHM OF 852 00:44:58,424 --> 00:45:00,259 TOOLS TO MANAGE, DIAGNOSIS AND 853 00:45:00,259 --> 00:45:02,962 PREDICT AT THE ONSET OF DISEASE. 854 00:45:02,962 --> 00:45:03,796 THE THIRD IS CLINICAL 855 00:45:03,796 --> 00:45:04,897 IMPLEMENTATION HOW DO YOU GET 856 00:45:04,897 --> 00:45:06,499 THE TOOLS OUT IN THE REAL WORLD 857 00:45:06,499 --> 00:45:08,301 FROM PRECISION MEDICINE 858 00:45:08,301 --> 00:45:11,070 APPROACHES AND HOW CAN WE BUILD 859 00:45:11,070 --> 00:45:13,472 SUPPORT TOOLS THAT MIGHT BE 860 00:45:13,472 --> 00:45:14,240 INTEGRATED INTO ELECTRONIC 861 00:45:14,240 --> 00:45:15,808 HEALTH RECORD SYSTEMS AND THE 862 00:45:15,808 --> 00:45:19,579 LAST IS BUILDING TRUST AND 863 00:45:19,579 --> 00:45:20,446 COORDINATION AMONG DIFFERENT 864 00:45:20,446 --> 00:45:21,981 GROUPS AND DEVELOPING BEST 865 00:45:21,981 --> 00:45:27,420 PRACTICES AND ENSURING 866 00:45:27,420 --> 00:45:27,753 TRANSPARENCY. 867 00:45:27,753 --> 00:45:28,421 BIG PROJECT. 868 00:45:28,421 --> 00:45:31,624 A LOT OF EXCITEMENT ABOUT THE 869 00:45:31,624 --> 00:45:32,792 INTERSECTION OF INNOVATION AND 870 00:45:32,792 --> 00:45:33,292 CHRONIC DISEASE HERE. 871 00:45:33,292 --> 00:45:35,795 WE'VE BEEN EXCITED TO BE ONE OF 872 00:45:35,795 --> 00:45:38,364 THE GROUPS THAT'S HELPING LEAD 873 00:45:38,364 --> 00:45:39,699 THIS. 874 00:45:39,699 --> 00:45:41,934 SO STAY TUNED FOR THIS PRIMED 875 00:45:41,934 --> 00:45:43,803 A.I. BECAUSE I THINK THE VISION 876 00:45:43,803 --> 00:45:45,738 RESEARCH COMMUNITY HAS DONE A 877 00:45:45,738 --> 00:45:47,807 LOT OF NICE WORK IN THIS AREA 878 00:45:47,807 --> 00:45:51,844 AND I HOPE PEOPLE WILL BECOME 879 00:45:51,844 --> 00:46:00,252 INTERESTED IN THIS INITIATIVE. 880 00:46:00,252 --> 00:46:01,420 SOME BEAUTIFUL WORK INVOLVING 881 00:46:01,420 --> 00:46:03,456 CHRONIC DISEASE AND MYOPIA. 882 00:46:03,456 --> 00:46:05,691 WE TALKED ABOUT THE NASEM 883 00:46:05,691 --> 00:46:06,225 REPORT. 884 00:46:06,225 --> 00:46:08,494 I WON'T REHASH THAT BUT TO SAY 885 00:46:08,494 --> 00:46:09,495 THIS IS EMERGING. 886 00:46:09,495 --> 00:46:14,266 IT'S A HUGE PROBLEM RIGHT NOW 887 00:46:14,266 --> 00:46:16,535 AND EVERY INDICATION SUGGESTS 888 00:46:16,535 --> 00:46:17,436 IT'S GETTING WORSE IN THE 889 00:46:17,436 --> 00:46:18,738 U.S. AND WORLDWIDE. 890 00:46:18,738 --> 00:46:23,809 YOU ALL KNOW MEMBERS AND OVER 891 00:46:23,809 --> 00:46:27,813 150 MILLION AMERICANS WHO HAVE 892 00:46:27,813 --> 00:46:34,286 MEI -- MYOPIA RIGHT NOW AND THE 893 00:46:34,286 --> 00:46:38,557 PREDICTION IS BE MORE WORLDWIDE 894 00:46:38,557 --> 00:46:40,993 AND ALMOST 1 BILLION SO SOME 895 00:46:40,993 --> 00:46:42,662 WITH HIGH MYOPIA WORLDWIDE. 896 00:46:42,662 --> 00:46:45,564 WHY DOES THAT MATTER? 897 00:46:45,564 --> 00:46:48,534 WELL, A LOT OF DIFFERENT 898 00:46:48,534 --> 00:46:49,101 REASONS. 899 00:46:49,101 --> 00:46:51,337 DECREASED VISION, LOT OF 900 00:46:51,337 --> 00:46:51,804 PRODUCTIVITY. 901 00:46:51,804 --> 00:46:54,774 THE ISSUE IN TERM OF HIGH MYOPIA 902 00:46:54,774 --> 00:46:56,842 IS ALL THE DOWN STREAM 903 00:46:56,842 --> 00:46:57,176 COMPLICATIONS. 904 00:46:57,176 --> 00:47:01,147 VISION LOSS OR BLINDNESS FROM 905 00:47:01,147 --> 00:47:03,082 GLAUCOMA AND MACULAR 906 00:47:03,082 --> 00:47:05,885 DEGENERATION AND RETINAL 907 00:47:05,885 --> 00:47:06,185 DETACHMENTS. 908 00:47:06,185 --> 00:47:14,193 THE BLINK 2 STUD IT -- STUDY WAS 909 00:47:14,193 --> 00:47:17,396 PUBLISHED RECENTLY LED BY DAVID 910 00:47:17,396 --> 00:47:19,465 BERNSTEIN AND JEFF WALLENE AND 911 00:47:19,465 --> 00:47:25,838 OUR FRIEND DIAMUTI IN HOUSTON 912 00:47:25,838 --> 00:47:28,340 AND OHIO STATE. 913 00:47:28,340 --> 00:47:30,576 THEY LOOKED AT PEOPLE WITH 914 00:47:30,576 --> 00:47:33,312 CONTACT LENSES IN MYOPIA AND 915 00:47:33,312 --> 00:47:35,815 SHOWED IT COULD SLOW AXIAL EYE 916 00:47:35,815 --> 00:47:37,950 GROWTH AMONG OLDER TEENS WITHOUT 917 00:47:37,950 --> 00:47:40,553 CLEAR REBOUND OR WITH THE 918 00:47:40,553 --> 00:47:41,287 CONTACT LENS. 919 00:47:41,287 --> 00:47:44,190 THERE'S MANY THINGS ABOUT MYOPIA 920 00:47:44,190 --> 00:47:46,525 WE'VE GOTTEN EXCITED ABOUT AND 921 00:47:46,525 --> 00:47:48,094 ARE HOPEFUL FOR. 922 00:47:48,094 --> 00:47:53,232 SO STAY TUNED ABOUT THAT. 923 00:47:53,232 --> 00:48:03,676 THERE'S BEEN NICE WORK IN 924 00:48:08,848 --> 00:48:09,849 UVEITIS AND WE CAN'T LIST 925 00:48:09,849 --> 00:48:10,816 EVERYBODY WHOSE BEEN INVOLVED 926 00:48:10,816 --> 00:48:12,585 WITH THIS BUT I ESPECIALLY 927 00:48:12,585 --> 00:48:15,821 WANTED TO GIVE A SHOUT OUT TO 928 00:48:15,821 --> 00:48:21,293 THESE THREE. 929 00:48:21,293 --> 00:48:30,836 THE ADJUST STUDY AND STOPPING 930 00:48:30,836 --> 00:48:36,075 JIA, JUVENILE, ARTHRITIC UVEITIS 931 00:48:36,075 --> 00:48:39,044 AND IT CAN BE VERY AGGRESSIVE. 932 00:48:39,044 --> 00:48:42,314 THIS WAS THE FIRST RANDOMIZED 933 00:48:42,314 --> 00:48:43,682 CONTROL TRIAL TO PROVIDE AXIAL 934 00:48:43,682 --> 00:48:46,552 INFORMATION FOR WHEN YOU STOP 935 00:48:46,552 --> 00:48:48,554 THIS ABOUT STOPPING THE DRUG IN 936 00:48:48,554 --> 00:48:51,357 KIDS WITH GIA ASSOCIATED 937 00:48:51,357 --> 00:48:51,590 UVEITIS. 938 00:48:51,590 --> 00:48:54,827 WHAT THE GROUP SHOWED IS YOU CAN 939 00:48:54,827 --> 00:48:56,829 PREVENT VISION LOSS IF YOU STOP 940 00:48:56,829 --> 00:49:00,399 A DRUG BY CLOSE MONITORING AND 941 00:49:00,399 --> 00:49:01,967 RESUMING THE DRUG IF THERE'S 942 00:49:01,967 --> 00:49:02,334 REOCCURRENCE. 943 00:49:02,334 --> 00:49:04,537 SO THAT'S GOING TO HAVE 944 00:49:04,537 --> 00:49:07,807 SIGNIFICANT IMPLICATIONS AS A 945 00:49:07,807 --> 00:49:10,176 PEDIATRIC OPHTHALMOLOGIST AND 946 00:49:10,176 --> 00:49:20,619 THE MERIT STUDY, MACULAR 947 00:49:21,687 --> 00:49:26,859 RANIBIZUMAB AND 948 00:49:26,859 --> 00:49:27,493 INTRAVITREAL-ANTI-INFLAMMATORY 949 00:49:27,493 --> 00:49:27,793 THERAPY. 950 00:49:27,793 --> 00:49:28,861 IT'S A PROBLEM FOR MANY AT RISK 951 00:49:28,861 --> 00:49:31,630 FOR THIS. 952 00:49:31,630 --> 00:49:34,533 AND ONE OF THE PROMISING 953 00:49:34,533 --> 00:49:37,736 THERAPIES HAS BEEN STEROID 954 00:49:37,736 --> 00:49:46,545 IMPLAN 955 00:49:46,545 --> 00:49:51,784 IMPLANTS IT FOUND THE TWO 956 00:49:51,784 --> 00:50:02,228 OPTIONS ARE INTRAVITREAL 957 00:50:05,698 --> 00:50:09,602 TREATMENT AND THEY THIS UNDER 958 00:50:09,602 --> 00:50:11,804 SCORE THE IMPORTANCE OF 959 00:50:11,804 --> 00:50:14,039 CONSIDERING THE DEXAMETHAZONE AS 960 00:50:14,039 --> 00:50:16,976 A PRIMARY TREATMENT OPTION. 961 00:50:16,976 --> 00:50:24,750 THESE ARE TWO CLINICAL TRIALS 962 00:50:24,750 --> 00:50:26,652 FOR THESE REAL WORLD THERAPIES 963 00:50:26,652 --> 00:50:28,587 IN THESE CLINICS. 964 00:50:28,587 --> 00:50:31,023 CONGRATULATIONS FOR THE GROUPS 965 00:50:31,023 --> 00:50:35,794 FOR DOING WORK IN MYOPIA AND 966 00:50:35,794 --> 00:50:36,195 UVEITIS. 967 00:50:36,195 --> 00:50:37,162 CEREBRAL VISUAL IMPAIRMENT. 968 00:50:37,162 --> 00:50:40,900 I WANT TO GIVE AN UPDATE ON 969 00:50:40,900 --> 00:50:41,300 THAT. 970 00:50:41,300 --> 00:50:47,806 THIS IS A CHRONIC DISEASE THAT 971 00:50:47,806 --> 00:50:49,875 HAS BECOME THE LEADING CAUSE OF 972 00:50:49,875 --> 00:50:52,544 CHILDHOOD VISUAL IMPAIRMENT IN 973 00:50:52,544 --> 00:50:52,978 THE U.S. 974 00:50:52,978 --> 00:50:57,516 AND MANY OF YOU KNOW THE 975 00:50:57,516 --> 00:50:59,818 CAUSES/ASSOCIATIONS ARE 976 00:50:59,818 --> 00:51:02,354 PREMATURITY, PERINATAL BRAIN 977 00:51:02,354 --> 00:51:06,125 DAMAGE AND OXYGEN DEPRIVATION 978 00:51:06,125 --> 00:51:10,529 AND THESE CHILDREN WILL HAVE 979 00:51:10,529 --> 00:51:12,064 VISUAL ACUTITY AND FIELD 980 00:51:12,064 --> 00:51:13,933 DEFICITS BUT A HALLMARK IS THE 981 00:51:13,933 --> 00:51:18,170 HIGHER ORDER VISUAL DEFICITS. 982 00:51:18,170 --> 00:51:22,574 THEY MAY BE ABLE TO SEE EYE 983 00:51:22,574 --> 00:51:28,347 CHARTS REASONABLY WELL SOMETIMES 984 00:51:28,347 --> 00:51:30,950 BUT IN CROWDED ROOMS CAN'T 985 00:51:30,950 --> 00:51:34,386 ALWAYS TELL THE SIGNAL FROM THE 986 00:51:34,386 --> 00:51:36,288 NOISE AND LOOK AT ATTENTION AND 987 00:51:36,288 --> 00:51:36,655 RECOGNITION. 988 00:51:36,655 --> 00:51:39,325 AND ONE OF THE MAIN -- WE 989 00:51:39,325 --> 00:51:42,061 LEARNED A LOT ABOUT THIS DURING 990 00:51:42,061 --> 00:51:46,565 OUR STRATEGIC PLANNING PROCESS 991 00:51:46,565 --> 00:51:49,134 FOR FOUR YEARS AGO. 992 00:51:49,134 --> 00:51:51,804 WE'VE BEEN INTERESTED IN THIS 993 00:51:51,804 --> 00:51:52,838 SINCE THAT TIME. 994 00:51:52,838 --> 00:51:55,174 THERE'S BEEN MAJOR GAPS IN 995 00:51:55,174 --> 00:51:57,876 KNOWLEDGE AND WHAT'S THE NEURAL 996 00:51:57,876 --> 00:51:59,211 BASIS OF THE CONDITION AND HOW'S 997 00:51:59,211 --> 00:52:01,680 IT DIFFER FROM TRAUMATIC BRAIN 998 00:52:01,680 --> 00:52:06,418 INJURY AND STROKE AND HOW DO WE 999 00:52:06,418 --> 00:52:07,987 DEVELOP DIAGNOSIS FOR 1000 00:52:07,987 --> 00:52:09,121 CLASSIFICATION AND WHAT ARE BEST 1001 00:52:09,121 --> 00:52:10,756 PRACTICE FOR MANAGEMENT. 1002 00:52:10,756 --> 00:52:12,725 HOW DO WE BEST UNDERSTAND 1003 00:52:12,725 --> 00:52:14,760 REHABILITATION NEEDS FOR THE 1004 00:52:14,760 --> 00:52:18,397 BRAIN-BASED IMPAIRMENTS FOR CBI 1005 00:52:18,397 --> 00:52:19,832 AS FOR EYE BASED VISUAL 1006 00:52:19,832 --> 00:52:23,936 IMPAIRMENTS WE MORE OFTEN SEE. 1007 00:52:23,936 --> 00:52:25,604 AS A RESULT OF ALL THIS WE HAVE 1008 00:52:25,604 --> 00:52:28,240 PUT TOGETHER IN 1009 00:52:28,240 --> 00:52:29,274 MULTI-DISCIPLINARY WORKING GROUP 1010 00:52:29,274 --> 00:52:32,444 THAT INVOLVES OF COURSE US 1011 00:52:32,444 --> 00:52:34,780 TOGETHER WITH NICHD, CHILD 1012 00:52:34,780 --> 00:52:39,785 HEALTH, WITH NINDS NEUROLOGICAL 1013 00:52:39,785 --> 00:52:40,319 DISEASE AND STROKE. 1014 00:52:40,319 --> 00:52:40,953 IT'S BEEN GOING ON TWO YEARS 1015 00:52:40,953 --> 00:52:44,656 NOW. 1016 00:52:44,656 --> 00:52:48,894 MELINDA CHANG AND SHE'S AT USC 1017 00:52:48,894 --> 00:52:51,797 CHILDREN'S HOSPITAL LOS ANGELES 1018 00:52:51,797 --> 00:52:57,669 AND LOFTI IS AT HARVARD AND 1019 00:52:57,669 --> 00:53:00,239 THEY'VE DONE A GREAT JOB 1020 00:53:00,239 --> 00:53:01,306 MANAGING THIS GROUP AND THERE'S 1021 00:53:01,306 --> 00:53:03,809 BEEN WORK IN THIS AREA HELPING 1022 00:53:03,809 --> 00:53:08,147 TO LEAD THAT AS WELL. 1023 00:53:08,147 --> 00:53:10,582 I'M REALLY PROUD WE WERE ABLE TO 1024 00:53:10,582 --> 00:53:13,318 ADDRESS WHAT IS A SIGNIFICANT 1025 00:53:13,318 --> 00:53:15,387 CHRONIC DISEASE IN CHILDREN IN 1026 00:53:15,387 --> 00:53:16,588 MULTI-DISCIPLINARY WAY TOGETHER 1027 00:53:16,588 --> 00:53:17,956 WITH NICHD AND NINDS. 1028 00:53:17,956 --> 00:53:21,093 I WISH WE COULD SHOW EVERY 1029 00:53:21,093 --> 00:53:22,127 PROGRAM OFFICER INVOLVED FROM 1030 00:53:22,127 --> 00:53:23,228 THESE INSTITUTES ON THE SLIDE 1031 00:53:23,228 --> 00:53:32,337 BUT WE JUST RAN OUT OF ROOM. 1032 00:53:32,337 --> 00:53:36,608 SO WHAT HAS HAPPENED IS WITHIN 1033 00:53:36,608 --> 00:53:37,342 OPHTHALMOLOGY, MEANING THE 1034 00:53:37,342 --> 00:53:39,344 JOURNAL, WE PUBLISHED A WORKING 1035 00:53:39,344 --> 00:53:41,146 DEFINITION OF CBI. 1036 00:53:41,146 --> 00:53:43,816 WE MEANS MELINDA AND LOFTI AND 1037 00:53:43,816 --> 00:53:46,618 THE CBI WORKING GROUP IN 1038 00:53:46,618 --> 00:53:47,886 DECEMBER 2024. 1039 00:53:47,886 --> 00:53:50,989 THAT WAS ACCOMPANIED BY AN 1040 00:53:50,989 --> 00:53:54,359 EDITORIAL THAT WAS REALLY 1041 00:53:54,359 --> 00:54:04,736 DRAFTED BY SHEFFI AND ALICIA AND 1042 00:54:04,736 --> 00:54:07,339 ANY NAME WAS IN THERE AS WELL AS 1043 00:54:07,339 --> 00:54:11,410 AND VIRTUALLY THE SAME DAY 1044 00:54:11,410 --> 00:54:12,978 WITHIN THE PEDIATRICS LITERATURE 1045 00:54:12,978 --> 00:54:16,115 IN THE JOURNAL OF PEDIATRICS THE 1046 00:54:16,115 --> 00:54:20,586 OFFICIAL AMERICAN PEDIATRICS OF 1047 00:54:20,586 --> 00:54:23,255 JOURNAL WAS ONE PUBLISHED A 1048 00:54:23,255 --> 00:54:25,023 PAPER AND LINDA CHANG WAS A LEAD 1049 00:54:25,023 --> 00:54:26,391 ON THAT THAT EMPHASIZED THE 1050 00:54:26,391 --> 00:54:30,496 IMPORTANCE FOR PEDIATRICIANS TO 1051 00:54:30,496 --> 00:54:30,729 SCREEN. 1052 00:54:30,729 --> 00:54:33,899 THAT WAS -- THERE'S ALSO AN 1053 00:54:33,899 --> 00:54:35,801 ACCOMPANYING NICHD EDITORIAL AND 1054 00:54:35,801 --> 00:54:39,505 WITHIN THE ANNALS OF NEUROLOGY, 1055 00:54:39,505 --> 00:54:40,973 WALTER KOROSHETZ AND HIS GROUP 1056 00:54:40,973 --> 00:54:42,074 PUBLISHED AN EDITORIAL ABOUT 1057 00:54:42,074 --> 00:54:42,641 THIS. 1058 00:54:42,641 --> 00:54:45,944 SO WE'RE TRYING TO HIGHLIGHT 1059 00:54:45,944 --> 00:54:49,214 WE'RE WORKING TOGETHER ON THIS 1060 00:54:49,214 --> 00:54:50,816 AS EVIDENCED WE BRINGING THE 1061 00:54:50,816 --> 00:54:51,817 PUBLICATIONS OF DIFFERENT 1062 00:54:51,817 --> 00:54:52,751 COMMUNITIES TOGETHER TO POINT IN 1063 00:54:52,751 --> 00:55:02,461 THE SAME THING. 1064 00:55:02,461 --> 00:55:05,097 AND I'M EXCITED TO HIGHLIGHT THE 1065 00:55:05,097 --> 00:55:05,364 SYNERGIES. 1066 00:55:05,364 --> 00:55:12,404 AND LASTLY TO SAY WE'RE HOST IN 1067 00:55:12,404 --> 00:55:13,805 AND PLANNING A REGISTRY BY THE 1068 00:55:13,805 --> 00:55:18,143 NEI AND EXCITED ABOUT A LOT OF 1069 00:55:18,143 --> 00:55:21,880 ACTIVITY AND MELINDA AND LOFTI 1070 00:55:21,880 --> 00:55:23,215 HAVE DONE EXCITING WORK. 1071 00:55:23,215 --> 00:55:27,786 LET ME TALK ABOUT 1072 00:55:27,786 --> 00:55:32,791 REPRODUCIBILITY. 1073 00:55:32,791 --> 00:55:35,761 THERE ARE ONE ASPECTS AND ONE 1074 00:55:35,761 --> 00:55:38,330 THING HIGHLIGHTED BY JAY 1075 00:55:38,330 --> 00:55:41,466 BHATTACHARYA IS IT'S BEEN 1076 00:55:41,466 --> 00:55:46,605 PUBLISHED AND A PAPER GOT 1077 00:55:46,605 --> 00:55:49,141 PUBLICITY SHOWING THE VAST 1078 00:55:49,141 --> 00:55:51,810 MAJORITY OF DATA ARE WRONG AND 1079 00:55:51,810 --> 00:56:01,253 THAT WAS THE PREMISE OF THAT 1080 00:56:01,253 --> 00:56:02,554 PAPER AND LET ME TALK ABOUT THE 1081 00:56:02,554 --> 00:56:03,789 THINGS WE'VE BEEN DOING THAT 1082 00:56:03,789 --> 00:56:06,858 RELATE TO REPRODUCIBILITY. 1083 00:56:06,858 --> 00:56:07,893 IT'S SOMETHING THAT'S FASCINATED 1084 00:56:07,893 --> 00:56:14,600 ME FOR QUITE A WHILE. 1085 00:56:14,600 --> 00:56:17,903 I LOVE THIS AND INCENTIVIZING 1086 00:56:17,903 --> 00:56:18,270 DATA SHARING. 1087 00:56:18,270 --> 00:56:21,139 WE HAVE THIS SITUATION ALL THE 1088 00:56:21,139 --> 00:56:21,340 TIME. 1089 00:56:21,340 --> 00:56:23,108 THERE ARE MULTIPLE SMALL STUDIES 1090 00:56:23,108 --> 00:56:24,443 GOING ON IN PARALLEL AROUND THE 1091 00:56:24,443 --> 00:56:27,813 COUNTRY ESSENTIALLY TRYING TO 1092 00:56:27,813 --> 00:56:34,419 ANSWER THE SAME QUESTION YET 1093 00:56:34,419 --> 00:56:35,487 UNDER POWERED TO FIELD THE 1094 00:56:35,487 --> 00:56:36,521 QUESTIONS AND MORE THE FIELD 1095 00:56:36,521 --> 00:56:36,822 FORWARD. 1096 00:56:36,822 --> 00:56:38,223 HOW DO WE DO THE JOB? 1097 00:56:38,223 --> 00:56:40,492 ONE IS WE GET EVERYONE TO SHARE 1098 00:56:40,492 --> 00:56:42,594 THEIR DATA AMONG THE MULTIPLE 1099 00:56:42,594 --> 00:56:47,532 SMALL STUDIES AND OF COURSE TWO 1100 00:56:47,532 --> 00:56:51,837 YEARS AGO THERE WAS AN NIH DATA 1101 00:56:51,837 --> 00:56:53,872 SHARING REQUIREMENT AND IN THE 1102 00:56:53,872 --> 00:56:55,741 WORLD OF CARROTS AND STICKS, 1103 00:56:55,741 --> 00:57:01,947 THAT REQUIREMENT IS A STICK. 1104 00:57:01,947 --> 00:57:03,382 IF YOU DON'T COME UP WITH A PLAN 1105 00:57:03,382 --> 00:57:05,384 TO SHARE YOUR DATA, WE WON'T 1106 00:57:05,384 --> 00:57:06,885 FUND YOUR RESEARCH. 1107 00:57:06,885 --> 00:57:08,220 THIS COUNCIL KNOWS WELL WE HEARD 1108 00:57:08,220 --> 00:57:11,256 EVERY SINGLE COMPLAINT AND 1109 00:57:11,256 --> 00:57:21,700 CONCERN ABOUT THE POLICY. 1110 00:57:24,870 --> 00:57:26,438 PEOPLE ARE SHARING DATA AS THE 1111 00:57:26,438 --> 00:57:28,206 CHECK THE BOX EXERCISE AND I 1112 00:57:28,206 --> 00:57:30,509 DON'T WANT TO GET THE WORSE OF 1113 00:57:30,509 --> 00:57:31,643 BOTH WORLDS WHERE PEOPLE ARE 1114 00:57:31,643 --> 00:57:35,647 SHARING DATA THAT'S REALLY NOT 1115 00:57:35,647 --> 00:57:38,250 THAT USEFUL FOR POTENTIALLY 1116 00:57:38,250 --> 00:57:39,785 OBFUSCATED SO MY COMPETITOR 1117 00:57:39,785 --> 00:57:42,254 DOESN'T SEE MY DATA I'VE SPENT 1118 00:57:42,254 --> 00:57:43,789 SO LONG ON AND SCOOP ME ON THE 1119 00:57:43,789 --> 00:57:48,126 PAPER. 1120 00:57:48,126 --> 00:57:51,063 I FEEL LIKE MANY KNOW IS MY 1121 00:57:51,063 --> 00:57:52,664 OPINION IS A LOT OF THAT BOILS 1122 00:57:52,664 --> 00:57:55,467 DOWN TO THE ACADEMIC INCENTIVE 1123 00:57:55,467 --> 00:57:58,370 CULTURE THAT WE HAVE. 1124 00:57:58,370 --> 00:58:01,873 WHICH IS THAT PEOPLE ARE 1125 00:58:01,873 --> 00:58:04,142 INCENTIVIZED FOR BEING FIRST AND 1126 00:58:04,142 --> 00:58:08,246 LAST AUTHOR ON PAPERS AND GRANT 1127 00:58:08,246 --> 00:58:10,649 APPLICATIONS AND THOSE METRICS 1128 00:58:10,649 --> 00:58:21,159 PROMOTE PROMOTION AND TENURE. 1129 00:58:37,776 --> 00:58:39,811 AND I HOPE PEOPLE WILL WANT TO 1130 00:58:39,811 --> 00:58:42,881 DO THAT AND TRY TO PUSH THAT 1131 00:58:42,881 --> 00:58:45,617 ALONG, WE HAVE BEEN WORK ON AND 1132 00:58:45,617 --> 00:58:48,887 IN FACT HELPING TO LEAD AN NIH 1133 00:58:48,887 --> 00:58:51,890 DATA SHARING CHALLENGE WE'VE 1134 00:58:51,890 --> 00:58:53,024 INFORMALLY BEEN CALLING S INDEX 1135 00:58:53,024 --> 00:59:03,201 CHALLENGE. 1136 00:59:10,375 --> 00:59:14,479 THIS IS A ROBUST METRIC THAT 1137 00:59:14,479 --> 00:59:18,116 REWARDS PEOPLE TO SHARE DATA SO 1138 00:59:18,116 --> 00:59:20,318 THE MORE YOU SHARE THE HIGHER 1139 00:59:20,318 --> 00:59:22,254 YOUR INDEX WILL GO AND WHO WILL 1140 00:59:22,254 --> 00:59:23,922 DEVELOP A GOOD METRIC FOR DOING 1141 00:59:23,922 --> 00:59:24,389 THIS? 1142 00:59:24,389 --> 00:59:27,259 I'M REALLY EXCITED WE AT NEI ARE 1143 00:59:27,259 --> 00:59:29,194 LEADING THIS AND THERE ARE 1144 00:59:29,194 --> 00:59:30,495 PARTNERS FROM ALL THESE 1145 00:59:30,495 --> 00:59:30,996 DIFFERENT I.C.s. 1146 00:59:30,996 --> 00:59:32,831 SO I'M REALLY EXCITED SO MANY 1147 00:59:32,831 --> 00:59:34,666 OTHER GROUPS ARE INTERESTED IN 1148 00:59:34,666 --> 00:59:35,801 THIS AND WORKING TOGETHER ON 1149 00:59:35,801 --> 00:59:39,805 THIS. 1150 00:59:39,805 --> 00:59:40,872 AROUND THE DEADLINE FOR 1151 00:59:40,872 --> 00:59:41,773 SUBMITTING OCCURRED A FEW WEEKS 1152 00:59:41,773 --> 00:59:44,943 AGO AND I WAS EXCITED AMBER 1153 00:59:44,943 --> 00:59:47,813 RECENTLY TOLD ME WE HAD 44 FULL 1154 00:59:47,813 --> 00:59:49,548 SUBMISSIONS AND THERE WERE 92 1155 00:59:49,548 --> 00:59:52,250 GROUPS THAT ORIGINALLY 1156 00:59:52,250 --> 00:59:53,985 REGISTERED TO SUBMIT AMONG THEM 1157 00:59:53,985 --> 00:59:54,719 44 DID SUBMIT SOMETHING. 1158 00:59:54,719 --> 00:59:57,322 SO STAY TUNED FOR THIS. 1159 00:59:57,322 --> 00:59:58,957 THIS IS GOING TO BE REALLY 1160 00:59:58,957 --> 00:59:59,224 EXCITING. 1161 00:59:59,224 --> 01:00:00,859 ONE OF THE THINGS THAT I WANT TO 1162 01:00:00,859 --> 01:00:04,663 MAKE SURE THAT YOU KNOW IS THAT 1163 01:00:04,663 --> 01:00:07,632 JAY BHATTACHARYA PUBLISHED A 1164 01:00:07,632 --> 01:00:10,235 PAPER BACK IN 2020 IN THE NBR, 1165 01:00:10,235 --> 01:00:12,971 WITHIN THE NBER, NATIONAL BUREAU 1166 01:00:12,971 --> 01:00:16,675 OF ECONOMICS RESEARCH THAT 1167 01:00:16,675 --> 01:00:22,914 BASICALLY TALKED ABOUT ON THIS 1168 01:00:22,914 --> 01:00:23,682 AXIS IS TOTAL SCIENTIFIC EFFORT 1169 01:00:23,682 --> 01:00:26,551 AND IDEA AND ON THE Y AXIS IS 1170 01:00:26,551 --> 01:00:27,853 THE SCIENTIFIC IMPACT. 1171 01:00:27,853 --> 01:00:32,624 SO THE POINT HERE THAT JAY IS 1172 01:00:32,624 --> 01:00:35,794 TALKING ABOUT IS THAT THIS IS 1173 01:00:35,794 --> 01:00:38,830 VERY EARLY CURIOSITY DRIVEN 1174 01:00:38,830 --> 01:00:39,331 EXPLORATORY RESEARCH. 1175 01:00:39,331 --> 01:00:43,802 NOT A LOT OF CLEAR IMPACT. 1176 01:00:43,802 --> 01:00:45,570 BUT OCCASIONALLY SOMETHING 1177 01:00:45,570 --> 01:00:47,806 CATCHES ON AND BECOMES A 1178 01:00:47,806 --> 01:00:48,740 BREAKTHROUGH, THINK CRISPR. 1179 01:00:48,740 --> 01:00:52,644 SOMETHING REALLY TAKES OFF. 1180 01:00:52,644 --> 01:00:59,484 AND OVER HERE IS WORK THAT IS 1181 01:00:59,484 --> 01:01:02,087 REFINING THAT IDEA. 1182 01:01:02,087 --> 01:01:06,191 SO WHAT JAY CALLS INCREMENTAL 1183 01:01:06,191 --> 01:01:09,761 ADVANCES. 1184 01:01:09,761 --> 01:01:11,730 BUT THE PREMISE OF THE ARTICLE 1185 01:01:11,730 --> 01:01:14,266 IS DOING INCREMENTAL WORK IN 1186 01:01:14,266 --> 01:01:17,435 THINGS THAT ARE POST 1187 01:01:17,435 --> 01:01:21,273 BREAKTHROUGH IS WHERE PEOPLE 1188 01:01:21,273 --> 01:01:25,377 FEEL TO DO THIS BECAUSE IT'S 1189 01:01:25,377 --> 01:01:25,610 POPULAR. 1190 01:01:25,610 --> 01:01:28,313 WHEREAS THIS WORK DOWN HERE 1191 01:01:28,313 --> 01:01:30,181 ISN'T REALLY REWARDED THE SAME 1192 01:01:30,181 --> 01:01:30,515 WAY. 1193 01:01:30,515 --> 01:01:33,785 ONE OF THE PREMISES OF THIS 1194 01:01:33,785 --> 01:01:41,459 PAPER FROM JAY WAS HOW DO WE 1195 01:01:41,459 --> 01:01:43,428 DEVELOPED METHODS FOR THE WORK 1196 01:01:43,428 --> 01:01:44,496 AND THIS EXPLORATORY RESEARCH 1197 01:01:44,496 --> 01:01:46,264 AND THAT'S FASCINATED ME SINCE I 1198 01:01:46,264 --> 01:01:47,065 LEARNED ABOUT THIS. 1199 01:01:47,065 --> 01:01:49,301 IF ANY OF YOU IN THE COUNCIL AND 1200 01:01:49,301 --> 01:01:51,703 IN THE COMMUNITY HAVE THOUGHTS 1201 01:01:51,703 --> 01:01:54,739 ABOUT MOVING BACK TO THIS ISSUE 1202 01:01:54,739 --> 01:01:57,309 OF METRICS IN 21st CENTURY TEAM 1203 01:01:57,309 --> 01:01:57,542 SCIENCE. 1204 01:01:57,542 --> 01:01:58,677 I HAVE A LOT OF CONCERNS THAT 1205 01:01:58,677 --> 01:02:03,748 THE WAY THAT WE INCENTIVIZE 1206 01:02:03,748 --> 01:02:04,816 SCIENCE IS THE MODEL OF SCIENCE 1207 01:02:04,816 --> 01:02:06,785 FROM THE 20th CENTURY AND THE 1208 01:02:06,785 --> 01:02:08,954 WAY WE DO SCIENCE NOW IS 1209 01:02:08,954 --> 01:02:09,421 DIFFERENT. 1210 01:02:09,421 --> 01:02:11,790 AND SO WHAT WILL THOSE METRICS 1211 01:02:11,790 --> 01:02:14,626 THAT WE SHOULD BE INCENTIVIZING? 1212 01:02:14,626 --> 01:02:17,329 ARE THEY THINGS LIKE BE A GOOD 1213 01:02:17,329 --> 01:02:20,332 TEAM PLAYER, MENTORSHIP, 1214 01:02:20,332 --> 01:02:26,304 REPRODUCE ACT, CURIOSITY-DRIVEN 1215 01:02:26,304 --> 01:02:26,938 INNOVA 1216 01:02:26,938 --> 01:02:27,238 INNOVATION. 1217 01:02:27,238 --> 01:02:28,340 IF YOU HAVE THOUGHTS, SHOOT ME 1218 01:02:28,340 --> 01:02:29,474 AN E-MAIL OR LET'S TALK. 1219 01:02:29,474 --> 01:02:30,642 I THINK THERE'S ROOM FOR 1220 01:02:30,642 --> 01:02:31,676 EXCITING WORK IN THIS AREA. 1221 01:02:31,676 --> 01:02:34,779 AND OF COURSE I'M EXCITED THAT 1222 01:02:34,779 --> 01:02:36,915 PEOPLE LIKE AMBER AND KERRIE 1223 01:02:36,915 --> 01:02:43,888 HAVE DONE GREAT WORK IN LEADING 1224 01:02:43,888 --> 01:02:44,589 THIS CHALLENGE. 1225 01:02:44,589 --> 01:02:45,557 LET ME MOVE ON. 1226 01:02:45,557 --> 01:02:50,562 I'M ALMOST AT THE END, GUYS. 1227 01:02:50,562 --> 01:02:51,630 WE'VE BEEN INTERESTED IN THE 1228 01:02:51,630 --> 01:02:54,532 SPIRIT OF REPRODUCIBILITY 1229 01:02:54,532 --> 01:02:56,101 BUILDING A FEDERATED VISION 1230 01:02:56,101 --> 01:03:06,411 RESEARCH NETWORK. 1231 01:03:22,394 --> 01:03:24,529 WE'VE LOOKED AT GETTING AT THE 1232 01:03:24,529 --> 01:03:27,098 IDEA OF REPRODUCIBILITY AND 1233 01:03:27,098 --> 01:03:28,333 TRIANGULATION TO SEE WHAT THE 1234 01:03:28,333 --> 01:03:30,568 TRUTH IS OUT THERE. 1235 01:03:30,568 --> 01:03:32,070 WE AT THE NEI HAVE COLLABORATED 1236 01:03:32,070 --> 01:03:36,107 WITH THE AMERICAN ACADEMY OF 1237 01:03:36,107 --> 01:03:38,410 OPHTHALMOLOGY AND OBSERVATIONAL 1238 01:03:38,410 --> 01:03:41,813 HEALTH DATA SCIENCE AND 1239 01:03:41,813 --> 01:03:51,790 INFORMATICS A GLOBAL PRIVAA 1240 01:03:51,790 --> 01:03:53,091 PARTNERSHIP BASED ON THE DATA 1241 01:03:53,091 --> 01:03:53,525 MODEL. 1242 01:03:53,525 --> 01:03:58,496 OVER THE LAST YEAR WE PUT OUT A 1243 01:03:58,496 --> 01:03:59,564 $1 MILLION CHALLENGE COMPETITION 1244 01:03:59,564 --> 01:04:02,767 FOR INNOVATIVE IDEAS TO BUILD 1245 01:04:02,767 --> 01:04:07,839 OUT A FEDERATED VISION RESEARCH 1246 01:04:07,839 --> 01:04:18,316 NETWORK AND STANDARDIZE TWO 1247 01:04:23,388 --> 01:04:25,390 MODELS TO BASICALLY MAP KEY DATA 1248 01:04:25,390 --> 01:04:27,192 ELEMENTS AND BUILD OUT THIS 1249 01:04:27,192 --> 01:04:28,526 COMMON DATA MODEL. 1250 01:04:28,526 --> 01:04:32,597 A GROUP AT OREGON, MICHELLE 1251 01:04:32,597 --> 01:04:35,200 RIBAR IS FILLING OUT A DATA 1252 01:04:35,200 --> 01:04:36,634 COORDINATING CENTER TO HARMONIZE 1253 01:04:36,634 --> 01:04:36,835 DATA. 1254 01:04:36,835 --> 01:04:38,636 A GROUP AT COLUMBIA IS LOOKING 1255 01:04:38,636 --> 01:04:43,274 AT A SPECIFIC PROJECT TO LOOK AT 1256 01:04:43,274 --> 01:04:46,711 OPHTHALMOLOGY MEDICATION USE AND 1257 01:04:46,711 --> 01:04:55,754 ADHERENCE AND A GROUP AT 1258 01:04:55,754 --> 01:04:58,723 STANFORD IS BUILDING OUT A DATA 1259 01:04:58,723 --> 01:04:59,758 NETWORK AND THIS GROUP CONTAINS 1260 01:04:59,758 --> 01:05:02,861 A LOT OF PEOPLE WHO ARE ALSO 1261 01:05:02,861 --> 01:05:03,661 MEMBERS OF THE PDIG CLINICAL 1262 01:05:03,661 --> 01:05:13,371 TRIALS NETWORK. 1263 01:05:13,371 --> 01:05:14,939 AND WE HAVE THIS FEDERATED 1264 01:05:14,939 --> 01:05:15,473 VISION NETWORK. 1265 01:05:15,473 --> 01:05:17,175 I'M EXCITED BY THIS. 1266 01:05:17,175 --> 01:05:19,377 AND AMBER AND KERRIE DID A LOT 1267 01:05:19,377 --> 01:05:22,847 OF WORK IN SHEPHERDING THIS 1268 01:05:22,847 --> 01:05:28,153 CHALLENGE COMPETITION. 1269 01:05:28,153 --> 01:05:29,420 AND YOU KNOW WE'VE BEEN 1270 01:05:29,420 --> 01:05:29,721 INTERESTED. 1271 01:05:29,721 --> 01:05:34,259 YOU CAN'T HAVE REPRODUCIBILITY 1272 01:05:34,259 --> 01:05:36,194 WITHOUT INTEROPERABILITY AND 1273 01:05:36,194 --> 01:05:38,963 HAVE LOOKED AT STANDARD FOR 1274 01:05:38,963 --> 01:05:40,198 OCULAR IMAGING. 1275 01:05:40,198 --> 01:05:42,667 IMAGING DEVICES ARE THE SOURCE 1276 01:05:42,667 --> 01:05:44,469 OF ALL THIS REVOLUTION IN 1277 01:05:44,469 --> 01:05:46,838 CLINICAL CARE, A.I., DATA 1278 01:05:46,838 --> 01:05:49,641 SCIENCE, OTHER AREAS OF RESEARCH 1279 01:05:49,641 --> 01:05:51,810 IN ALMOST EVERY AREA AND NOT 1280 01:05:51,810 --> 01:05:52,844 JUST VISION RESEARCH BUT 1281 01:05:52,844 --> 01:05:56,514 RESEARCH MORE WIDELY. 1282 01:05:56,514 --> 01:05:58,950 AND RAW DATA COMES OUT OF THESE 1283 01:05:58,950 --> 01:06:02,287 MACHINES THAT GET CONVERTED TO 1284 01:06:02,287 --> 01:06:03,788 PICTURES AND NUMBERS AND ONE OF 1285 01:06:03,788 --> 01:06:06,324 THE HUGE CHALLENGES THAT YOU 1286 01:06:06,324 --> 01:06:08,593 OFTEN CAN'T GET RAW DATA OUT OF 1287 01:06:08,593 --> 01:06:11,362 THESE DEVICES BECAUSE THEY'RE 1288 01:06:11,362 --> 01:06:13,364 LOCKED IN PROPRIETARY STANDARDS 1289 01:06:13,364 --> 01:06:16,467 AND DATA SHARING AND IN THE 1290 01:06:16,467 --> 01:06:17,502 RADIOLOGY FIELD THEY'VE GONE A 1291 01:06:17,502 --> 01:06:20,471 LONG WAY TOWARDS ADDRESSING THIS 1292 01:06:20,471 --> 01:06:23,808 THROUGH THE DICOM STANDARD WHERE 1293 01:06:23,808 --> 01:06:28,179 ALL THE RADIOLOGICAL DEVICE PLUG 1294 01:06:28,179 --> 01:06:30,582 AND PLAY FOR DECADES BECAUSE 1295 01:06:30,582 --> 01:06:32,383 THEY CONFORM TO THE STANDARD. 1296 01:06:32,383 --> 01:06:34,686 IN THE VISION FIELD WE HAVE 1297 01:06:34,686 --> 01:06:36,120 DICOM STANDARDS FOR MOST THE 1298 01:06:36,120 --> 01:06:37,589 DEVICES AND HAVE HAD THEM FOR 1299 01:06:37,589 --> 01:06:44,963 YEARS OR OVER A DECADE IN CASES 1300 01:06:44,963 --> 01:06:55,473 BUT THEY'RE OFTEN NOT ADOPTED. 1301 01:06:56,241 --> 01:06:58,076 WE'VE TRIED TO MOVE THAT NEEDAL 1302 01:06:58,076 --> 01:07:00,345 WITH PARTNERS AND YOU KNOW ABOUT 1303 01:07:00,345 --> 01:07:02,347 THE WORKSHOP WE'VE CONDUCTED A 1304 01:07:02,347 --> 01:07:04,649 FEW YEARS AGO A POSITION PAPER 1305 01:07:04,649 --> 01:07:10,288 PUT OUT BY THE ARPO AND PUT OUT 1306 01:07:10,288 --> 01:07:14,525 THE GUIDE NOTICE AND IT 1307 01:07:14,525 --> 01:07:18,162 BASICALLY SAYS WE DON'T WANT TO 1308 01:07:18,162 --> 01:07:21,833 USE RESEARCH IF IT USES DEVICE 1309 01:07:21,833 --> 01:07:24,636 DON'T CONFORM TO STANDARDS LIKE 1310 01:07:24,636 --> 01:07:24,836 DICOM. 1311 01:07:24,836 --> 01:07:26,771 THE FDA HAS BEEN GREAT IN 1312 01:07:26,771 --> 01:07:28,206 HELPING US. 1313 01:07:28,206 --> 01:07:32,377 INITIALLY IT WAS EDELMAN AND NOW 1314 01:07:32,377 --> 01:07:35,713 MARTIAL TARVER AND ASTM, OSC 1315 01:07:35,713 --> 01:07:36,881 WANTS TO LIMIT INFORMATION 1316 01:07:36,881 --> 01:07:37,315 LOCKING. 1317 01:07:37,315 --> 01:07:41,219 THE WAY I'VE BEEN MESSAGING THIS 1318 01:07:41,219 --> 01:07:44,555 IS THAT IF YOU WORK ON A STUDY 1319 01:07:44,555 --> 01:07:48,326 AND SUBMIT A GRANT AND GETS A 1 1320 01:07:48,326 --> 01:07:50,461 PERCENTILE AND USES DEVICES THAT 1321 01:07:50,461 --> 01:07:55,800 AREN'T DICOM OR ANOTHER STANDARD 1322 01:07:55,800 --> 01:07:58,903 THEN WE DON'T FUND IT, DON'T 1323 01:07:58,903 --> 01:08:00,672 COMPLAIN TO YOUR PROGRAM 1324 01:08:00,672 --> 01:08:01,406 OFFICER. 1325 01:08:01,406 --> 01:08:03,608 GO TO THE VENDOR AND TALK TO 1326 01:08:03,608 --> 01:08:04,909 THEM ABOUT THIS BECAUSE THIS IS 1327 01:08:04,909 --> 01:08:05,977 HOW WE'LL DO THE BEST RESEARCH 1328 01:08:05,977 --> 01:08:07,445 AND THIS IS HOW WE'RE GOING TO 1329 01:08:07,445 --> 01:08:10,782 TAKE THE BEST CARE OF PATIENTS 1330 01:08:10,782 --> 01:08:11,816 THAT'S OPERABLE AND 1331 01:08:11,816 --> 01:08:14,018 REPRODUCIBLE. 1332 01:08:14,018 --> 01:08:17,555 WHERE IS THIS HEADING RIGHT NOW? 1333 01:08:17,555 --> 01:08:22,293 WE'VE BEEN WORKINGS WITH NIBIB 1334 01:08:22,293 --> 01:08:23,795 AND BIO ENGINEERING AND THE FDA 1335 01:08:23,795 --> 01:08:27,799 ON DISCUSSIONS HOW TO ADVANCE 1336 01:08:27,799 --> 01:08:32,303 THE PHANTOMS FOR IMAGING 1337 01:08:32,303 --> 01:08:32,804 STANDARDS. 1338 01:08:32,804 --> 01:08:36,908 PEOPLE COMPLAIN WHY DOES ONE 1339 01:08:36,908 --> 01:08:40,712 MACHINE MEASURE THIS MICRONS AND 1340 01:08:40,712 --> 01:08:41,746 THOUGH I MEASURE THE SAME 1341 01:08:41,746 --> 01:08:42,914 PATIENT BACK-TO-BACK AND HOPE 1342 01:08:42,914 --> 01:08:50,655 THIS CAN ADDRESS THE CHALLENGES. 1343 01:08:50,655 --> 01:08:53,291 IN COUNCIL ABOUT A YEAR AGO JOSH 1344 01:08:53,291 --> 01:08:57,829 DENNY SPOKE ABOUT THE ALL OF US 1345 01:08:57,829 --> 01:08:59,464 PROJECT AND WE'VE HAD A SPEAKER 1346 01:08:59,464 --> 01:09:03,801 FROM NIBIB ABOUT ALL AREAS OF 1347 01:09:03,801 --> 01:09:06,504 OPHTHALMIC IMAGING. 1348 01:09:06,504 --> 01:09:11,642 AND SO THE GOAL OF THE STUDY NOW 1349 01:09:11,642 --> 01:09:15,747 CALLED EYES ON HEALTH IS TO 1350 01:09:15,747 --> 01:09:17,982 COLLECT RETINAL IMAGES. 1351 01:09:17,982 --> 01:09:23,688 AND FUND THE PHOTOS FROM 5,000 1352 01:09:23,688 --> 01:09:24,989 PEOPLE IN THREE "ALL OF US" 1353 01:09:24,989 --> 01:09:27,592 SITES AND HOW TO DO THAT TO 1354 01:09:27,592 --> 01:09:30,595 BUILD A DATA SET TO BE USED FOR 1355 01:09:30,595 --> 01:09:34,699 KNOWLEDGE DISCOVERY AND 1356 01:09:34,699 --> 01:09:38,669 MULTI-OMIC SCORES AND HOW DO WE 1357 01:09:38,669 --> 01:09:49,213 INTEGRATE IMAGES INTO RESEARCH? 1358 01:09:56,954 --> 01:09:57,822 IT WILL BE THE FIRST TIME FOR 1359 01:09:57,822 --> 01:09:59,557 THE ALL OF US STUDY. 1360 01:09:59,557 --> 01:10:01,626 THE PEOPLE WHO PARTICIPATE IN 1361 01:10:01,626 --> 01:10:07,865 THIS ARE GOING TO GET A PHOTO 1362 01:10:07,865 --> 01:10:11,936 AND EDUCATIONAL MATERIALS AND 1363 01:10:11,936 --> 01:10:13,905 FOR THEIR TIME AND IF THEY HAVE 1364 01:10:13,905 --> 01:10:17,442 SIGNS OF OCULAR TUMORS THEY'LL 1365 01:10:17,442 --> 01:10:18,743 BE NOTIFIED ABOUT THAT. 1366 01:10:18,743 --> 01:10:22,680 SO EXCITED ABOUT THIS AND JOSH 1367 01:10:22,680 --> 01:10:24,482 DENNY, THANK YOU TO YOU AND YOUR 1368 01:10:24,482 --> 01:10:26,317 TEAM AND AMBER REED, THANK YOU 1369 01:10:26,317 --> 01:10:28,119 FOR THE WORK YOU'VE DONE IN THIS 1370 01:10:28,119 --> 01:10:32,590 AREA. 1371 01:10:32,590 --> 01:10:33,758 THERE'S BEEN MANY THINGS THAT 1372 01:10:33,758 --> 01:10:37,428 HAVE EVOLVED ABOUT THE FUNDING 1373 01:10:37,428 --> 01:10:38,729 LANDSCAPE HERE AT NIH AND TO 1374 01:10:38,729 --> 01:10:45,303 MAKE SURE YOU KNOW ABOUT A FEW 1375 01:10:45,303 --> 01:10:46,504 RESOURCES. 1376 01:10:46,504 --> 01:10:47,805 INFORMATION ABOUT TERMINATED 1377 01:10:47,805 --> 01:10:51,008 GRANTS IS AVAILABLE AT A NEW 1378 01:10:51,008 --> 01:10:51,409 WEBSITE. 1379 01:10:51,409 --> 01:10:52,677 HERE'S THE QR CODE THAT TAKES 1380 01:10:52,677 --> 01:10:54,112 YOU TO THAT WEBSITE AND THE 1381 01:10:54,112 --> 01:10:55,480 TITLE IS TRACKING ACCOUNTABILITY 1382 01:10:55,480 --> 01:11:05,957 AND GOVERNMENT GRANT SYSTEM. 1383 01:11:08,493 --> 01:11:10,361 IS THERE A RELATIVELY NEW NIH 1384 01:11:10,361 --> 01:11:12,196 SYSTEM CALLED THE NIH GRANTS AND 1385 01:11:12,196 --> 01:11:16,200 FUNDING INFORMATION STATUS WEB 1386 01:11:16,200 --> 01:11:24,709 PAGE. 1387 01:11:24,709 --> 01:11:26,444 I KNOW PEOPLE GOT CONFUSED ABOUT 1388 01:11:26,444 --> 01:11:27,411 THE COMMUNICATIONS AND 1389 01:11:27,411 --> 01:11:28,379 INFORMATION ABOUT THE 1390 01:11:28,379 --> 01:11:29,080 APPLICATION PROCESSES, WHAT DO 1391 01:11:29,080 --> 01:11:30,748 YOU NEED TO SUBMIT AND WHAT 1392 01:11:30,748 --> 01:11:31,482 DON'T YOU? 1393 01:11:31,482 --> 01:11:32,817 REVIEW PROCESSES, WHAT'S 1394 01:11:32,817 --> 01:11:36,487 HAPPENING WITH STUDY SECTIONS, 1395 01:11:36,487 --> 01:11:37,321 POLICIES, ADMINISTRATION. 1396 01:11:37,321 --> 01:11:39,790 PLEASE CONSIDER BOOKMARKING 1397 01:11:39,790 --> 01:11:42,660 THAT. 1398 01:11:42,660 --> 01:11:44,695 WE ARE ACCEPTING APPLICATIONS 1399 01:11:44,695 --> 01:11:45,930 FOR FUNDING OPPORTUNITIES. 1400 01:11:45,930 --> 01:11:46,964 YOU KNOW THERE'S BEEN SOME 1401 01:11:46,964 --> 01:11:48,132 OPPORTUNITIES UNPUBLISHED AND 1402 01:11:48,132 --> 01:11:50,968 OTHERS HAVE BEEN UPDATED TO 1403 01:11:50,968 --> 01:11:54,205 ALIGN WITH DIFFERENT AGENCY 1404 01:11:54,205 --> 01:12:03,147 PRIORITIES. 1405 01:12:03,147 --> 01:12:04,982 PLEASE REREAD THEM AND WHAT IS 1406 01:12:04,982 --> 01:12:07,852 NO LONGER REQUIRED IS THE S AND 1407 01:12:07,852 --> 01:12:10,021 DIVERSITY PLANS OR RECRUITMENT 1408 01:12:10,021 --> 01:12:13,891 PLANS TO ENHANCE DIVERSITY. 1409 01:12:13,891 --> 01:12:14,859 PLEASE BOOKMARK THESE SITES. 1410 01:12:14,859 --> 01:12:18,729 I WANT TO MAKE SURE YOU'RE AWARE 1411 01:12:18,729 --> 01:12:24,235 OF THESE FUNDING OPPORTUNITIES 1412 01:12:24,235 --> 01:12:25,937 THROUGH THE BRAIN RESEARCH. 1413 01:12:25,937 --> 01:12:27,772 MARTHA FLANDERS HAS DONE GREAT 1414 01:12:27,772 --> 01:12:31,342 WORK IN LEADING US THROUGH THE 1415 01:12:31,342 --> 01:12:31,742 BRAIN INITIATIVE. 1416 01:12:31,742 --> 01:12:34,912 A NEW INITIATIVE, A NEW CONCEPT 1417 01:12:34,912 --> 01:12:36,747 IN EARLY STAGE RESEARCH FOR 1418 01:12:36,747 --> 01:12:39,383 RECORDING AND MODULATION IN THE 1419 01:12:39,383 --> 01:12:39,817 NERVOUS SYSTEM. 1420 01:12:39,817 --> 01:12:41,986 THIS IS THE RFA. 1421 01:12:41,986 --> 01:12:46,991 THE SECOND ONE HERE IS PROMOTING 1422 01:12:46,991 --> 01:12:48,993 HEATH THROUGH ALL THROUGH BRAIN 1423 01:12:48,993 --> 01:12:49,527 TECHNOLOGY PARTNERSHIPS. 1424 01:12:49,527 --> 01:12:51,762 THIS IS TARGETED FOR 1425 01:12:51,762 --> 01:12:53,965 INVESTIGATORS AT PLACES THAT 1426 01:12:53,965 --> 01:12:55,800 HAVEN'T BEEN MAJOR RECIPIENTS OF 1427 01:12:55,800 --> 01:12:57,535 NIH FUNDING. 1428 01:12:57,535 --> 01:13:01,272 AGAIN FOR BOTH OF THESE THE 1429 01:13:01,272 --> 01:13:05,009 CONTACT PERSON IS MARTHA AND 1430 01:13:05,009 --> 01:13:06,844 TO 1431 01:13:06,844 --> 01:13:09,847 TONY GOVER HAS BECOME INTERESTED 1432 01:13:09,847 --> 01:13:11,782 IN ACADEMIC PARTNERSHIPS FOR 1433 01:13:11,782 --> 01:13:21,425 TRANSLATION OF TECHNOLOGIES. 1434 01:13:21,425 --> 01:13:26,497 HE'S BEEN PROMOTING THIS RO1 TO 1435 01:13:26,497 --> 01:13:29,433 UNDERSTAND DISEASE OR IN APPLIED 1436 01:13:29,433 --> 01:13:33,037 RESEARCH TO ASSESS RISK, DETECT, 1437 01:13:33,037 --> 01:13:34,105 TREAT OR MANAGE DISEASE. 1438 01:13:34,105 --> 01:13:35,806 HERE'S THE PAR AND IF YOU'RE 1439 01:13:35,806 --> 01:13:39,210 INTERESTED IN THIS, TALK TO 1440 01:13:39,210 --> 01:13:39,410 TONO. 1441 01:13:39,410 --> 01:13:39,944 -- TONY. 1442 01:13:39,944 --> 01:13:41,545 LET ME FINISH AS I KNOW WE'RE AT 1443 01:13:41,545 --> 01:13:43,481 THE END OF THE HOUR. 1444 01:13:43,481 --> 01:13:45,416 ONE OF THE PARTS OF OUR MISSION 1445 01:13:45,416 --> 01:13:50,688 IS TO RECRUIT, INSPIRE AND TRAIN 1446 01:13:50,688 --> 01:13:51,088 THE WORKFORCE. 1447 01:13:51,088 --> 01:13:55,793 TO SHOUT OUT TO PEOPLE AT THE 1448 01:13:55,793 --> 01:13:57,428 NIH POST ORE DAY A COUPLE MONTHS 1449 01:13:57,428 --> 01:14:01,265 AGO, SIX OF OUR PEOPLE RESOURCED 1450 01:14:01,265 --> 01:14:11,776 OUTSTANDING POSTER AWARDS SO 1451 01:14:17,315 --> 01:14:18,149 CONGRATULATIONS TO THIS GROUP. 1452 01:14:18,149 --> 01:14:21,819 FOR THE PAST THREE YEARS WE'VE 1453 01:14:21,819 --> 01:14:28,993 CONDUCTED A HIGH SCHOOL VIDEO 1454 01:14:28,993 --> 01:14:33,230 CONTEST TO TRY TO KIDS 1455 01:14:33,230 --> 01:14:34,999 INTERESTED IN SCIENCE AND 1456 01:14:34,999 --> 01:14:35,800 OPHTHALMOLOGY AND THIS YEAR 1457 01:14:35,800 --> 01:14:39,403 BECAUSE OF SO MANY CHANGES WE 1458 01:14:39,403 --> 01:14:43,941 DECIDED TO DO THIS VIRTUALLY AND 1459 01:14:43,941 --> 01:14:45,843 WE'RE NOW HOSTING STUDENTS IN 1460 01:14:45,843 --> 01:14:47,011 BETHESDA BUT WANTED TO GIVE A 1461 01:14:47,011 --> 01:14:48,546 SHOUT OUT TO THE STUDENTS WHO 1462 01:14:48,546 --> 01:14:50,114 RECEIVED THESE BECAUSE THESE 1463 01:14:50,114 --> 01:14:53,150 VIDEOS WERE REALLY GOOD. 1464 01:14:53,150 --> 01:14:56,821 WE GOT MORE SUBMISSIONS THIS 1465 01:14:56,821 --> 01:14:58,622 YEAR THAN EVER BEFORE. 1466 01:14:58,622 --> 01:15:00,424 JACK LYNCH FROM MISSOURI WAS THE 1467 01:15:00,424 --> 01:15:03,994 WINNER OF SCIENCE IN YOUR WORLD 1468 01:15:03,994 --> 01:15:05,763 CATEGORY. 1469 01:15:05,763 --> 01:15:09,467 AND WE HAVE A WINNER FROM 1470 01:15:09,467 --> 01:15:10,234 WASHINGTON FROM THE SCIENCE IN 1471 01:15:10,234 --> 01:15:12,837 ACTION CATEGORY AND THE SCIENCE 1472 01:15:12,837 --> 01:15:17,007 IN YOUR FUTURE, MAXWELL GRACE 1473 01:15:17,007 --> 01:15:27,418 AND MUHAMMAD FAWAAZ AND 1474 01:15:27,852 --> 01:15:29,854 CONGRATULATIONS TO THIS GROUP. 1475 01:15:29,854 --> 01:15:31,655 LASTLY ONE BIG THING WE'VE BEEN 1476 01:15:31,655 --> 01:15:33,958 TRYING TO PROMOTE IS CAREER 1477 01:15:33,958 --> 01:15:34,258 DEVELOPMENT. 1478 01:15:34,258 --> 01:15:38,195 I'VE WORKED WITH THE 1479 01:15:38,195 --> 01:15:45,669 EDITOR-IN-CHIEF OF THE LEADING 1480 01:15:45,669 --> 01:15:50,274 VISUAL JOURNALS AND WE'VE HAD 1481 01:15:50,274 --> 01:15:51,909 HELP QUARTERBACKING THE GROUP 1482 01:15:51,909 --> 01:15:55,079 AND WE DEVELOPED A PROGRAM AS 1483 01:15:55,079 --> 01:15:58,883 FAR AS I KNOW MANY JOURNALS HAVE 1484 01:15:58,883 --> 01:16:00,584 EDITORIAL BOARDS MEANT TO TRAIN 1485 01:16:00,584 --> 01:16:01,552 JUNIOR PEOPLE BUT AS FAR AS I 1486 01:16:01,552 --> 01:16:03,788 KNOW THIS IS THE ONLY SUCH 1487 01:16:03,788 --> 01:16:06,056 PROGRAM ACROSS AN ENTIRE FIELD 1488 01:16:06,056 --> 01:16:07,158 OF DIFFERENT JOURNALS WORKING 1489 01:16:07,158 --> 01:16:08,325 TOGETHER AND I THINK IT'S A 1490 01:16:08,325 --> 01:16:11,395 TESTAMENT TO THE COMMUNITY THAT 1491 01:16:11,395 --> 01:16:14,231 WE HAVE. 1492 01:16:14,231 --> 01:16:16,567 SO THE GOAL IS THAT FROM MY 1493 01:16:16,567 --> 01:16:19,804 PERSPECTIVE I WANT TO CREATE 1494 01:16:19,804 --> 01:16:20,538 CAREER DEVELOPMENT OPPORTUNITIES 1495 01:16:20,538 --> 01:16:22,506 FOR YOUNG SCIENTISTS AND 1496 01:16:22,506 --> 01:16:27,144 CLINICIAN SCIENTISTS K AWARDEES. 1497 01:16:27,144 --> 01:16:31,348 AND FROM THE JOURNAL'S 1498 01:16:31,348 --> 01:16:34,151 PERSPECTIVE THEY WANT EDITORIAL 1499 01:16:34,151 --> 01:16:34,385 MEMBERS. 1500 01:16:34,385 --> 01:16:38,489 WE RECENTLY ANNOUNCED A SECOND 1501 01:16:38,489 --> 01:16:42,059 COHORT OF FACULTY OF NINE PEOPLE 1502 01:16:42,059 --> 01:16:44,028 PICTURED HERE. 1503 01:16:44,028 --> 01:16:47,598 THERE'S A SCIENCE OF SCIENCE 1504 01:16:47,598 --> 01:16:48,699 SCHOLARS PILOT PROGRAM WITHIN 1505 01:16:48,699 --> 01:16:50,501 THE OFFICE OF THE DIRECTOR AND 1506 01:16:50,501 --> 01:16:53,070 PAIRS RESEARCHERS INTERESTED IN 1507 01:16:53,070 --> 01:16:54,605 METASCIENCE TOGETHER WITH NIH 1508 01:16:54,605 --> 01:16:57,141 STAFF TO ANALYZE NIH PROCESSES 1509 01:16:57,141 --> 01:16:59,510 AND THEY'LL GET ACCESS TO NIH 1510 01:16:59,510 --> 01:16:59,977 ADMINISTRATIVE DATA. 1511 01:16:59,977 --> 01:17:06,484 AND IRA IS THE LEAD ON THIS. 1512 01:17:06,484 --> 01:17:10,087 IF YOU'RE INTERESTED HERE'S THE 1513 01:17:10,087 --> 01:17:15,092 QR CODE AND THESE TWO HAVE BEEN 1514 01:17:15,092 --> 01:17:17,094 MANAGING THE EARLY STAGE 1515 01:17:17,094 --> 01:17:17,995 INVESTIGATOR RO1 GRANTS AND THE 1516 01:17:17,995 --> 01:17:25,936 WAY YOU QUALINGFYFY IS YOU'RE N 1517 01:17:25,936 --> 01:17:26,570 EXPECTED TO HAVE PRELIMINARY 1518 01:17:26,570 --> 01:17:26,770 DATA. 1519 01:17:26,770 --> 01:17:27,805 IF YOU'RE INTERESTED TALK TO 1520 01:17:27,805 --> 01:17:36,680 THEM. 1521 01:17:36,680 --> 01:17:38,616 YOU KNOW THIS IS UNDER A LOT OF 1522 01:17:38,616 --> 01:17:41,118 DEBATE RIGHT NOW AND THE ONE 1523 01:17:41,118 --> 01:17:43,787 THING WE DO KNOW FOR CERTAIN IS 1524 01:17:43,787 --> 01:17:45,589 THAT WE ARE UNDER CONTINUING 1525 01:17:45,589 --> 01:17:46,056 RESOLUTION. 1526 01:17:46,056 --> 01:17:49,026 THAT WAS PASSED IN MARCH 2025. 1527 01:17:49,026 --> 01:17:51,795 AND THAT PROVIDES CONTINUING 1528 01:17:51,795 --> 01:17:53,130 FY25 APPROPRIATIONS FOR FEDERAL 1529 01:17:53,130 --> 01:17:55,366 AGENCIES THROUGH THE END OF THE 1530 01:17:55,366 --> 01:17:58,335 PHYSICAL YEAR WHICH FOR -- 1531 01:17:58,335 --> 01:18:00,104 FISCAL YEAR AND WE'VE CONTINUED 1532 01:18:00,104 --> 01:18:03,173 AT FY24 LEVELS. 1533 01:18:03,173 --> 01:18:11,115 SO I'M GOING END IT WITH THAT 1534 01:18:11,115 --> 01:18:15,786 AND OPEN UP IF PEOPLE HAVE 1535 01:18:15,786 --> 01:18:26,163 COMMENTS OR QUESTIONS. 1536 01:18:33,904 --> 01:18:37,508 >> THANK YOU FOR THE REVIEW OF 1537 01:18:37,508 --> 01:18:38,676 WHAT THE VISION RESEARCH 1538 01:18:38,676 --> 01:18:40,010 COMMUNITY AND NEI HAS BEEN ABLE 1539 01:18:40,010 --> 01:18:50,254 TO ACCOMPLISH. 1540 01:18:59,029 --> 01:19:01,432 IT'S IMPRESSIVE NEI HAS BEEN IN 1541 01:19:01,432 --> 01:19:03,534 ITS MISSION AND HOPE IT WAS MORE 1542 01:19:03,534 --> 01:19:05,135 IMPRESSIVE TO THOSE OUTSIDE THE 1543 01:19:05,135 --> 01:19:15,312 COMMUNITY. 1544 01:19:21,518 --> 01:19:27,224 PART OF CONTINUING OF NEI 1545 01:19:27,224 --> 01:19:29,126 FULFILLING ITS MISSION WORKING 1546 01:19:29,126 --> 01:19:31,161 TOWARDS NEI AS AN INDEPENDENT 1547 01:19:31,161 --> 01:19:31,428 INSTITUTE. 1548 01:19:31,428 --> 01:19:33,163 I HAVE GREAT CONCERNS ABOUT THE 1549 01:19:33,163 --> 01:19:36,500 DISCUSSIONS OF CONSOLIDATION AT 1550 01:19:36,500 --> 01:19:39,803 INSTITUTES WITH ME HERE TO THE 1551 01:19:39,803 --> 01:19:50,080 COUNCIL MEETING. 1552 01:20:00,524 --> 01:20:02,993 IS THERE ANY ANALYSIS OR STUDY 1553 01:20:02,993 --> 01:20:07,865 AT THIS POINT ABOUT THE AFFECT 1554 01:20:07,865 --> 01:20:10,668 ON CONSOLIDATION ON THE NEI'S 1555 01:20:10,668 --> 01:20:12,736 ABILITY TO CONTINUE ITS MISSION. 1556 01:20:12,736 --> 01:20:14,938 WE'RE ALL INTERESTED IN 1557 01:20:14,938 --> 01:20:17,107 EFFICIENCIES AND SO FORTH. 1558 01:20:17,107 --> 01:20:19,777 DOES CONSOLIDATION SERVE NEI'S 1559 01:20:19,777 --> 01:20:22,880 PURPOSES AND I DON'T KNOW HOW 1560 01:20:22,880 --> 01:20:24,448 MUCH YOU'RE AT LIBERTY TO 1561 01:20:24,448 --> 01:20:26,684 DISCUSS OR KNOW AT THIS POINT. 1562 01:20:26,684 --> 01:20:33,357 EVOLUTION IS WE ADAPT AND EVOLVE 1563 01:20:33,357 --> 01:20:35,426 DO WE HAVE A SENSE OF THE EFFECT 1564 01:20:35,426 --> 01:20:39,063 OF CONSOLIDATION ON NEI'S 1565 01:20:39,063 --> 01:20:42,332 ABILITY TO CONTINUE ITS MISSION? 1566 01:20:42,332 --> 01:20:47,137 >> THANK YOU FOR RAISING THESE 1567 01:20:47,137 --> 01:20:57,281 ISSUES. 1568 01:21:02,352 --> 01:21:06,123 NONE OF US ARE PERMITTED TO 1569 01:21:06,123 --> 01:21:06,724 OPINE ON SPENDING LEGISLATION 1570 01:21:06,724 --> 01:21:07,524 BUT WE ARE ALLOWED TO DO IS TALK 1571 01:21:07,524 --> 01:21:09,159 ABOUT FACTS SO I'LL TRY TO LAY 1572 01:21:09,159 --> 01:21:11,128 OUT SOME OF THE FACTS IN 1573 01:21:11,128 --> 01:21:18,268 RESPONSE TO WHAT YOU MENTIONED. 1574 01:21:18,268 --> 01:21:21,805 MY JOB IS TO TALK ABOUT WHAT WE 1575 01:21:21,805 --> 01:21:23,807 DO IN THE SETTING WE'RE IN AND 1576 01:21:23,807 --> 01:21:26,143 WITH THE RESOURCE WE HAVE. 1577 01:21:26,143 --> 01:21:27,611 I'M EXTRAORDINARY PROUD OF WHAT 1578 01:21:27,611 --> 01:21:29,646 THIS COMMUNITY HAS DONE AND WHAT 1579 01:21:29,646 --> 01:21:33,317 WE'VE BEEN ABLE TO DO AND I 1580 01:21:33,317 --> 01:21:37,421 THINK THAT WHAT WE TALK ABOUT 1581 01:21:37,421 --> 01:21:43,060 HERE IN THIS HOUR IS TRULY IN MY 1582 01:21:43,060 --> 01:21:43,594 ASSESSMENT THE TIP OF THE 1583 01:21:43,594 --> 01:21:44,261 ICEBERG IN TERMS OF WHAT'S BEEN 1584 01:21:44,261 --> 01:21:46,363 HAPPENING IN BETHESDA AND THAT'S 1585 01:21:46,363 --> 01:21:48,766 A TESTAMENT TO ME AND THE TEAM 1586 01:21:48,766 --> 01:21:50,200 WE HAVE HERE AND HOW PEOPLE LIKE 1587 01:21:50,200 --> 01:21:51,802 YOU ON COUNCIL HAVE HELPED GUIDE 1588 01:21:51,802 --> 01:22:01,645 US THROUGH THIS. 1589 01:22:01,645 --> 01:22:05,516 I WOULD SAY SO A COUPLE OF THE 1590 01:22:05,516 --> 01:22:10,387 FACTS ARE THAT WE WERE FOUNDED 1591 01:22:10,387 --> 01:22:13,457 IN 1968 AS ABLE INDEPENDENT 1592 01:22:13,457 --> 01:22:14,958 INSTITUTE AND BEFORE THAT WE 1593 01:22:14,958 --> 01:22:16,393 WERE WITHIN THE NEUROLOGY 1594 01:22:16,393 --> 01:22:16,760 INSTITUTE. 1595 01:22:16,760 --> 01:22:27,304 BACK IN 1968, ONE OF THE REASONS 1596 01:22:31,909 --> 01:22:32,409 NEI WAS FOUNDED WITHIN THE 1597 01:22:32,409 --> 01:22:33,043 VISION COMMUNITY THERE WERE DATA 1598 01:22:33,043 --> 01:22:34,044 SHOWING AMERICANS WERE MORE 1599 01:22:34,044 --> 01:22:35,179 CONCERNED ABOUT VISION LOSS 1600 01:22:35,179 --> 01:22:36,847 COMPARED TO MANY OF THE OTHER 1601 01:22:36,847 --> 01:22:42,152 PROBLEMS THAT PEOPLE CAN HAVE. 1602 01:22:42,152 --> 01:22:44,354 THE OTHER CONCERN THAT LED TO 1603 01:22:44,354 --> 01:22:48,492 THE FOUNDING IN 1968 WAS VISION 1604 01:22:48,492 --> 01:22:52,396 PROPOSALS OFTEN GOT LOST WITHIN 1605 01:22:52,396 --> 01:22:54,198 OTHER THINGS IN THE BRAIN AND 1606 01:22:54,198 --> 01:22:55,799 THINGS THAT AREN'T INVOLVING THE 1607 01:22:55,799 --> 01:22:58,569 BRAIN. 1608 01:22:58,569 --> 01:23:06,777 OR NEUROSCIENCE PER SE. 1609 01:23:06,777 --> 01:23:07,811 THAT'S WHAT'S LED TO NEI BEING 1610 01:23:07,811 --> 01:23:08,045 FOUNDED. 1611 01:23:08,045 --> 01:23:11,215 THE OTHER FACTOR IS THAT SINCE 1612 01:23:11,215 --> 01:23:14,518 1968 WE NOW HAVE WAYS TO MANAGE 1613 01:23:14,518 --> 01:23:16,253 ALMOST ALL THE COMMON CAUSES OF 1614 01:23:16,253 --> 01:23:17,588 VISION LOSS. 1615 01:23:17,588 --> 01:23:19,122 THEY DON'T ALWAYS WORK AS WELL 1616 01:23:19,122 --> 01:23:23,160 AS WE WOULD LIKE BUT IN 1968 WE 1617 01:23:23,160 --> 01:23:28,532 DIDN'T HAVE THOSE AND MOST WERE 1618 01:23:28,532 --> 01:23:28,899 BLINDING. 1619 01:23:28,899 --> 01:23:36,573 ONE OF THE THINGS AND BECAUSE OF 1620 01:23:36,573 --> 01:23:40,611 THINGS AT THE NEI AND WHEN I SAY 1621 01:23:40,611 --> 01:23:44,381 WE, I WASN'T AROUND IN 1968 AND 1622 01:23:44,381 --> 01:23:47,184 CERTAINLY WASN'T LEADING THIS 1623 01:23:47,184 --> 01:23:54,725 INSTITUTE. 1624 01:23:54,725 --> 01:23:57,194 THOSE ARE FACTS. 1625 01:23:57,194 --> 01:23:58,795 NOW, THAT DOESN'T PROVE ANY 1626 01:23:58,795 --> 01:23:59,796 ASSOCIATION. 1627 01:23:59,796 --> 01:24:02,900 THE OTHER FACT IS YES, IT IS AS 1628 01:24:02,900 --> 01:24:05,636 YOU'RE SUGGESTING THERE'S A 1629 01:24:05,636 --> 01:24:09,840 BUDGET AND A BILL THAT PROPOSES 1630 01:24:09,840 --> 01:24:11,575 CONSOLIDATION OF 27 INSTITUTES 1631 01:24:11,575 --> 01:24:15,779 INTO EIGHT INSTITUTES AND IN 1632 01:24:15,779 --> 01:24:26,290 THAT PROPOSAL WE GO WITH THE 1633 01:24:26,857 --> 01:24:27,190 VISUAL RESEARCH. 1634 01:24:27,190 --> 01:24:32,062 I THINK DIFFERENT -- WE'RE GOING 1635 01:24:32,062 --> 01:24:34,164 TO DO FROM MY PERSPECTIVE WE'RE 1636 01:24:34,164 --> 01:24:35,799 GOING TO DO THE BEST JOB IN THE 1637 01:24:35,799 --> 01:24:38,268 SETTING WE'RE PLACED IN. 1638 01:24:38,268 --> 01:24:48,712 AND PEOPLE HAVE OPINIONS. 1639 01:24:52,049 --> 01:24:52,616 THERE ARE MECHANISMS THAT SHARE 1640 01:24:52,616 --> 01:24:52,983 THOSE OPINIONS. 1641 01:24:52,983 --> 01:24:53,617 THAT'S NOT MY JOB OR WHAT TO SAY 1642 01:24:53,617 --> 01:24:54,251 MY JOB IS TO DO THE BEST I CAN 1643 01:24:54,251 --> 01:24:54,818 DO IN THE SETTING WE'RE IN. 1644 01:24:54,818 --> 01:25:02,793 AND I DO THINK THAT ONE OPINION 1645 01:25:02,793 --> 01:25:03,427 THAT I AM PERMITTED TO SHARE IS 1646 01:25:03,427 --> 01:25:04,061 THAT I'M PROUD OF THE JOB WE'VE 1647 01:25:04,061 --> 01:25:04,728 DONE AND I DON'T FEEL I CAN BE 1648 01:25:04,728 --> 01:25:07,264 THE ONE THAT TAKES THE CREDIT. 1649 01:25:07,264 --> 01:25:13,403 FOR -- THAT WE TRY TO HIGHLIGHT 1650 01:25:13,403 --> 01:25:14,705 THOSE DOING THE REAL WORK ON 1651 01:25:14,705 --> 01:25:14,905 THAT. 1652 01:25:14,905 --> 01:25:18,075 I HOPE THAT ADDRESSES SOME OF 1653 01:25:18,075 --> 01:25:22,012 THE THINGS YOU'RE GETTING AT 1654 01:25:22,012 --> 01:25:22,813 HERE. 1655 01:25:22,813 --> 01:25:25,282 >> I APPRECIATE YOUR ADVOCACY. 1656 01:25:25,282 --> 01:25:28,719 IT'S VERY MUCH APPRECIATED AND I 1657 01:25:28,719 --> 01:25:35,225 APPRECIATE YOUR ANSWER TO A 1658 01:25:35,225 --> 01:25:35,659 SENSITIVE QUESTION. 1659 01:25:35,659 --> 01:25:36,293 I GUESS WITHIN THE CONSTRAINTS 1660 01:25:36,293 --> 01:25:45,435 THEIR FACTS, ARE YOU AWARE OF 1661 01:25:45,435 --> 01:25:48,071 ANY EVEN-HANDED ANALYSIS WITH OR 1662 01:25:48,071 --> 01:25:53,176 WITHOUT NIH OF SORT OF POSTCONS 1663 01:25:53,176 --> 01:26:01,918 AND BALANCE OF CONTROL OF 1664 01:26:01,918 --> 01:26:03,387 LEGISLATION OR ALL I CAN TELL 1665 01:26:03,387 --> 01:26:06,056 YOU IS HERE'S THE GOOD WE'VE 1666 01:26:06,056 --> 01:26:06,256 DONE. 1667 01:26:06,256 --> 01:26:09,593 YOU MAKE THE CALL LEGISLATIVELY. 1668 01:26:09,593 --> 01:26:13,864 IS THERE ANY ANALYSIS OR IS IT 1669 01:26:13,864 --> 01:26:16,066 GOING TO BE A LEGISLATIVE 1670 01:26:16,066 --> 01:26:22,039 DECISION? 1671 01:26:22,039 --> 01:26:24,341 >> ITEM NOT AWARE OF ANY 1672 01:26:24,341 --> 01:26:24,908 ANALYSIS. 1673 01:26:24,908 --> 01:26:28,979 THESE ARE THINGS YOU CAN'T DO 1674 01:26:28,979 --> 01:26:31,014 CONTROL STUDIES ON VERSUS 1675 01:26:31,014 --> 01:26:31,415 WITHOUT. 1676 01:26:31,415 --> 01:26:35,419 ONE OF THE THINGS -- I SEE AS MY 1677 01:26:35,419 --> 01:26:41,558 JOB TO REPRESENT A COMMUNITY. 1678 01:26:41,558 --> 01:26:43,794 IN THIS CASE THE COMMUNITY IS 1679 01:26:43,794 --> 01:26:47,130 PEOPLE LIKE, NUMBER ONE WHO HAVE 1680 01:26:47,130 --> 01:26:49,533 DISEASE THAT AFFECT THE EYE OR 1681 01:26:49,533 --> 01:26:52,602 WHO HAVE VISION LOSS OR 1682 01:26:52,602 --> 01:26:59,643 CONCERNED ABOUT DISEASES. 1683 01:26:59,643 --> 01:27:02,446 AND THAT'S THE COMMUNITY IT 1684 01:27:02,446 --> 01:27:04,347 THAT'S THE CONSTITUENCY FOR LACK 1685 01:27:04,347 --> 01:27:05,782 OF A BETTER WORD. 1686 01:27:05,782 --> 01:27:07,184 THE OTHER COMMUNITY WE REPRESENT 1687 01:27:07,184 --> 01:27:09,219 IS THE PEOPLE WHO DO RESEARCH IN 1688 01:27:09,219 --> 01:27:11,521 THAT AREA -- IN THOSE AREAS AND 1689 01:27:11,521 --> 01:27:13,890 THE PEOPLE WHO POTENTIALLY CAN 1690 01:27:13,890 --> 01:27:15,058 BE DOING RESEARCH BECAUSE OF 1691 01:27:15,058 --> 01:27:20,397 THEIR EXPERTISE OVERLAPS AND SO 1692 01:27:20,397 --> 01:27:22,632 I THINK REGARDLESS OF WHAT THE 1693 01:27:22,632 --> 01:27:23,733 SITUATION IS, WE'LL HAVE TO FIND 1694 01:27:23,733 --> 01:27:25,335 WAYS TO CONNECT WITH THOSE 1695 01:27:25,335 --> 01:27:25,635 COMMUNITIES. 1696 01:27:25,635 --> 01:27:28,004 RIGHT NOW OF COURSE THERE'S A 1697 01:27:28,004 --> 01:27:29,272 NATIONAL WAY TO DO IT BECAUSE 1698 01:27:29,272 --> 01:27:30,207 WE'RE AN EYE INSTITUTE. 1699 01:27:30,207 --> 01:27:33,276 I THINK THOSE ARE SOME OF THE 1700 01:27:33,276 --> 01:27:33,844 ISSUES THAT WE'VE ALL BEEN 1701 01:27:33,844 --> 01:27:44,154 THINKING THROUGH. 1702 01:27:47,991 --> 01:27:50,160 >> THANK YOU, MICHAEL. 1703 01:27:50,160 --> 01:27:58,568 >> ANNA, I MAY TURN BACK TO YOU? 1704 01:27:58,568 --> 01:28:00,303 >> THANK YOU FOR THAT. 1705 01:28:00,303 --> 01:28:03,006 LET'S TAKE I'M GOING TO ROUND IT 1706 01:28:03,006 --> 01:28:03,440 UP. 1707 01:28:03,440 --> 01:28:06,009 LET'S TAKE A 17-MINUTE BREAK. 1708 01:28:06,009 --> 01:28:08,879 LET'S RETURN AT 11:45. 1709 01:28:08,879 --> 01:28:14,985 AND THEN WE WILL START WITH 1710 01:28:14,985 --> 01:28:19,256 DR. HONGMAN SONG AND TAKE A 1711 01:28:19,256 --> 01:28:20,924 QUICK BREAK AND 11:45 WE'LL 1712 01:28:20,924 --> 01:28:21,791 RESUME AND AFTER OPEN SESSION 1713 01:28:21,791 --> 01:28:23,627 WE'LL GO RIGHT INTO THE CLOSED 1714 01:28:23,627 --> 01:28:23,860 SESSION. 11:45. 1715 01:28:23,860 --> 01:28:42,641 SEE YOU THEN. 1716 01:28:42,641 --> 01:28:52,918 I'D LIKE TO INTRODUCE PRADEET 1717 01:28:52,918 --> 01:28:55,587 RAMULU. 1718 01:28:55,587 --> 01:28:57,556 CAN YOU UNMUTE AND INTRODUCE 1719 01:28:57,556 --> 01:28:58,257 YOURSELF TO THE AUDIENCE, 1720 01:28:58,257 --> 01:29:08,400 PLEASE. 1721 01:29:18,410 --> 01:29:20,913 >> SURE. 1722 01:29:20,913 --> 01:29:24,016 SORRY I WASN'T HERE EARLIER. 1723 01:29:24,016 --> 01:29:26,185 THIS IS OUR ANNUAL RESIDENCE 1724 01:29:26,185 --> 01:29:26,985 DAY. 1725 01:29:26,985 --> 01:29:32,391 MICHAEL, CONGRATULATIONS ON 1726 01:29:32,391 --> 01:29:36,929 BEING ALUMNI AND I'M WITH JOHN 1727 01:29:36,929 --> 01:29:39,031 HOPKINS MY RESEARCH IS IN 1728 01:29:39,031 --> 01:29:41,033 FUNCTIONAL IMPAIRMENT AND HOW IT 1729 01:29:41,033 --> 01:29:45,471 DERIVES FROM DIMINISHED 1730 01:29:45,471 --> 01:29:48,240 CAPABILITY AND HOW IT MAY BE 1731 01:29:48,240 --> 01:29:53,879 REHABILITATED. 1732 01:29:53,879 --> 01:29:54,813 >> HOW TO FOR BEING HERE. 1733 01:29:54,813 --> 01:29:56,181 I KNOW YOU'RE IN TWO PLACES AT 1734 01:29:56,181 --> 01:29:56,782 THE SAME TIME. 1735 01:29:56,782 --> 01:29:58,751 GREAT TO SEE YOU AND THANK YOU. 1736 01:29:58,751 --> 01:29:59,518 ANNA, CAN WE GO BACK TO YOU? 1737 01:29:59,518 --> 01:30:02,621 >> THANK YOU. 1738 01:30:02,621 --> 01:30:10,262 SO WE WILL NOW HAVE INE -- AN 1739 01:30:10,262 --> 01:30:16,235 UPDATE FROM DR. SONG ON THE 1740 01:30:16,235 --> 01:30:26,712 TRIENNIAL INCLUSION REPORT. 1741 01:30:35,087 --> 01:30:45,431 >> DR. SONG YOUR MUTED. 1742 01:30:57,843 --> 01:31:00,512 >> WE'LL TRY THAT AGAIN. 1743 01:31:00,512 --> 01:31:02,948 THERE YOU GO. 1744 01:31:16,195 --> 01:31:19,398 >> WE NEED TO REPORT TO THE 1745 01:31:19,398 --> 01:31:29,875 COUNCIL FROM THE NEI IN THE 1746 01:31:32,177 --> 01:31:32,878 CERTIFYING COMPLIANCE WITH THE 1747 01:31:32,878 --> 01:31:35,881 NIH PARTICIPANT INCLUSION 1748 01:31:35,881 --> 01:31:38,283 GUIDELINES AND SUPPORTING THE 1749 01:31:38,283 --> 01:31:38,917 RESEARCH AND PRESENT THE DATA TO 1750 01:31:38,917 --> 01:31:46,358 THE COUNCIL. 1751 01:31:46,358 --> 01:31:47,693 UTE -- 1752 01:31:51,797 --> 01:31:56,168 OUTLINED HERE IS THE POLICY. 1753 01:31:56,168 --> 01:31:59,771 THIS POLICY IS ALWAYS ON OUR 1754 01:31:59,771 --> 01:32:00,706 WEBSITE. 1755 01:32:00,706 --> 01:32:10,082 THE FUNDING OPPORTUNITY THERE'S 1756 01:32:10,082 --> 01:32:12,284 TO ADVOCATE AND INSTRUCT PEER 1757 01:32:12,284 --> 01:32:13,952 REVIEW MANUALS AND TRAIN OUR 1758 01:32:13,952 --> 01:32:14,152 STAFF. 1759 01:32:14,152 --> 01:32:17,956 WE ALSO HAVE TRACKING SYSTEM TO 1760 01:32:17,956 --> 01:32:20,392 DOCUMENT THE COMPLIANCE IN FACTS 1761 01:32:20,392 --> 01:32:24,429 IN ADDITION PROGRAM DIRECTORS 1762 01:32:24,429 --> 01:32:29,234 AND ANALYSIS IN THE TRIALS AND 1763 01:32:29,234 --> 01:32:30,802 PROVIDE OVERSIGHT TO ENSURE 1764 01:32:30,802 --> 01:32:31,470 COMPLIANT. 1765 01:32:31,470 --> 01:32:34,172 AND I WANT TO OFFER THE SLIDE IN 1766 01:32:34,172 --> 01:32:39,545 TERMS OF DATA WE HAVE HERE. 1767 01:32:39,545 --> 01:32:45,784 THIS TABLE OF ENROLLMENT FOR NEI 1768 01:32:45,784 --> 01:32:48,420 SUPPORTED RESEARCH. 1769 01:32:48,420 --> 01:32:52,157 OVER THE PAST THREE YEARS THE 1770 01:32:52,157 --> 01:32:55,394 SECOND HERE SHOWS THE NUMBER OF 1771 01:32:55,394 --> 01:33:02,501 TOTAL IERs AT NEI AND SOME 1772 01:33:02,501 --> 01:33:07,472 PROJECT HAVE NOT YET ENROLLED 1773 01:33:07,472 --> 01:33:07,773 PARTICIPANT. 1774 01:33:07,773 --> 01:33:12,311 SO THERE'S A RESULT IN I ASK THE 1775 01:33:12,311 --> 01:33:16,415 RESULT IN ENROLLMENT. 1776 01:33:16,415 --> 01:33:23,655 ON AVERAGE PER YEAR AS SHOWN IN 1777 01:33:23,655 --> 01:33:24,823 THE ORANGE BOX. 1778 01:33:24,823 --> 01:33:28,727 MOST OF THESE STUDIES ARE 1779 01:33:28,727 --> 01:33:35,167 CONDUCTED AT THE SITES. 1780 01:33:35,167 --> 01:33:37,069 AND HAVE FEMALE OR MALE ONLY 1781 01:33:37,069 --> 01:33:37,936 STUDIES. 1782 01:33:37,936 --> 01:33:42,808 AND THE MAJORITY OF IERs WITH 1783 01:33:42,808 --> 01:33:44,476 ENROLLMENT INCLUDE BOTH MALE AND 1784 01:33:44,476 --> 01:33:54,786 FEMALE PARTICIPANTS. 1785 01:33:54,786 --> 01:33:57,789 LET'S FIRST LOOK AT DATA BY SEX. 1786 01:33:57,789 --> 01:34:00,459 THIS IS FOR DOMESTIC PARTICIPANT 1787 01:34:00,459 --> 01:34:03,895 THE SUPPORTED SUBJECT RESEARCH. 1788 01:34:03,895 --> 01:34:08,133 THE BLACK IS THE NEI AND THE 1789 01:34:08,133 --> 01:34:09,167 WHITE IS THE U.S. POPULATION. 1790 01:34:09,167 --> 01:34:14,573 AND THE SUPPORTED STUDIES 54% OF 1791 01:34:14,573 --> 01:34:16,441 PARTICIPANTS ARE FEMALE WHICH IS 1792 01:34:16,441 --> 01:34:20,445 COMPARABLE TO THE PERCENTAGE IN 1793 01:34:20,445 --> 01:34:25,083 THE POPULATION. 1794 01:34:25,083 --> 01:34:29,154 HERE WE LOOK AT THE MAKE UP OF 1795 01:34:29,154 --> 01:34:31,990 PARTICIPANTS AS SHOWN IN THE 1796 01:34:31,990 --> 01:34:33,258 CHART. 1797 01:34:33,258 --> 01:34:37,062 WE'RE PUTTING PEOPLE FROM ALMOST 1798 01:34:37,062 --> 01:34:39,765 EVERY CATEGORY. 1799 01:34:39,765 --> 01:34:44,302 IF YOU LOOK AT THE HISPANIC, 1800 01:34:44,302 --> 01:34:47,706 NON-HISPANIC IT'S MORE THAN 15% 1801 01:34:47,706 --> 01:34:50,142 PARTICIPANT IDENTIFY AS HISPANIC 1802 01:34:50,142 --> 01:34:54,746 IN THE IN OUR HUMAN PROJECTS. 1803 01:34:54,746 --> 01:34:58,650 THE NEXT IS TRIALS. 1804 01:34:58,650 --> 01:35:01,353 THE CHART SHOWS THE PERCENTAGES 1805 01:35:01,353 --> 01:35:04,322 OF MALE AND FEMALE PARTICIPANTS 1806 01:35:04,322 --> 01:35:09,695 IN OUR TRIALS. 1807 01:35:09,695 --> 01:35:16,702 AND HERE AGAIN THE PARTICIPANS 1808 01:35:16,702 --> 01:35:19,538 IN THE U.S. POPULATION. 1809 01:35:19,538 --> 01:35:23,108 IN TERMS OF CATEGORIES, 1810 01:35:23,108 --> 01:35:26,912 INDIVIDUALS REPRESENT THE 13% OF 1811 01:35:26,912 --> 01:35:31,116 PARTICIPANTS IN OUR TRIALS. 1812 01:35:31,116 --> 01:35:32,350 THANK YOU FOR YOUR ATTENTION. 1813 01:35:32,350 --> 01:35:40,058 I'LL NOW HAND IT BACK TO DR 1814 01:35:40,058 --> 01:35:40,325 DR. FANG. 1815 01:35:40,325 --> 01:35:41,126 >> THANK YOU VERY MUCH. 1816 01:35:41,126 --> 01:35:44,696 WE WOULD LIKE TO NOW OPEN THE 1817 01:35:44,696 --> 01:35:45,931 MEETING FOR GENERAL DISCUSSION 1818 01:35:45,931 --> 01:35:47,065 FOR THE COUNCIL MEMBERS. 1819 01:35:47,065 --> 01:35:49,668 IF YOU HAVE A QUESTION YOU CAN 1820 01:35:49,668 --> 01:35:51,069 ASK DIRECTLY TO DR. SONG OR OPEN 1821 01:35:51,069 --> 01:35:51,636 IT UP. 1822 01:35:51,636 --> 01:35:54,239 I'LL HAND IT OVER TO DR. CHIANG 1823 01:35:54,239 --> 01:35:58,977 TO MODERATE. 1824 01:35:58,977 --> 01:35:59,978 >> THANK YOU. 1825 01:35:59,978 --> 01:36:03,381 HAPPY IT TALK ABOUT ANY COMMENTS 1826 01:36:03,381 --> 01:36:08,453 PEOPLE HAVE 1827 01:36:08,453 --> 01:36:13,759 >> THANKS FOR THE REPORT. 1828 01:36:13,759 --> 01:36:16,428 THIS IS DON MUTI. 1829 01:36:16,428 --> 01:36:19,731 IT LOOKS POSITIVE IN TERMS OF 1830 01:36:19,731 --> 01:36:20,098 REPRESENTATION. 1831 01:36:20,098 --> 01:36:23,502 ONE THOUGHT I HAD AS I WAS 1832 01:36:23,502 --> 01:36:25,337 READING AND HEARING YOUR 1833 01:36:25,337 --> 01:36:26,505 PRESENTATION IT REMINDED ME OF 1834 01:36:26,505 --> 01:36:28,006 WHAT DR. CHANG WAS SAYING EARLY 1835 01:36:28,006 --> 01:36:33,612 ON WHEN HE WAS DESCRIBING NIH 1836 01:36:33,612 --> 01:36:34,613 DIRECTOR'S PRIORITIES FOR 1837 01:36:34,613 --> 01:36:40,118 GENERALIZABILITY. 1838 01:36:40,118 --> 01:36:42,053 SOMETIMES VOCABULARY MATTERS AND 1839 01:36:42,053 --> 01:36:45,423 WORD CHOICE MATTERS AND IF 1840 01:36:45,423 --> 01:36:46,057 DIVERSITY, EQUITY AND INCLUSION 1841 01:36:46,057 --> 01:36:48,693 HAVE BECOME POLITICAL CRY 1842 01:36:48,693 --> 01:36:55,433 CHARGED, GENERALIZABILITY LOOKS 1843 01:36:55,433 --> 01:36:58,837 LIKE THIS UNIVERSAL SCIENTIFIC 1844 01:36:58,837 --> 01:37:09,314 VALUE THAT IS -- IS NOT A 1845 01:37:13,118 --> 01:37:15,620 POLITICAL WORD AND HAVE 1846 01:37:15,620 --> 01:37:18,456 EFFECTIVE SCIENTIFIC RESEARCH 1847 01:37:18,456 --> 01:37:27,532 BUT MAYBE AVOID VOCABULARY THAT 1848 01:37:27,532 --> 01:37:28,333 MIGHT BE PROBLEMATIC AND 1849 01:37:28,333 --> 01:37:30,602 STRIVING FOR GENERALIZABILITY 1850 01:37:30,602 --> 01:37:34,239 AND THE USE OF THE WORD 1851 01:37:34,239 --> 01:37:36,441 GENERALIZABILITY MAY BE A GOOD 1852 01:37:36,441 --> 01:37:38,510 VOCABULARY SUBSTITUTION THAT 1853 01:37:38,510 --> 01:37:40,345 DOESN'T CREATE PROBLEMS BUT 1854 01:37:40,345 --> 01:37:44,449 STILL MAINTAINS THE VALUE OF OUR 1855 01:37:44,449 --> 01:37:50,655 SCIENCE. 1856 01:37:50,655 --> 01:37:52,057 >> DON, THANK YOU FOR MAKING 1857 01:37:52,057 --> 01:37:52,457 THOSE POINTS. 1858 01:37:52,457 --> 01:38:00,432 GREAT POINTS. 1859 01:38:00,432 --> 01:38:10,976 OPEN FOR MEANT PEOPLE MAY HAVE. 1860 01:38:14,579 --> 01:38:16,948 >> THANK YOU FOR GOING THROUGH 1861 01:38:16,948 --> 01:38:20,452 THE WONDERFUL VAST AND 1862 01:38:20,452 --> 01:38:23,722 INCREDIBLY BREADTH OF JUST THE 1863 01:38:23,722 --> 01:38:34,232 BREADTH OF WHAT NEI IS DOING. 1864 01:38:38,370 --> 01:38:41,172 I WISH WE COULD EXPAND THE 1865 01:38:41,172 --> 01:38:43,808 MISSION AS A COLLEGIAL GROUP OF 1866 01:38:43,808 --> 01:38:46,344 INVESTIGATORS AND OTHER 1867 01:38:46,344 --> 01:38:48,346 INDIVIDUALS JUST TRYING TO 1868 01:38:48,346 --> 01:38:50,048 MAINTAIN A VERY HIGH LEVEL OF 1869 01:38:50,048 --> 01:38:51,249 VISION SCIENCE. 1870 01:38:51,249 --> 01:38:55,253 AND I WAS JUST -- EVERY TIME YOU 1871 01:38:55,253 --> 01:38:58,323 PRESENT I'M JUST SO IN AWE OF 1872 01:38:58,323 --> 01:39:02,327 THE BREADTH OF THE WORK AND THE 1873 01:39:02,327 --> 01:39:04,329 TALENT OF THE INVESTIGATORS AND 1874 01:39:04,329 --> 01:39:11,636 I WISH THERE WAS SO WAY A.I. 1875 01:39:11,636 --> 01:39:13,238 COULD BRING OUT HOW SPECIAL WE 1876 01:39:13,238 --> 01:39:17,876 ARE AND THE INSTITUTE IS AND THE 1877 01:39:17,876 --> 01:39:18,510 INDIVI 1878 01:39:18,510 --> 01:39:19,077 INDIVIDUALITY NEEDS TO BE 1879 01:39:19,077 --> 01:39:22,113 MAINTAINED TO CONTINUE THE HIGH 1880 01:39:22,113 --> 01:39:24,616 LEVEL OF EXCELLENCE. 1881 01:39:24,616 --> 01:39:26,484 I THINK WE ALL NEED TO BE PART 1882 01:39:26,484 --> 01:39:26,818 OF SOMETHING. 1883 01:39:26,818 --> 01:39:28,219 NO MATTER WHO WE ARE, WHAT WE 1884 01:39:28,219 --> 01:39:33,124 ARE, WE NEED TO HAVE A COHORT OF 1885 01:39:33,124 --> 01:39:36,328 OUR OWN AND I THINK SOMETIMES 1886 01:39:36,328 --> 01:39:39,497 THE WAY WE PROCEED TO ALL THE 1887 01:39:39,497 --> 01:39:42,767 DIFFICULT TIMES UP AND DOWN IT'S 1888 01:39:42,767 --> 01:39:47,906 OUR GROUP OF COLLEAGUES AND 1889 01:39:47,906 --> 01:39:48,406 STUDENTS. 1890 01:39:48,406 --> 01:39:49,808 IT'S A WIDE NET BUT WE'RE ALL 1891 01:39:49,808 --> 01:39:51,343 PART OF SOMETHING REALLY UNIQUE. 1892 01:39:51,343 --> 01:39:57,349 I JUST REALLY HOPE THAT WE COULD 1893 01:39:57,349 --> 01:40:04,489 SHOUM -- EXTEND THE MESSAGE OUT 1894 01:40:04,489 --> 01:40:06,124 AND I THIS WERE HARD QUESTIONS I 1895 01:40:06,124 --> 01:40:08,660 WAS AFRAID TO ASK. 1896 01:40:08,660 --> 01:40:10,328 SO I'M GLAD HE ASKED THEM AND I 1897 01:40:10,328 --> 01:40:13,431 WANT TO REITERATE. 1898 01:40:13,431 --> 01:40:18,570 I'M SO I THINK WE HAVE SO MUCH 1899 01:40:18,570 --> 01:40:21,873 TO BE PROUD OF AND SHOULD BE 1900 01:40:21,873 --> 01:40:27,345 ABLE TO TELL THE WORLD AND MAYBE 1901 01:40:27,345 --> 01:40:28,513 MAINTAIN OUR INDIVIDUALITY AS AN 1902 01:40:28,513 --> 01:40:28,780 INSTITUTE. 1903 01:40:28,780 --> 01:40:29,280 THAT'S ALL. 1904 01:40:29,280 --> 01:40:30,515 I WANTED TO THANK YOU BECAUSE I 1905 01:40:30,515 --> 01:40:34,319 KNOW THAT WAS A LOT OF WORK TO 1906 01:40:34,319 --> 01:40:39,624 PREPARE AND ESPECIALLY NOW DOING 1907 01:40:39,624 --> 01:40:40,425 AN EXCELLENT JOB OF HIGHLIGHTING 1908 01:40:40,425 --> 01:40:44,396 KEY AREAS. 1909 01:40:44,396 --> 01:40:45,397 I HOPE OTHER IMPORTANT PEOPLE 1910 01:40:45,397 --> 01:40:46,998 THAT MAKE DECISIONS CAN HAVE 1911 01:40:46,998 --> 01:40:49,834 ACCESS TO THAT KIND OF 1912 01:40:49,834 --> 01:40:50,935 INFORMATION BECAUSE THEY HAVE 1913 01:40:50,935 --> 01:40:52,170 ACCESS BUT WHETHER THEY READ IT 1914 01:40:52,170 --> 01:40:56,441 OR ARE AWARE OF IT, I THINK THAT 1915 01:40:56,441 --> 01:41:03,314 WOULD HELP OUR CAUSE. 1916 01:41:03,314 --> 01:41:04,816 >> THANKS FOR SAYING ALL THE 1917 01:41:04,816 --> 01:41:07,385 THINGS YOU SAID. 1918 01:41:07,385 --> 01:41:10,855 I GUESS PART OF PARTLY THE WAY 1919 01:41:10,855 --> 01:41:15,960 I'LL START MY REBOUSPONSE IS 1920 01:41:15,960 --> 01:41:17,729 OBVIOUSLY THERE ARE SOME THINGS 1921 01:41:17,729 --> 01:41:25,570 DISH CANNOT OWE PINE ABOUT WHAT 1922 01:41:25,570 --> 01:41:27,005 I THINK IS ABOUT PENDING 1923 01:41:27,005 --> 01:41:28,273 LEGISLATION BUT MY JOB IS TO DO 1924 01:41:28,273 --> 01:41:32,577 THE BEST JOB WE CAN DO WITH THE 1925 01:41:32,577 --> 01:41:34,412 SITUATION WE'RE IN AND THE 1926 01:41:34,412 --> 01:41:43,288 RESOURCE THAT WE HAVE. 1927 01:41:43,288 --> 01:41:46,291 AS WE SAID, I'M PROUD WE'VE BEEN 1928 01:41:46,291 --> 01:41:47,492 TRYING DO THAT AND I THINK WE'VE 1929 01:41:47,492 --> 01:41:57,836 DONE IT REALLY WELL. 1930 01:42:00,472 --> 01:42:01,940 MARIA, GETTING TO THE POINTS YOU 1931 01:42:01,940 --> 01:42:04,042 MADE AND FOLLOWING ON THEM. 1932 01:42:04,042 --> 01:42:05,910 ONE THING I'VE TRIED TO DO IS 1933 01:42:05,910 --> 01:42:07,645 HAVE A GROUP AND INSTITUTE 1934 01:42:07,645 --> 01:42:10,415 THAT'S MISSION ORIENTED AND 1935 01:42:10,415 --> 01:42:12,350 FOCUSSED AROUND THE STRATEGIC 1936 01:42:12,350 --> 01:42:14,586 PLAN. 1937 01:42:14,586 --> 01:42:16,721 YOU ALL KNOW THIS AND THE WAY I 1938 01:42:16,721 --> 01:42:20,425 PHRASED IT TO OUR LEADERSHIP IS 1939 01:42:20,425 --> 01:42:26,231 THAT WE TALK ABOUT THE MISSION 1940 01:42:26,231 --> 01:42:30,135 ALL THE TIME AND FOCUS ON THE 1941 01:42:30,135 --> 01:42:30,969 INITIATIVES FROM A STRATEGIC 1942 01:42:30,969 --> 01:42:36,207 PLANNING PROCESS WITHIN THE 1943 01:42:36,207 --> 01:42:36,808 FIRST YEAR AND PUBLISHED IT A 1944 01:42:36,808 --> 01:42:37,275 YEAR AFTER I STARTED. 1945 01:42:37,275 --> 01:42:37,942 AND WE'VE BEEN TRYING TO CHECK 1946 01:42:37,942 --> 01:42:38,309 OFF THINGS. 1947 01:42:38,309 --> 01:42:39,844 OF COURSE IT EVOLVES OVER TIME 1948 01:42:39,844 --> 01:42:44,449 AND WE HAVE A GREAT GROUP OF 1949 01:42:44,449 --> 01:42:48,586 STAFF PROGRAM OFFICERS AND 1950 01:42:48,586 --> 01:42:50,355 INTRAMURAL PEOPLE IN HOW DO WE 1951 01:42:50,355 --> 01:42:53,525 BEST MEET OUR MISSION AND 1952 01:42:53,525 --> 01:43:03,801 ACHIEVE THE CURRENT SUB STAN -- 1953 01:43:03,801 --> 01:43:04,769 SUBSTANTIATION OF WHAT WE WANT 1954 01:43:04,769 --> 01:43:06,437 TO DO WITH THE STRATEGIC PLAN 1955 01:43:06,437 --> 01:43:08,640 AND THAT'S HOW WE RUN A GOOD 1956 01:43:08,640 --> 01:43:08,973 ORGANIZATION. 1957 01:43:08,973 --> 01:43:10,875 TO THE COHORT CONCEPT YOU GAVE, 1958 01:43:10,875 --> 01:43:13,077 MARIA, I THINK ONE OF THE THINGS 1959 01:43:13,077 --> 01:43:17,415 I LOVE ABOUT THIS FIELD IS THAT 1960 01:43:17,415 --> 01:43:19,517 IN MY ASSESSMENT I AGREE WITH 1961 01:43:19,517 --> 01:43:22,287 YOU THAT WE'RE SMALL ENOUGH THAT 1962 01:43:22,287 --> 01:43:24,222 EVERYBODY KNOWS -- WE KNOW ALL 1963 01:43:24,222 --> 01:43:25,823 THE KEY -- WE GIVE THESE PEOPLE, 1964 01:43:25,823 --> 01:43:28,059 THESE AWARDS AND THE DIFFERENT 1965 01:43:28,059 --> 01:43:28,626 THINGS WE KNOW THESE PEOPLE 1966 01:43:28,626 --> 01:43:33,965 WITHIN THE COMMUNITY. 1967 01:43:33,965 --> 01:43:35,767 ONE OF THEY WILL PEOPLE THAT 1968 01:43:35,767 --> 01:43:37,235 USED TO BE ON THE COUNCIL, CHRIS 1969 01:43:37,235 --> 01:43:41,573 VAN GELDER WE WERE IN A MEETING 1970 01:43:41,573 --> 01:43:43,441 A YEAR AGO AND RUSS MADE THE 1971 01:43:43,441 --> 01:43:44,709 COMMENT AND I DON'T REMEMBER THE 1972 01:43:44,709 --> 01:43:46,311 EXACT NUMBER BUT IF YOU WERE 1973 01:43:46,311 --> 01:43:48,680 JUST TO LOOK AT OPHTHALMOLOGISTS 1974 01:43:48,680 --> 01:43:51,316 THERE'S 500 OR 600 PER YEAR THAT 1975 01:43:51,316 --> 01:43:54,219 GO INTO THE WORKFORCE AND THAT'S 1976 01:43:54,219 --> 01:43:57,722 BASICALLY A LARGE HIGH SCHOOL. 1977 01:43:57,722 --> 01:44:06,831 SO WE KNOW -- AND WE CAN DO 1978 01:44:06,831 --> 01:44:07,765 STRATEGIC PLANNING AND EVERYONE 1979 01:44:07,765 --> 01:44:10,101 CAN WORK TOGETHER AND THE 1980 01:44:10,101 --> 01:44:12,036 CONCEPT OF THE WHOLE BEING 1981 01:44:12,036 --> 01:44:16,407 GREATER THAN THE SUM OF THE 1982 01:44:16,407 --> 01:44:20,445 PARTS, WE ALL TALK ABOUT IT. 1983 01:44:20,445 --> 01:44:23,615 CANDIDLY, MARIA, WE NEED TO LOOK 1984 01:44:23,615 --> 01:44:25,850 IN THE MIRROR AND IS THE WHOLE 1985 01:44:25,850 --> 01:44:27,619 REALLY GREATER THAN THE SUM OF 1986 01:44:27,619 --> 01:44:29,020 THE PARTS? 1987 01:44:29,020 --> 01:44:32,490 DO WE HAVE PARTS SCATTERED. 1988 01:44:32,490 --> 01:44:35,226 MY ASPIRATION HAS ALWAYS BEEN TO 1989 01:44:35,226 --> 01:44:38,496 CREATE AN ECO SYSTEM WHERE THE 1990 01:44:38,496 --> 01:44:39,530 WHOLE REALLY IS GREATER THAN THE 1991 01:44:39,530 --> 01:44:42,634 SUM OF THE PARTS AND DO THAT 1992 01:44:42,634 --> 01:44:44,002 WITH TEAM SCIENCE AND 1993 01:44:44,002 --> 01:44:47,705 COLLABORATIONS THAT MEANS NEW 1994 01:44:47,705 --> 01:44:51,776 INCENTIVES AND IS THE COMMUNITY 1995 01:44:51,776 --> 01:44:54,212 WE HAVE CAN PILOT THOSE THINGS 1996 01:44:54,212 --> 01:44:55,146 AND STARTED DOING IT. 1997 01:44:55,146 --> 01:44:57,148 THOSE ARE -- AT THE SAME TIME 1998 01:44:57,148 --> 01:44:58,182 WHILE BEING SMALL ENOUGH TO DO 1999 01:44:58,182 --> 01:45:01,919 THAT, I THINK WE WORK IN A 2000 01:45:01,919 --> 01:45:02,720 PROBLEM VISION THAT'S IMPORTANT 2001 01:45:02,720 --> 01:45:05,156 ENOUGH AND BIG ENOUGH THAT IT 2002 01:45:05,156 --> 01:45:08,126 MAKES A DIFFERENCE AT SCALE. 2003 01:45:08,126 --> 01:45:09,227 PEOPLE WILL NOTICE I HOPE WHAT 2004 01:45:09,227 --> 01:45:10,495 THE COMMUNITY DOES BECAUSE WE 2005 01:45:10,495 --> 01:45:14,032 WANT TO SOLVE PROBLEMS THAT ARE 2006 01:45:14,032 --> 01:45:15,400 IMPORTANT TO AMERICANS. 2007 01:45:15,400 --> 01:45:19,070 SO THOSE ARE SOME OF MY 2008 01:45:19,070 --> 01:45:22,440 REACTIONS TO WHAT YOU SAID ABOUT 2009 01:45:22,440 --> 01:45:24,509 BEING -- I GUESS YOUR WORD WAS 2010 01:45:24,509 --> 01:45:28,479 BEING SPECIAL AND A COHORT OF 2011 01:45:28,479 --> 01:45:29,681 OUR OWN. 2012 01:45:29,681 --> 01:45:31,849 COMING UP WITH WAYS TO PROVE WE 2013 01:45:31,849 --> 01:45:33,017 CAN HAVE A WHOLE THAT'S GREATER 2014 01:45:33,017 --> 01:45:41,192 THAN THE SUM OF ITS PARTS. 2015 01:45:41,192 --> 01:45:43,628 THANK YOU FOR RAISING THAT. 2016 01:45:43,628 --> 01:45:43,795 DON. 2017 01:45:43,795 --> 01:45:44,529 >> SPECIAL HITS ME AS A KEY WORD 2018 01:45:44,529 --> 01:45:51,969 HERE. 2019 01:45:51,969 --> 01:45:53,604 I'VE APPRECIATED YOUR TOPIC ON 2020 01:45:53,604 --> 01:45:56,574 THE FOUNDING NEI AND WHY IT'S A 2021 01:45:56,574 --> 01:45:59,344 SEPARATE INSTITUTE. 2022 01:45:59,344 --> 01:46:01,713 I THINK THE INSTITUTE IS SPECIAL 2023 01:46:01,713 --> 01:46:03,381 BECAUSE VISION IS SPECIAL. 2024 01:46:03,381 --> 01:46:07,118 WE LOVE BEING A PART OF VISION 2025 01:46:07,118 --> 01:46:10,488 RESEARCH BECAUSE OF HOW HIGHLY 2026 01:46:10,488 --> 01:46:16,060 WE PRIZE VISION. 2027 01:46:16,060 --> 01:46:17,495 YOU MENTIONED PEOPLE'S CONCERN 2028 01:46:17,495 --> 01:46:20,631 ABOUT BLINDING EYE DISEASE AS 2029 01:46:20,631 --> 01:46:24,102 BEING AS STRONG AS BEING 2030 01:46:24,102 --> 01:46:28,439 AFFECTED BY ANY NUMBER OR ANY 2031 01:46:28,439 --> 01:46:34,612 OTHER DISEASES AND I DON'T THINK 2032 01:46:34,612 --> 01:46:36,447 THAT'S GONE AWAY. 2033 01:46:36,447 --> 01:46:40,885 WHAT WAS TRUE IN 1968 IS AS TRUE 2034 01:46:40,885 --> 01:46:46,224 THEN AS IT IS TODAY VISION 2035 01:46:46,224 --> 01:46:47,692 RESEARCH IS UNIQUE BECAUSE 2036 01:46:47,692 --> 01:46:50,962 VISION IS A UNIQUE SENSE AND 2037 01:46:50,962 --> 01:46:53,231 WOULD HATE TO SEE ANY DILUTION 2038 01:46:53,231 --> 01:46:57,969 OF WHAT HAS BEEN A SUPERB EFFORT 2039 01:46:57,969 --> 01:47:01,339 OVER THE LAST 50 SOME YEARS. 2040 01:47:01,339 --> 01:47:04,242 THINKING BACK TO 1968 IT MAY BE 2041 01:47:04,242 --> 01:47:05,510 ONE OF THE BEST THINGS TO COME 2042 01:47:05,510 --> 01:47:07,412 OUT OF THAT YEAR IS A 2043 01:47:07,412 --> 01:47:08,713 RECOGNITION THAT VISION RESEARCH 2044 01:47:08,713 --> 01:47:16,521 SHOULD BE A SEPARATE INSTITUTE. 2045 01:47:16,521 --> 01:47:26,164 >> THANKS FOR THAT COMMENT. 2046 01:47:26,164 --> 01:47:28,433 >> WELL, I'LL DO ONE LAST CALL 2047 01:47:28,433 --> 01:47:30,902 AND HAPPY TO END IT HERE IF YOU 2048 01:47:30,902 --> 01:47:32,170 FEEL IT'S A GOOD POINT TO STOP 2049 01:47:32,170 --> 01:47:34,705 IT AND TURN IT BACK TO ANNA. 2050 01:47:34,705 --> 01:47:38,309 GREAT, ANNA, BACK TO YOU AND 2051 01:47:38,309 --> 01:47:39,010 THANK YOU TO EVERYONE. 2052 01:47:39,010 --> 01:47:40,378 >> THANK YOU, THIS WITH US 2053 01:47:40,378 --> 01:47:40,578 GREAT. 2054 01:47:40,578 --> 01:47:41,946 BEFORE WE CLOSE TODAY, IF YOU 2055 01:47:41,946 --> 01:47:43,381 HAVE ANY IDEAS FOR TOPICS YOU 2056 01:47:43,381 --> 01:47:44,715 WOULD LIKE FOR US TO COVER IN 2057 01:47:44,715 --> 01:47:46,317 THE FUTURE MEETINGS ESPECIALLY 2058 01:47:46,317 --> 01:47:47,819 WE HAVE ONE COMING UP IN 2059 01:47:47,819 --> 01:47:48,686 OCTOBER, IF THERE'S SOMETHING 2060 01:47:48,686 --> 01:47:50,922 YOU WOULD LIKE TO LEARN MORE 2061 01:47:50,922 --> 01:47:52,623 ABOUT, PLEASE DON'T HESITATE TO 2062 01:47:52,623 --> 01:47:54,225 LET US KNOW, CONTACT US. 2063 01:47:54,225 --> 01:47:56,461 SO RIGHT NOW WE HAVE A SLIGHT 2064 01:47:56,461 --> 01:47:57,895 CHANGE FROM THE AGENDA. 2065 01:47:57,895 --> 01:47:59,764 WE'RE NOW GOING TO TRANSITION 2066 01:47:59,764 --> 01:48:01,265 SINCE WE'RE AHEAD A LITTLE BIT 2067 01:48:01,265 --> 01:48:02,733 DIRECTLY TO THE CLOSED SESSION. 2068 01:48:02,733 --> 01:48:04,802 SO THOSE JOINING THE CLOSED 2069 01:48:04,802 --> 01:48:10,541 SESSION, COUNCIL MEMBERS, OD AND 2070 01:48:10,541 --> 01:48:12,877 NEA EXTRAMURAL STAFF LOG OFF 2071 01:48:12,877 --> 01:48:15,480 THIS SESSION AND USE THE CLOSED 2072 01:48:15,480 --> 01:48:17,715 SESSION LINK AND AGAIN, LOG OFF, 2073 01:48:17,715 --> 01:48:18,950 REJOIN IN THE CLOSED SESSION 2074 01:48:18,950 --> 01:48:19,250 LINK. 2075 01:48:19,250 --> 01:48:22,053 I'LL SEE YOU OVER ON THE CLOSED 2076 01:48:22,053 --> 01:48:22,386 SESSION SIDE. 2077 01:48:22,386 --> 01:48:23,988 FOR THE REST OF YOU, THANK YOU 2078 01:48:23,988 --> 01:48:25,656 ALL OF YOU, FOR JOINING TODAY. 2079 01:48:25,656 --> 01:48:27,358 WE REALLY APPRECIATE IT AND 2080 01:48:27,358 --> 01:48:28,426 HOPEFULLY WE WILL SEE YOU BACK 2081 01:48:28,426 --> 01:48:31,329 IN OCTOBER. 2082 01:48:31,329 --> 01:48:32,897 >> AND BEFORE EVERYONE SIGNS OFF 2083 01:48:32,897 --> 01:48:36,133 I WANT TO GIVE YOU AND NATHAN A 2084 01:48:36,133 --> 01:48:37,835 SHOUT OUT FOR PUTTING THIS 2085 01:48:37,835 --> 01:48:40,471 TOGETHER BECAUSE NATHAN HAS 2086 01:48:40,471 --> 01:48:47,345 ALWAYS DONE AN AWESOME JOB WITH 2087 01:48:47,345 --> 01:48:49,380 COORDINATING THIS AND CONNECTING 2088 01:48:49,380 --> 01:48:53,417 ALL THE DOTS. 2089 01:48:53,417 --> 01:48:57,655 NATHAN'S DOING IT IN A 2090 01:48:57,655 --> 01:48:58,289 CHALLENGING CIRCUMSTANCE 2091 01:48:58,289 --> 01:48:59,991 CONVERTING VIRTUAL AND ANNA YOU 2092 01:48:59,991 --> 01:49:01,726 HAVE DONE A GREAT JOB TODAY OF 2093 01:49:01,726 --> 01:49:02,627 PUTTING THIS TOGETHER AND TALK 2094 01:49:02,627 --> 01:49:04,428 ABOUT 0 TO 60 AND THE TIME YOU 2095 01:49:04,428 --> 01:49:08,766 HAD TO GO FROM 0 TO 60 WAS VERY 2096 01:49:08,766 --> 01:49:09,033 SHORT. 2097 01:49:09,033 --> 01:49:11,002 AND I WANTED TO MAKE SURE PEOPLE 2098 01:49:11,002 --> 01:49:13,638 KNOW THAT PUBLICALLY SO WITH 2099 01:49:13,638 --> 01:49:14,972 THAT I'LL FINISH IN SAYING WHAT 2100 01:49:14,972 --> 01:49:16,541 YOU SAID, THANK YOU TO EVERYONE. 2101 01:49:16,541 --> 01:49:18,409 WE'LL SEE YOU ON THE CLOSED 2102 01:49:18,409 --> 01:49:20,645 SESSION SIDE FOR THOSE JOINING. 2103 01:49:20,645 --> 01:49:21,312 OKAY. 2104 01:49:21,312 --> 01:49:21,913 ANNA, NATHAN, THANKS AGAIN. 2105 01:49:21,913 --> 01:49:22,480